<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6562586</article-id><article-id pub-id-type="doi">10.3390/md17050282</article-id><article-id pub-id-type="publisher-id">marinedrugs-17-00282</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Oceans as a Source of Immunotherapy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ahmad</surname><given-names>Bilal</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Masaud</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5920-7848</contrib-id><name><surname>Choi</surname><given-names>Sangdun</given-names></name><xref rid="c1-marinedrugs-17-00282" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-marinedrugs-17-00282">Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea; <email>bilalpharma77@gmail.com</email> (B.A.); <email>masaudghalib@hotmail.com</email> (M.S.)</aff><author-notes><corresp id="c1-marinedrugs-17-00282"><label>*</label>Correspondence: <email>sangdunchoi@ajou.ac.kr</email>; Tel.: +82-312192600</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><volume>17</volume><issue>5</issue><elocation-id>282</elocation-id><history><date date-type="received"><day>30</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>06</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Marine flora is taxonomically diverse, biologically active, and chemically unique. It is an excellent resource, which offers great opportunities for the discovery of new biopharmaceuticals such as immunomodulators and drugs targeting cancerous, inflammatory, microbial, and fungal diseases. The ability of some marine molecules to mediate specific inhibitory activities has been demonstrated in a range of cellular processes, including apoptosis, angiogenesis, and cell migration and adhesion. Immunomodulators have been shown to have significant therapeutic effects on immune-mediated diseases, but the search for safe and effective immunotherapies for other diseases such as sinusitis, atopic dermatitis, rheumatoid arthritis, asthma and allergies is ongoing. This review focuses on the marine-originated bioactive molecules with immunomodulatory potential, with a particular focus on the molecular mechanisms of specific agents with respect to their targets. It also addresses the commercial utilization of these compounds for possible drug improvement using metabolic engineering and genomics.</p></abstract><kwd-group><kwd>immunotherapy</kwd><kwd>inflammation</kwd><kwd>marine drug</kwd><kwd>marine flora</kwd><kwd>Toll-like receptor</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-marinedrugs-17-00282"><title>1. Introduction</title><p>Immune system dysfunction leads to the development of allergies, autoimmune and chronic inflammatory diseases, and cancers. Inflammation has been suggested to be the principal cause of chronic illnesses such as obesity, diabetes, cancer, rheumatoid arthritis (RA), neurodegenerative, and autoimmune diseases (ADs). The hallmark of autoimmunity is chronic inflammation that leads to the release of pro-inflammatory cytokines and other mediators, known as danger-associated molecular patterns (DAMPS), that activate pathogen recognition receptors (PRR) expressed by immune cells. Autoantibodies recognize these DAMPs and activate myeloid immune cells with an enhanced inflammatory response, leading to exacerbation of the condition. This self-perpetuating cycle continues, in order to assist with injury repair [<xref rid="B1-marinedrugs-17-00282" ref-type="bibr">1</xref>,<xref rid="B2-marinedrugs-17-00282" ref-type="bibr">2</xref>,<xref rid="B3-marinedrugs-17-00282" ref-type="bibr">3</xref>].</p><p>Recent estimates suggest that 7.6&#x02013;9.4% of the world&#x02019;s population is affected by immune-mediated diseases. Such diseases include inflammatory bowel disease (IBD), type 1 diabetes mellitus (TIDM), and RA. Women are up to ten times as likely to be sufferers as men [<xref rid="B4-marinedrugs-17-00282" ref-type="bibr">4</xref>]. ADs are among the ten leading causes of death for women, and affect them disproportionately in every age group up to 75 years of age [<xref rid="B5-marinedrugs-17-00282" ref-type="bibr">5</xref>]. According to the NIH report, around 23.5 million Americans have ADs, while the American Autoimmune Related Diseases Association (AARDA) puts this figure at 50 million. More than 80 different ADs have been identified and 40 additional diseases are suspected as being ADs [<xref rid="B6-marinedrugs-17-00282" ref-type="bibr">6</xref>,<xref rid="B7-marinedrugs-17-00282" ref-type="bibr">7</xref>]. The holy grail of immunotherapy is the reprograming of the immune system to maintain or restore homeostasis, and there is an urgent need to develop such drugs.</p><p>The search for novel immunomodulators is challenging, despite the existence of considerable amounts of demographic and epidemiological data about ADs. Questions about how autoimmunity is triggered and how self-tolerance is broken down remain to be fully answered. Nevertheless, progression in our understanding of the pathophysiology of ADs has led to the possibility of identifying new drug targets and new effective compounds with significant therapeutic potential. Several drug discovery and development programs are focused on the search for bioactive compounds obtained from natural sources. The study of nature&#x02019;s enormous arsenal of new bioactive compounds and natural metabolites has historically led to immense benefits with respect to drug discovery [<xref rid="B8-marinedrugs-17-00282" ref-type="bibr">8</xref>]. The bioactivity of marine-derived natural products is significantly higher than that of compounds of terrestrial origin. For instance, in a National Cancer Institute preclinical cytotoxicity screen, approximately 1% of the marine samples tested showed anti-tumor potential in comparison with 0.1% of the terrestrial samples tested [<xref rid="B9-marinedrugs-17-00282" ref-type="bibr">9</xref>].</p><p>Oceans cover three quarters of the Earth&#x02019;s surface, and contain the world&#x02019;s greatest biodiversity, with at least 300,000 species of animals and plants described to date [<xref rid="B10-marinedrugs-17-00282" ref-type="bibr">10</xref>,<xref rid="B11-marinedrugs-17-00282" ref-type="bibr">11</xref>]. The diverse environments of oceanic zones provide a rich source of organisms. The hostile and competitive oceanic environment, with its high salt concentration and variations in hydrostatic pressure, produces microorganisms which are resistant to various kinds of stress, leading to the production of unique biomolecules. This enormous source of marine microorganisms has been exploited as a source of medicine since ancient times. The oceans are an exceptional storehouse of structurally and chemically novel bioactive compounds with unique biological features that are not generally found in terrestrial natural products. Over 60% of the active compounds of marketed formulations are natural products or their synthetic derivatives or mimics [<xref rid="B12-marinedrugs-17-00282" ref-type="bibr">12</xref>]. Nearly 3000 new compounds from marine sources have been identified over the last few years, and some have entered clinical trials [<xref rid="B13-marinedrugs-17-00282" ref-type="bibr">13</xref>]. Due to improved technologies for deep-sea sample collection and large-scale drug production through aquaculture and drug synthesis, the extent of this activity has been increasing steadily. Advanced engineering and the use of new technologies such as scuba diving techniques, remotely operated vehicles (ROVs) and manned submersibles have opened up the scientific exploration of the marine environment [<xref rid="B14-marinedrugs-17-00282" ref-type="bibr">14</xref>,<xref rid="B15-marinedrugs-17-00282" ref-type="bibr">15</xref>,<xref rid="B16-marinedrugs-17-00282" ref-type="bibr">16</xref>]. </p><p>Marine compounds have been shown to have significant activity in antiviral, analgesic, antitumor, immunomodulatory, and anti-inflammatory assays [<xref rid="B17-marinedrugs-17-00282" ref-type="bibr">17</xref>,<xref rid="B18-marinedrugs-17-00282" ref-type="bibr">18</xref>]. Currently, six out of nine drugs in the market for cancer treatment are of marine origin, while several more are under clinical trials [<xref rid="B18-marinedrugs-17-00282" ref-type="bibr">18</xref>]. Undoubtedly, in the area of cancer, the marine metabolic arsenal plays a dominant role. </p></sec><sec id="sec2-marinedrugs-17-00282"><title>2. Oceanic Sources of Immunotherapy</title><p>Immunotherapies induce, enhance or suppress an immune response to ameliorate a pathological condition. Immune response activation therapies are used in vaccines for conditions such as cancer, while immune response suppression therapies can be used to prevent graft rejection and treat autoimmune conditions and allergies. The metabolic products of microbes, phytoplankton, and zooplanktons obtained from marine environments offer a great diversity of physical and chemical attributes. Exploitation of marine microorganisms, which are the source of new genes, has led to the discovery of new drugs and targets. </p><sec id="sec2dot1-marinedrugs-17-00282"><title>2.1. Oceanic Bacteria</title><p>Marine bacteria synthesize a wide range of valuable compounds with potential pharmaceutical applications [<xref rid="B19-marinedrugs-17-00282" ref-type="bibr">19</xref>,<xref rid="B20-marinedrugs-17-00282" ref-type="bibr">20</xref>]. Bacteria have yielded novel anti-inflammatory agents such as pseudopterosins, topsentins, scytonemin, and manoalide, anticancer and immunomodulatory agents including sarcodictylin eleutherobin, bryostatins and discodermolide, and antibiotics like marinone. Lactobacilli stimulate and modulate the mucosal immune system by reducing the production of pro-inflammatory cytokines through their actions on nuclear factor-<italic>&#x003ba;</italic>B (NF-<italic>&#x003ba;</italic>B) pathways. This effect is mediated by the production of anti-inflammatory cytokine interleukin-10 (IL-10) and host defense peptide <italic>&#x003b2;</italic>&#x02013;defensin 2. The production of immunoglobulin A (IgA), dendritic cell maturation, and cell apoptosis is enhanced in response to short chain fatty acids [<xref rid="B21-marinedrugs-17-00282" ref-type="bibr">21</xref>]. Three diketopiperazine derivatives, cyclo(L-Pro-D-Val), cyclo(L-Pro-L-Tyr), and cyclo(L-pro-D-Leu), have been derived from two marine bacteria, <italic>Bacillus</italic> sp. HC001 and <italic>Piscicoccus</italic> sp. 12L081. These compounds show anti-inflammatory effects by suppressing polyphosphate mediated septic responses and hyper-permeability through the inhibition of p38 mitogen-activated protein kinases (MAPKs) activation. Downregulation of tumor necrosis factor (TNF-<italic>&#x003b1;</italic>), IL-6, NF-<italic>&#x003ba;</italic>B and ERK1/2 was also observed after administration of these three compounds [<xref rid="B22-marinedrugs-17-00282" ref-type="bibr">22</xref>]. A novel exopolysaccharide (EPS) EPS1-T14, a water-soluble non-toxic exopolymer obtained from the marine bacterium <italic>Bacillus licheniformis</italic>, is able to stimulate an immune response. EPS1-T14 exhibits antiviral activity, as it inhibits the replication of HSV-2 in human peripheral blood mononuclear cells (hPBMCs). EPS1-T14 also stimulates the Th1 cell-mediated immune response [<xref rid="B23-marinedrugs-17-00282" ref-type="bibr">23</xref>]. Another EPS, TA-1, isolated from the thermophilic marine bacterium, <italic>Thermus aquaticus,</italic> is the strongest candidate for the EPS-binding receptor such as toll-like receptors (TLRs). TA-1 stimulates the release of the proinflammatory cytokines TNF-<italic>&#x003b1;</italic> and IL-6 from murine macrophages via a TLR-2 mediated pathway [<xref rid="B24-marinedrugs-17-00282" ref-type="bibr">24</xref>]. Prodigiosin (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>1</bold>) derived from marine bacteria such as <italic>Pseudoalteromonas denitrificans, Vibro psychroerythru</italic>s, and <italic>Serratia marcescens,</italic> has a strong inhibitory effect on many protozoan, fungal, and bacterial species, and induces apoptosis in cancer cell lines, as observed by the development of characteristic DNA laddering and apoptotic bodies [<xref rid="B25-marinedrugs-17-00282" ref-type="bibr">25</xref>,<xref rid="B26-marinedrugs-17-00282" ref-type="bibr">26</xref>]. Cycloprodigisin, a stable analog of prodigiosin (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>1</bold>) from <italic>Pseudoalteromonas dentrificans</italic> inhibits TNF-<italic>&#x003b1;</italic> induced NF-<italic>&#x003ba;</italic>B activation, as determined through luciferase assay. This NF-<italic>&#x003ba;</italic>B-inhibitory effect of cycloprodigiosin was retained under multiple stimuli in HeLa, U373, and COS7 cell lines [<xref rid="B27-marinedrugs-17-00282" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-17-00282" ref-type="bibr">28</xref>,<xref rid="B29-marinedrugs-17-00282" ref-type="bibr">29</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine bacteria are listed in <xref rid="marinedrugs-17-00282-t001" ref-type="table">Table 1</xref>. </p></sec><sec id="sec2dot2-marinedrugs-17-00282"><title>2.2. Cyanobacteria</title><p>Cyanobacteria are a fascinating and versatile, biologically important group of bacteria. Cyanobacteria unquestionably constitute one of the richest sources of novel and existing bioactive compounds, including toxins with a wide range of pharmaceutical applications. Cyanobacteria-derived bioactive molecules have a broad spectrum of activities, including antibacterial, antiviral, protease inhibition, anticancer and immunomodulatory activity (<xref rid="marinedrugs-17-00282-t002" ref-type="table">Table 2</xref>) [<xref rid="B44-marinedrugs-17-00282" ref-type="bibr">44</xref>]. Marine cyanobacterial lipopolysaccharide (LPS) has the potential to act as a TLR4 antagonist [<xref rid="B45-marinedrugs-17-00282" ref-type="bibr">45</xref>]. A cyanobacterial LPS (CyP), isolated from <italic>Oscillatoria planktothrix</italic> FP1 shows antagonism to TLR4 activation and exhibits protective effects in inflammatory conditions. CyP acts as a potential inhibitor of the LPS-induced inflammatory response in human and mouse dendritic cells, inhibiting both the MyD88-dependent and MyD88-independent TLR4 signaling pathways. CyP completely inhibits LPS-induced IL-1<italic>&#x003b2;</italic>, TNF-<italic>&#x003b1;</italic>, and IL-8 production [<xref rid="B46-marinedrugs-17-00282" ref-type="bibr">46</xref>,<xref rid="B47-marinedrugs-17-00282" ref-type="bibr">47</xref>]. CyP, when co-incubated with <italic>Porphyromonas gingivalis</italic> LPS (Pg-LPS) inhibited IL-1<italic>&#x003b2;</italic>, IL-8, and TNF-<italic>&#x003b1;</italic> expression more efficiently than LPS. CyP can modulate the Pg-LPS-induced pro-inflammatory response, by blocking TLR4-MD2, and also by preserving miR-146a expression [<xref rid="B48-marinedrugs-17-00282" ref-type="bibr">48</xref>]. Malyngamides, a class of compounds derived from the marine cyanobacterium <italic>Lyngbya majuscula</italic> has potent anti-inflammatory activity. One compound of this class, Malyngamide F (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>2</bold>) acetate, can inhibit the production of nitric oxide (NO) and other inflammatory biomarkers in RAW 264.7 cells. It selectively inhibits the MyD88-dependent pathway, because LPS stimulation decreases IL-1<italic>&#x003b2;</italic> and increases TNF-<italic>&#x003b1;</italic> transcription in MyD88 knockout mice via an MyD88-independent pathway [<xref rid="B49-marinedrugs-17-00282" ref-type="bibr">49</xref>]. Polysaccharides that have been extracted from <italic>Arthrospira platensis</italic> (<italic>Spirulina</italic>) have been reported to exhibit immune modulation. Immulina is one of these polysaccharides, and has been reported to decrease levels of TNF-<italic>&#x003b1;</italic> and IL-4 in Fc&#x003b5;RI-activated RBL-2H3 cells [<xref rid="B50-marinedrugs-17-00282" ref-type="bibr">50</xref>,<xref rid="B51-marinedrugs-17-00282" ref-type="bibr">51</xref>]. Potent grassystatin A-C were obtained from the marine cyanobacterium <italic>Lyngbya confervoides</italic>. In response to exogenous antigen, grassystatin A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>3</bold>) significantly reduces the proliferation of T cells. Grassystatin A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>3</bold>) inhibit upregulation of IL-17 and interferon-<italic>&#x003b3;</italic> (INF-<italic>&#x003b3;</italic>) in response to antigen presentation [<xref rid="B52-marinedrugs-17-00282" ref-type="bibr">52</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine cyanobacteria are listed in <xref rid="marinedrugs-17-00282-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec2dot3-marinedrugs-17-00282"><title>2.3. Sponges </title><p>Sponges are currently the most important source of biologically active natural marine products and are considered to be a treasure trove of drugs [<xref rid="B53-marinedrugs-17-00282" ref-type="bibr">53</xref>,<xref rid="B54-marinedrugs-17-00282" ref-type="bibr">54</xref>]. Due to their lack of physical defenses, they have evolved a wide suite of defensive chemicals to deter predators [<xref rid="B55-marinedrugs-17-00282" ref-type="bibr">55</xref>]. New biomolecules discovered from marine sponges have strong immunosuppressive activities (<xref rid="marinedrugs-17-00282-t003" ref-type="table">Table 3</xref>). Didemnins, members of a depsipeptide class of compounds isolated from the Caribbean tunicate <italic>Trididemnum solidum,</italic> exhibit a variety of biological activities [<xref rid="B56-marinedrugs-17-00282" ref-type="bibr">56</xref>]. In particular, didemnin B (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>4</bold>) is characterized as immunosuppressive, and inhibits lymphocyte activation [<xref rid="B57-marinedrugs-17-00282" ref-type="bibr">57</xref>,<xref rid="B58-marinedrugs-17-00282" ref-type="bibr">58</xref>]. Target deconvolution studies, which aim to identify the molecular targets of active hits, have revealed that didemnin B (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>4</bold>) binds to the eukaryotic elongation factor 1<italic>&#x003b1;</italic> and palmitoyl-protein thioesterase 1. Large amounts of didemnin B (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>4</bold>) were taken up by proliferating cells, so this compound appears to be a promising drug for cancer treatment or the suppression of activation of the immune system [<xref rid="B59-marinedrugs-17-00282" ref-type="bibr">59</xref>].</p><p><italic>Dysidea</italic> sp. has contributed significantly to biomolecule production [<xref rid="B18-marinedrugs-17-00282" ref-type="bibr">18</xref>,<xref rid="B60-marinedrugs-17-00282" ref-type="bibr">60</xref>,<xref rid="B61-marinedrugs-17-00282" ref-type="bibr">61</xref>]. Polyoxygenated sterols derived from <italic>Dysidea</italic> sp., have been shown to have strong selective immunosuppressive capability, blocking the interaction between IL-8 and its receptor [<xref rid="B62-marinedrugs-17-00282" ref-type="bibr">62</xref>]. Pateamine A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>5</bold>) derived from <italic>Mycale</italic> sp., selectively inhibits the production of IL-2 in the T and B cells that produce the secondary immune response [<xref rid="B63-marinedrugs-17-00282" ref-type="bibr">63</xref>,<xref rid="B64-marinedrugs-17-00282" ref-type="bibr">64</xref>]. Discodermolide (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>6</bold>), a unique immunosuppressive and cytotoxic agent, is isolated from <italic>Discodermia dissolute,</italic> a deep water sponge [<xref rid="B65-marinedrugs-17-00282" ref-type="bibr">65</xref>]. An evaluation by the Longley group found that (+)-discodermolide has immunosuppressive properties at low concentrations, both in vivo and in vitro [<xref rid="B66-marinedrugs-17-00282" ref-type="bibr">66</xref>]. (+)-discodermolide was found to suppress the two-way mixed lymphocyte reaction in hPBMCs and murine splenocytes.</p><table-wrap id="marinedrugs-17-00282-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t002_Table 2</object-id><label>Table 2</label><caption><p>Marine cyanobacteria and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cyanobacteria Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Oscillatoria planktothrix</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CyP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CyP modulates pro-inflammatory effect and inhibits TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic> and IL-8.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-marinedrugs-17-00282" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lyngbya majuscula</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microcolin-A (Peptides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses murine splenocytes and inhibits LFA-1 and ICAM-1 mediated cell adhesion.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-marinedrugs-17-00282" ref-type="bibr">49</xref>,<xref rid="B67-marinedrugs-17-00282" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lyngbya sordida</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malyngamide 2 (lipopeptide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits production of NO in LPS-primed RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-marinedrugs-17-00282" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Arthrospira platensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immolina (Polysaccharide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces TNF-<italic>&#x003b1;</italic> and IL-4 levels in RBL-2H3 Fc&#x003b5;RI-activated cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-marinedrugs-17-00282" ref-type="bibr">50</xref>,<xref rid="B51-marinedrugs-17-00282" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trichodesmium Erythraeum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory effects in carrageenan-induced inflammation in rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-marinedrugs-17-00282" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lyngbya cf. confervoides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Grassystatins A-C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits presentation of T cell antigen and expression of Cathepsin E, IL-17, and IFN- <italic>&#x003b3;</italic>.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-marinedrugs-17-00282" ref-type="bibr">52</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CyP, cyanobacterial LPS; ICAM-1, intercellular cell adhesion molecule-1; IFN, interferon; IL, interleukin; LFA-1, lymphocyte function-associated molecule-1; TNF, tumour necrosis factor.</p></fn></table-wrap-foot></table-wrap><table-wrap id="marinedrugs-17-00282-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t003_Table 3</object-id><label>Table 3</label><caption><p>Marine sponges and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sponge Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Plakortis simplex</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Simplexides Glycolopids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits T cell proliferation and induces cytokines and chemokines in a CD1d-dependent manner.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-marinedrugs-17-00282" ref-type="bibr">70</xref>,<xref rid="B71-marinedrugs-17-00282" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dysidea</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dendroceratida &#x00026; bolinaquinone (Polyoxygenated sterols)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits neutrophilic infiltration and IL-1, IL-8, PGE2, COX-2<break/>expression in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-marinedrugs-17-00282" ref-type="bibr">62</xref>,<xref rid="B72-marinedrugs-17-00282" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Petrosia contignata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contignasterol (Oxygenated sterol)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits histamine release in mast cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-marinedrugs-17-00282" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Petrosia</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Petrocortyne A (polyacetylenic alcohols)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits macrophages, reduces the production of TNF-<italic>&#x003b1;</italic> and the expression of phlogistic infiltration cell factors.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-17-00282" ref-type="bibr">27</xref>,<xref rid="B74-marinedrugs-17-00282" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mycale</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pateamine (Thiazole macrolide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Specifically targets translation initiation factors. Inhibits eIF4A-eIF4G association and promotes stable ternary complex formation between eIF4A and eIF4B. IL-2 inhibitor.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-marinedrugs-17-00282" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-17-00282" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Callyspongia</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Callyspongidiol (Polyketide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dendritic cell activation with enhanced IL-4 and IL-10 production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-17-00282" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ianthella quadrangulata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iso-iantheran (Polyketide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Has implication in tumor or autoimmune diseases. Ionotropic P2Y<sub>11</sub> receptor activation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-marinedrugs-17-00282" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Xestospongia bergquisita</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xestobergsterol (Polyhidroxylated steroid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the generation of IP3 and PLC activity and intracellular Ca<sup>2 +</sup> mobilization.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-marinedrugs-17-00282" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Clathria</italic>
<break/>
<italic>lissosclera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clathriols (Polyoxygenated steroids)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits superoxide production from neutrophils of hPBMCs.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-marinedrugs-17-00282" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hyritos sponge</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heteronemin (Sesterterpene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits TNF-<italic>&#x003b1;</italic> induced NF-<italic>&#x003ba;</italic>B activation and induces caspase-dependent apoptosis in K562 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-marinedrugs-17-00282" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Xestospongia testudinaria</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits anti-inflammatory activity against carrageen-induced paw inflammation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-marinedrugs-17-00282" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Plakortis angulospiculatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plakortide P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO inhibition in LPS stimulated macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-marinedrugs-17-00282" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Geodia cydonium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanolic and Chloroform extraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces IL-8, CXCL10 and VEGF levels and increases IL-4 and IL-10 levels.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-marinedrugs-17-00282" ref-type="bibr">84</xref>,<xref rid="B85-marinedrugs-17-00282" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Coscinoderma mathewsi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coscinolactams A-B (Terpenes) &#x00026; suvanine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGE2 and NO inhibition in RAW 264.7 cells stimulated by LPS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-marinedrugs-17-00282" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophytum crassum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lobocrassin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits LPS-induced BMDC activation by inhibiting TNF-<italic>&#x003b1;</italic> production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-marinedrugs-17-00282" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Petrosaspongia nigra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Petrosaspongiolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits chronic inflammation by lowering the production of eicosanoids and TNF-<italic>&#x003b1;</italic>.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-marinedrugs-17-00282" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hyrrios erecta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puupehedione, dipuupehedione,<break/>bispuupehenone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits cytotoxic and immunomodulatory potential against A-549 human cancer cell line.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-marinedrugs-17-00282" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Gelliodes fibrosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenes, steroids and lipids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate extracts from <italic>Gelliodes Fibrosa and Tedania anhelans</italic> on in vivo carbon clearance tests showed a moderate immunostimulant effect.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-marinedrugs-17-00282" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ircinia variabilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fasciculatin (Sesterterpenes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits moderate cytotoxicity and no selectivity in the cancer cell lines.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-marinedrugs-17-00282" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dendrilla nigra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipopolysaccharides &#x00026; neolamellarins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dendrilla</italic> exhibits enhanced phagocytosis against <italic>Escherichia coli.</italic> Neolamellarins inhibits HIF-1 activation and VEGF secretion in T47D cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-marinedrugs-17-00282" ref-type="bibr">92</xref>,<xref rid="B93-marinedrugs-17-00282" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Theonella swinhoei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solomonsterol A,<break/>perthamides C &#x00026; D (Peptides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Theonella</italic> peptolides show mild immunosuppressive activity, inhibition of murine hind paw oedema.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-marinedrugs-17-00282" ref-type="bibr">94</xref>,<xref rid="B95-marinedrugs-17-00282" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Discodermia spp</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Discodermolide (Polyhydroxylated lactone)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits murine T cell proliferation and causes cell cycle arrest in gap2 or mitosis phase of human and murine cell lines.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-marinedrugs-17-00282" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Reniera spp</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclic Tripeptide<break/>(Renieramide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In preliminary tests renieramide showed immunomodulating activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-marinedrugs-17-00282" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trididemnum solidum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Didemnins<break/>depsipeptides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits viral replication in vitro and <italic>P388</italic> leukemia in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pseudoaxinyssa cantharella</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Girolline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits of IL-8, NF-<italic>&#x003ba;</italic>B and AP-1 in macrophages derived from THP1. Reduction of IL-8 and IL-6 in primary mononuclear human cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-marinedrugs-17-00282" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Callyspongia siphonella</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Callysterol (Sterol)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potentially inhibits rat hind paw oedema, reduced release of TXB2 from LPS-activated rat brain microglia.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-marinedrugs-17-00282" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Axinella verrucosa, Acanthella aurantica and Stylissa massa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits expression of NF-<italic>&#x003ba;</italic>B and production of IL-8, IL-2 and TNF-<italic>&#x003b1;</italic>.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-marinedrugs-17-00282" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Tedania ignis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tedanol (Diterpenoid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory action to reduce carrageenan-induced mouse paw oedema. Strong inhibition of COX-2 and iNOS expressions.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-marinedrugs-17-00282" ref-type="bibr">101</xref>,<xref rid="B102-marinedrugs-17-00282" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Haliclona</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Halipeptins (Depsipeptide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strong anti-inflammatory activity, in vivo and in vitro.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-marinedrugs-17-00282" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cacospongia</italic>
<break/>
<italic>mollior</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesterterpenoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the production of LPS-induced PGE2.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-marinedrugs-17-00282" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fascaplysinopsis</italic><break/><italic>Bergquist</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fascaplysin (Indole alkaloid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CDK 4 inhibitor, potential to elicit anti-neuroinflammatory or neuroprotective responses in neuroinflammatory disease models.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-marinedrugs-17-00282" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Terpios</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpioside B (Glycolipid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits macrophage iNOS expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-marinedrugs-17-00282" ref-type="bibr">106</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>AP-1, activator protein; CDK, cyclin-dependent kinase 4; HIF-1, Hypoxia-inducible factor-1; IFN, interferon; IL, interleukin; iNKT, Natural killer T cells with an invariant T cell receptor alpha chain; iNOS, inducible nitric oxide synthase; NF-<italic>&#x003ba;</italic>B, nuclear factor-<italic>&#x003ba;</italic>B; PGE2, prostaglandin E2; PLC, phospholipase C; TNF, tumour necrosis factor; TXB2, thromboxane B2; VEGF, Vascular endothelial growth factor.</p></fn></table-wrap-foot></table-wrap><p>In several other non-lymphoid cell lines (+)-discodermolide exhibited antiproliferative effects by arresting the cell cycle at G2 and M phase due to microtubule network stabilization [<xref rid="B107-marinedrugs-17-00282" ref-type="bibr">107</xref>,<xref rid="B108-marinedrugs-17-00282" ref-type="bibr">108</xref>]. Petrosaspongiolide M (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>7</bold>) isolated from the Caledonian marine sponge <italic>Petrosa spongia nigra</italic> significantly inhibits chronic inflammation in rats and mice by diminishing eicosanoids and TNF-<italic>&#x003b1;</italic> production [<xref rid="B88-marinedrugs-17-00282" ref-type="bibr">88</xref>]. Petrosaspongiolide M (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>7</bold>) decreases the NF-<italic>&#x003ba;</italic>B-DNA binding in response to zymosan in mouse peritoneal macrophages [<xref rid="B109-marinedrugs-17-00282" ref-type="bibr">109</xref>]. A marine sesterterpene, heteronemin (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>8</bold>), isolated from <italic>Hyritos</italic> sponge species has been found to affect cellular processes including cell cycle and apoptosis, and inhibits TNF-<italic>&#x003b1;</italic>-induced NF-<italic>&#x003ba;</italic>B activation [<xref rid="B81-marinedrugs-17-00282" ref-type="bibr">81</xref>]. Methanolic extracts of <italic>Xestospongia testudinaria</italic>, the Red Sea marine sponge, prevent carrageenan-induced acute local inflammation in rats. Malondialdehyde and NO in inflamed rat paws was decreased by this extract, while glutathione, glutathione peroxidase, and catalase activities were increased. It appears to have antioxidant, anti-inflammatory, and immunomodulatory effects [<xref rid="B82-marinedrugs-17-00282" ref-type="bibr">82</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine sponges are listed in <xref rid="marinedrugs-17-00282-t003" ref-type="table">Table 3</xref>. </p></sec><sec id="sec2dot4-marinedrugs-17-00282"><title>2.4. Algae</title><p>Marine algae are rich sources of vitamins, minerals, essential amino acids, lipids, fatty acids, dietary fiber, and polysaccharides [<xref rid="B110-marinedrugs-17-00282" ref-type="bibr">110</xref>,<xref rid="B111-marinedrugs-17-00282" ref-type="bibr">111</xref>,<xref rid="B112-marinedrugs-17-00282" ref-type="bibr">112</xref>,<xref rid="B113-marinedrugs-17-00282" ref-type="bibr">113</xref>,<xref rid="B114-marinedrugs-17-00282" ref-type="bibr">114</xref>]. Bioactivity studies of marine algae have revealed numerous health-promoting effects including anticoagulant, antibacterial, anti-hypolipidemic, anti-hypertensive, antioxidant, anticancer, and immunomodulatory activities [<xref rid="B115-marinedrugs-17-00282" ref-type="bibr">115</xref>]. Fucoidans (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>9</bold>) from the brown algae <italic>Laminaria cichorioides</italic>, <italic>Laminaria japonica</italic> and <italic>Fucus evanescens</italic> specifically interact with TLRs in vitro, causing the activation of NF-<italic>&#x003ba;</italic>B via the MyD88 and TRIF-signaling pathways [<xref rid="B116-marinedrugs-17-00282" ref-type="bibr">116</xref>]. Brown algae-derived fucoidans activate genes that are responsible for cytokine synthesis, exhibiting pronounced immunotropic activity <italic>ex vivo</italic> and promoting defense against various pathogens [<xref rid="B117-marinedrugs-17-00282" ref-type="bibr">117</xref>]. Sugariura <italic>et al.</italic> showed that a diet including dried <italic>Eisenia arborea</italic> powder reduced serum IgE levels and shifted the Th1/Th2 balance by suppressing the release of Th2-type cytokines IL-4 and IL-10 and enhancing the expression of Th1 and IFN-<italic>&#x003b3;</italic> in rat spleen and mesenteric lymph node-derived lymphocytes [<xref rid="B118-marinedrugs-17-00282" ref-type="bibr">118</xref>]. The red alga <italic>Gracilaria verrucosa</italic> has anticancer and antioxidant properties. The two enone fatty acids (E)-9-Oxooctadec-10-enoic-acid (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>10</bold>) and (E)-10-Oxooctadec-8-enoic-acid (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>11</bold>) isolated from <italic>Gracilaria verrucosa</italic> inhibit the production of inflammatory biomarkers including NO, IL-6 and TNF-<italic>&#x003b1;</italic> by suppressing the nuclear translocation of NF-<italic>&#x003ba;</italic>B and phosphorylation of STAT1 in LPS-stimulated RAW 264.7 cells [<xref rid="B119-marinedrugs-17-00282" ref-type="bibr">119</xref>]. Lectins from marine algae <italic>Solieria filiformis, Caulerpa cupressoides</italic> and <italic>Pterocladiella capillacea</italic> demonstrate anti-inflammatory effects by enhancing IL-10 and IL-6 formation without affecting the IFN-<italic>&#x003b3;</italic> and IL-12 production in murine splenocytes [<xref rid="B120-marinedrugs-17-00282" ref-type="bibr">120</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine algae are listed in <xref rid="marinedrugs-17-00282-t004" ref-type="table">Table 4</xref>. </p></sec><sec id="sec2dot5-marinedrugs-17-00282"><title>2.5. Marine Fungi </title><p>Recent developments in marine mycology have led to a large amount of research into natural products from substrate-insulated fungi in various marine habitats [<xref rid="B121-marinedrugs-17-00282" ref-type="bibr">121</xref>]. The discovery rate of novel marine-derived natural products from fungi increased exponentially over the period from 1970 to 2010 [<xref rid="B121-marinedrugs-17-00282" ref-type="bibr">121</xref>]. Cyclosporins (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>12</bold>) are produced by species of fungi including <italic>Tolypocladium inflatum gams</italic> [<xref rid="B122-marinedrugs-17-00282" ref-type="bibr">122</xref>], <italic>Neocosmospora vasinfecta, Verticillium spp. and Microdochium nivale</italic> [<xref rid="B123-marinedrugs-17-00282" ref-type="bibr">123</xref>,<xref rid="B124-marinedrugs-17-00282" ref-type="bibr">124</xref>]. Owing to their potent immune-modulation properties, cyclosporins (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>12</bold>) are used in patients with organ transplants. The agent specifically binds to cyclophilin expressed in T lymphocytes. The production of IL-2, IL-3, IL-4, granulocyte colony-stimulating factor (G-CSF) and TNF-<italic>&#x003b1;</italic> is reduced by cyclosporine in T-lymphocytes [<xref rid="B125-marinedrugs-17-00282" ref-type="bibr">125</xref>,<xref rid="B126-marinedrugs-17-00282" ref-type="bibr">126</xref>]. Sirolimus (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>13</bold>) (Rapamycin) a macrocyclic lactone immunosuppressive drug was also derived from the fungus <italic>Streptomyces hygroscopicus</italic> [<xref rid="B127-marinedrugs-17-00282" ref-type="bibr">127</xref>]. It binds to FK-bound protein 12 and serine threonine kinase, mTOR, inhibiting the transduction of IL-2R and other cytokine signals relevant to allograft rejection [<xref rid="B128-marinedrugs-17-00282" ref-type="bibr">128</xref>,<xref rid="B129-marinedrugs-17-00282" ref-type="bibr">129</xref>]. </p><table-wrap id="marinedrugs-17-00282-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t004_Table 4</object-id><label>Table 4</label><caption><p>Marine algal flora and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Algal Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eisenia arborea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phlorotannin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits IgE and exhibits anti-degranulation effects; changes Th1/Th2 balance in Brown Norway rat strain.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-marinedrugs-17-00282" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Endarachne binghamiae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides<break/>(Sodium alginate, alginic)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulates concentration-dependent proliferation of T cells and significant induction of the production of TNF-<italic>&#x003b1;</italic> and nitric oxide in macrophages and IFN-<italic>&#x003b3;</italic> in T cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B130-marinedrugs-17-00282" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Caulerpa cupressoides, Pterocladiella capillacea and Solieria demonstrate</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lectins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improves the IL-10 induction and induces the immune response of Th2 in mouse splenocytes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-marinedrugs-17-00282" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Gracilaria verrucosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enone fatty acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of NO, TNF-<italic>&#x003b1;</italic>, and IL-6 inflammatory biomarkers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-marinedrugs-17-00282" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sargassum ilicifolium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenes, steroids and lipids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Demonstrate chemotactic, phagocytic and intracellular killing of human neutrophils, and show a significant immunostimulatory effect in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-marinedrugs-17-00282" ref-type="bibr">90</xref>,<xref rid="B131-marinedrugs-17-00282" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Laminaria japonica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laminarin oligosaccharides &#x00026;<break/>polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apoptotic cell death protein was significantly reduced by laminarin oligosaccharides.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-marinedrugs-17-00282" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nannochloropsis oceanica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits NO generation and downregulates NF-<italic>&#x003ba;</italic>B and <italic>&#x003b2;</italic>-secretase activities in BV-2 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B133-marinedrugs-17-00282" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Monostroma nitidum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulfated<break/>polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAW 264.7 cells were stimulated by polysaccharides, which produced considerable NO, and PGE2 induces strong immunomodulation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B134-marinedrugs-17-00282" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hijikia fusiforme</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced activity for the proliferative response of spleen cells in endotoxin nonrespondent C3H / HeJ mice.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-marinedrugs-17-00282" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Gyrodinium impudicum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Gyrodinium impudicum</italic> show immunostimulatory effects and enhance the tumoricidal activities of macrophages and NK cells in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-marinedrugs-17-00282" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ulva fasciata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipopolysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ulva</italic> in the diet significantly increases defense factors such as haemogram, agglutination index, phagocytic rate, bacterial clearance and serum bactericidal activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-marinedrugs-17-00282" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sargassum thunbergii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucoidan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucoidan enhances phagocytosis and macrophage chemiluminescence.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B137-marinedrugs-17-00282" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Meristotheca papulosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extracts of <italic>M. papulosa</italic> significantly stimulated the proliferation of human lymphocytes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-marinedrugs-17-00282" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Focellatus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrageenan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003bb;-carrageenan showed antitumor activity and lymphocyte activation in mice transplanted tumor.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-marinedrugs-17-00282" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chlorella stigmatophora</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Chlorella stigmatophora</italic> extract shows anti-inflammatory effect in paw oedema test and immunomodulatory effects in delayed hypersensitivity test.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B140-marinedrugs-17-00282" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Spirulina fusiformis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides &#x00026; <italic>&#x003b2;</italic> -carotene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Spirulina fusiformis</italic> suppresses adjuvant-induced arthritis in mice.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B141-marinedrugs-17-00282" ref-type="bibr">141</xref>,<xref rid="B142-marinedrugs-17-00282" ref-type="bibr">142</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ceratodictyon spongiosum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">trans-ceratospongamide (Peptide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent inhibition of sPLA2 expression in an anti-inflammatory cell model.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B143-marinedrugs-17-00282" ref-type="bibr">143</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eisenia bicyclis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phlorotannins Dieckol, Eckol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits LPS-induced NO production, iNOS and COX-2 protein levels and t-BHP-induced ROS generation in RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B144-marinedrugs-17-00282" ref-type="bibr">144</xref>,<xref rid="B145-marinedrugs-17-00282" ref-type="bibr">145</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eckolonia cava</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucodiphloroethol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Degranulation in RBL-2H3 cells induced by IgE.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B146-marinedrugs-17-00282" ref-type="bibr">146</xref>,<xref rid="B147-marinedrugs-17-00282" ref-type="bibr">147</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Rhipocephalus phoenix</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhipocephalin (Sesquiterpene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bee venom sPLA2 inhibitory activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B148-marinedrugs-17-00282" ref-type="bibr">148</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Crypthecodinium cohnii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exopolysaccharide EPCP1-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulates the expression of TLR-4, MAPK and NF-<italic>&#x003ba;</italic>B signaling pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B149-marinedrugs-17-00282" ref-type="bibr">149</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Gyrodinium impudium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulphated polysaccharide P-KG103.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activates NO production in a JNK-dependent manner and stimulates cytokines IL-1, IL-6, and TNF-<italic>&#x003b1;</italic> production in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-marinedrugs-17-00282" ref-type="bibr">136</xref>,<xref rid="B150-marinedrugs-17-00282" ref-type="bibr">150</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ishige okamurae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diphlorethohydroxycarmal-ol (Phlorotannin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the IL-6 production and expression of NF-<italic>&#x003ba;</italic>B in murine macrophage RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-marinedrugs-17-00282" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Fucus distichus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phlorotannin subfraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces TNF-<italic>&#x003b1;</italic>, IL-10, MCP-1 and COX-2 expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B152-marinedrugs-17-00282" ref-type="bibr">152</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dinoflagellates</italic>
<break/>
<italic>(Protoceratium reticulatum, Lingulodinium polyedrum, Gonyaulax spinifera)</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yessotoxin (Polyketide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits macrophage phagocytosis and TNF-<italic>&#x003b1;</italic>, MIP-1<italic>&#x003b1;</italic> &#x00026; MIP-2 expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B153-marinedrugs-17-00282" ref-type="bibr">153</xref>,<xref rid="B154-marinedrugs-17-00282" ref-type="bibr">154</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Laurencia claviformis, Laurencia filiformis, Laurencia tasmanica,</italic>
<break/>
<italic>Laurencia undulata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pacifenol (Terpenoid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory activity, reduces the production of leukotriene B4 (LTB4) and thromboxane B2 (TXB2).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B155-marinedrugs-17-00282" ref-type="bibr">155</xref>,<xref rid="B156-marinedrugs-17-00282" ref-type="bibr">156</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stypopodium flabelliforme</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epitaondiol (Terpenoid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory effects, inhibits the release and modulation of the COX pathway eicosanoids (LTB4 and TXB2).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B157-marinedrugs-17-00282" ref-type="bibr">157</xref>,<xref rid="B158-marinedrugs-17-00282" ref-type="bibr">158</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophora variegata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lobophorins (Macrolides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory properties.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-marinedrugs-17-00282" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cymopolia barbata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bromohydroquinones<break/>cymopol and cyclocymopol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bee venom sPLA2 inhibitory activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-marinedrugs-17-00282" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stypoposium flabelliforme</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meroterpene epitaondiol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory agent with strong activity on TPA induced ear oedema in mice and human neutrophils.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B161-marinedrugs-17-00282" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Vidilia obtusaloba</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bromophenols vidalols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bee venom sPLA2 inhibitory activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B162-marinedrugs-17-00282" ref-type="bibr">162</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>COX, cyclooxygenase; IFN, interferon; IL, interleukin; JNK, c-Jun NH2-terminal kinase; IgE, immunoglobulin E; iNOS, inducible nitric oxide synthase; LKB4; leukotriene B4; LPS, lipopolysaccharide; MAPK; mitogen-activated protein kinase; MCP-1, monocyte chemoattractive protein-1; MIP, macrophage inflammatory protein; NF-<italic>k</italic>B, nuclear factor-<italic>&#x003ba;</italic>B; NO, nitric oxide; PGE2, prostaglandin E2; PLA2, phospholipase A; t-BHP, tert-butylhydroperoxide; TLR, toll-like receptor; TNF, tumour necrosis factor; TPA, 12-O-tetradecanoylphorbol13-acetate; TXB2, thromboxane B2.</p></fn></table-wrap-foot></table-wrap><p>Semivioxanthin (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>14</bold>) from marine derived fungi are found to regulate the production of TNF-<italic>&#x003b1;</italic> and upregulate the expression of MHC II, CD80, and CD86 [<xref rid="B163-marinedrugs-17-00282" ref-type="bibr">163</xref>]. Brevicompanine E (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>15</bold>) isolated from the oceanic fungus <italic>Penicillium</italic> sp. is potentially useful for modulating neuroinflammation by attenuating NF-<italic>&#x003ba;</italic>B and activator protein-1 (AP-1) activity in LPS-induced microglia [<xref rid="B164-marinedrugs-17-00282" ref-type="bibr">164</xref>]. Brevicompanine E (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>15</bold>) inhibits LPS-induced I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> degradation and NF-<italic>&#x003ba;</italic>B nuclear translocation, and represses phosphorylation of c-Jun NH2-terminal kinase (JNK) and Akt (serine/threonine-specific protein kinase) [<xref rid="B164-marinedrugs-17-00282" ref-type="bibr">164</xref>]. Azonazine (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>16</bold>) hexacyclic dipeptide obtained from the Hawaiian marine sedimentary fungus <italic>Aspergillus insulicola</italic> exhibits anti-inflammatory activity by inhibiting the production of NF-<italic>&#x003ba;</italic>B [<xref rid="B165-marinedrugs-17-00282" ref-type="bibr">165</xref>]. Three isocoumarins, (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>17</bold>) dichlorodiaportintone, desmethyldichlorodiaportintone, and desmethyldichlorodiaportinol, from the marine mangrove endophytic fungus, <italic>Ascomycota</italic> sp. CYSK-4, produce anti-inflammatory activity by inhibiting LPS-induced NO production in RAW 264.7 cells [<xref rid="B166-marinedrugs-17-00282" ref-type="bibr">166</xref>]. An anthraquinone derivative, questinol (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>18</bold>), isolated from the fungus <italic>Eurotium amstelodami</italic> exhibits an anti-inflammatory effect by significantly inhibiting prostaglandin E2 (PGE2) and NO production in LPS-stimulated RAW 264.7 cells. The production of pro-inflammatory cytokines, including IL-1, IL-6 and TNF-<italic>&#x003b1;</italic> is inhibited and inducible nitric oxide synthase (iNOS) expression levels suppressed in a dose-dependent manner [<xref rid="B167-marinedrugs-17-00282" ref-type="bibr">167</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine fungi are listed in <xref rid="marinedrugs-17-00282-t005" ref-type="table">Table 5</xref>. </p><p>Apart from their economic importance, fungi have been utilized as food, usually collected from their fruiting bodies, mushrooms. Some mushrooms can stimulate the immune system, modulate cellular and humoral immunity, and potentiate anti-tumorigenic activity, and potentially rejuvenate immune systems weakened by the chemotherapy and radiotherapy used for cancer treatment. This ability of mushrooms therefore qualifies them as candidates for immunotherapy in cancer and other diseases [<xref rid="B168-marinedrugs-17-00282" ref-type="bibr">168</xref>]. </p></sec><sec id="sec2dot6-marinedrugs-17-00282"><title>2.6. Mangroves and Other Higher Plants</title><p>Partially submerged in the ocean, mangroves form a tangled network of above-ground roots, which creates a unique and complex habitat for all sorts of marine life. Mangroves have long been used in fisher-folk medicine to treat disease [<xref rid="B169-marinedrugs-17-00282" ref-type="bibr">169</xref>,<xref rid="B170-marinedrugs-17-00282" ref-type="bibr">170</xref>]. Some mangroves, like <italic>Rhizophora mangle</italic> and <italic>R. mucronata,</italic> have been screened for their anti-ulcer, anti-viral, and anti-inflammatory activities [<xref rid="B171-marinedrugs-17-00282" ref-type="bibr">171</xref>,<xref rid="B172-marinedrugs-17-00282" ref-type="bibr">172</xref>,<xref rid="B173-marinedrugs-17-00282" ref-type="bibr">173</xref>]. Leaf extract from <italic>Rhizophora apiculata</italic> has been shown to inhibit HIV-1 or HIV-2 or SIV viruses in various cell cultures [<xref rid="B174-marinedrugs-17-00282" ref-type="bibr">174</xref>]. Extract of <italic>Rhizophora apiculata</italic> has shown anti-inflammatory and anti-tumor activity against B16F10 melanoma cells in BALB/c mice. <italic>Rhizophora apiculata</italic> substantially reduces acute inflammation in mice induced by carrageenan, as well as inflammatory oedema induced by formalin [<xref rid="B175-marinedrugs-17-00282" ref-type="bibr">175</xref>]. Extract of rhizome from <italic>Acorus calamus</italic> inhibited the growth of many human and mouse cell lines. In hPBMCs the production of IL-2, NO, and TNF-<italic>&#x003b1;</italic> was inhibited, IFN-<italic>&#x003b3;</italic> and cell-surface markers CD16 and HLA-DR were not affected, but CD25 was downregulated [<xref rid="B176-marinedrugs-17-00282" ref-type="bibr">176</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine mangroves are listed in <xref rid="marinedrugs-17-00282-t006" ref-type="table">Table 6</xref>. </p></sec><sec id="sec2dot7-marinedrugs-17-00282"><title>2.7. Marine Animals and Others</title><p>Entire marine animals, and their parts, contribute to the triggering of several biomedical mechanisms involved in inflammatory/allergic cascades [<xref rid="B177-marinedrugs-17-00282" ref-type="bibr">177</xref>]. An extract from the Caribbean Gorgonian <italic>Pseudopterogorgia elisabethae</italic> shows anti-inflammatory activity due to the presence of unusual diterpene glycosides, and is now used in cosmetic skin products as an anti-allergic factor [<xref rid="B178-marinedrugs-17-00282" ref-type="bibr">178</xref>]. Stichodactyla toxin (ShK)-186, a peptide toxin from sea anemones, blocks Kv1.3 potassium channels with a high degree of specificity. Kv1.3 potassium channels play a critical role in regulating the function of effector-memory T cells and class-switched memory B cells that are implicated in ADs [<xref rid="B179-marinedrugs-17-00282" ref-type="bibr">179</xref>]. Whole-body extracts of the marine prawn <italic>Nematopaleamon tenuipes</italic> (PEP), two gastropods, <italic>Euchelus asper</italic> (EAE) and <italic>Hemifusus pulgilinus</italic> (HPE), produced immunosuppression on Swiss albino mice in a concentration dependent manner [<xref rid="B180-marinedrugs-17-00282" ref-type="bibr">180</xref>]. An <italic>&#x003b1;</italic>-d-Glucan called MP-A, isolated from <italic>Mytilus coruscus</italic> (hard-shelled mussel), has shown anti-inflammatory activity in THP-1 human macrophage cells. MP-A suppresses LPS-induced TNF-<italic>&#x003b1;</italic>, NO, and PEG2 production via the TLR4 pathway [<xref rid="B181-marinedrugs-17-00282" ref-type="bibr">181</xref>]. Fatty acid extract from the tunicate <italic>Halocynthia aurantium</italic> significantly and dose-dependently increases NO and PGE2 production in RAW264.7 cells, producing immune enhancement without cytotoxicity. These fatty acids also regulate the transcription of immune-associated genes, including iNOS, IL-1<italic>&#x003b2;</italic>, IL-6, COX-2, and TNF-<italic>&#x003b1;</italic> [<xref rid="B182-marinedrugs-17-00282" ref-type="bibr">182</xref>]. Some representative immunomodulatory and anti-inflammatory chemical constituents isolated from marine creatures are listed in <xref rid="marinedrugs-17-00282-t006" ref-type="table">Table 6</xref>. </p><table-wrap id="marinedrugs-17-00282-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t005_Table 5</object-id><label>Table 5</label><caption><p>Marine fungi and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Marine Fungi</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Neocosmospora vasinfecta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cyclosporine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Calcineurine complex inhibition with cyclophilines.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B183-marinedrugs-17-00282" ref-type="bibr">183</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Streptomyces hygroscopicus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sirolimus macrocyclic lactone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits IL-2R signal transduction and other cytokine signals.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-marinedrugs-17-00282" ref-type="bibr">127</xref>,<xref rid="B128-marinedrugs-17-00282" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTD-13C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Semivioxanthin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulates expression of TNF-<italic>&#x003b1;</italic>, CD80, CD86 and MHC II in RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B163-marinedrugs-17-00282" ref-type="bibr">163</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Penicillium</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brevicompanine E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces the production of proinflammatory cytokines induced by LPS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B164-marinedrugs-17-00282" ref-type="bibr">164</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Toxicocladosporium</italic> sp. SF-5699.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citreohybridonol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses neuroinflammatory enzymes and cytokines associated with NF-&#x0043a;B and MAPK in BV2 cells stimulated by LPS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B184-marinedrugs-17-00282" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aspergillus insulicola</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azonazine (Dipeptide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of NF-<italic>&#x003ba;</italic>B luciferase and nitrite.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B165-marinedrugs-17-00282" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aspergillus</italic> sp. SF-5921</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aurantiamide acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits NF-<italic>&#x003ba;</italic>B, JNK, and p38 inhibition in BV2 microglia cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B185-marinedrugs-17-00282" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ascomycota</italic> sp. CYSK-4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isocoumarins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of NO in LPS-induced RAW 264.7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-marinedrugs-17-00282" ref-type="bibr">166</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Xylaria</italic> sp. 2508</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xyloketal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits neuroprotective effect on neonatal hypoxic-ischemic brain injury both in vivo and in vitro.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B186-marinedrugs-17-00282" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eurotium amstelodami</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Questinol (Anthraquinone)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits NO and PGE2 production in LPS-stimulated RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-marinedrugs-17-00282" ref-type="bibr">167</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eurotium</italic> sp. SF-5989</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neoechinulins A and B (Diketopiperazine)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGE2 and NO generation as well as iNOS and COX2 expression are downregulated. Diminishes IL-1 and TNF-<italic>&#x003b1;</italic> secretion.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B187-marinedrugs-17-00282" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chaetomium globosum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chaetoglobosin Fex</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses LPS-stimulated IL-6, monocyte chemotactic protein-1, and TNF-<italic>&#x003b1;</italic> in peritoneal macrophages and mouse macrophage cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B188-marinedrugs-17-00282" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Penicillium paxilli Ma(G)K</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyrenocine A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits gene expression in LPS-stimulated macrophages due to NF-<italic>&#x003ba;</italic>B-mediated signal transduction.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B189-marinedrugs-17-00282" ref-type="bibr">189</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ecklonia</italic>
<break/>
<italic>stolonifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phlorofucofuroeckol (Phlorotannin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits NO and PGE2 production by the suppressing iNOS and COX-2 protein expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B190-marinedrugs-17-00282" ref-type="bibr">190</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CD, cluster of differentiation; COX, cyclooxygenase; IL, interleukin; JNK, c-Jun NH2-terminal kinase; iNOS, inducible nitric oxide synthase; LKB4; leukotriene B4; MAPK; mitogen-activated protein kinase; MHC, major histocompatibility complex; NF-kB, nuclear factor-<italic>&#x003ba;</italic>B; NO, nitric oxide; PGE2, prostaglandin E2; PLA2, phospholipase A2; TLR, toll-like receptor; TNF, tumor necrosis factor.</p></fn></table-wrap-foot></table-wrap><table-wrap id="marinedrugs-17-00282-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t006_Table 6</object-id><label>Table 6</label><caption><p>Mangroves, corals and other marine creatures and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ecteinascidia turbinate</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yondelis (Trabectedin)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces the proliferation of monocytes and the differentiation of <italic>ex vivo</italic> macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B191-marinedrugs-17-00282" ref-type="bibr">191</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Rhizophora apiculata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaf extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits HIV-1 or HIV-2 and reduces acute inflammation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B174-marinedrugs-17-00282" ref-type="bibr">174</xref>,<xref rid="B175-marinedrugs-17-00282" ref-type="bibr">175</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Acorus calamus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rhizome extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits cell proliferation and IL-2, NO, and TNF-<italic>&#x003b1;</italic> production is encouraged.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B176-marinedrugs-17-00282" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pseudopterogorgia elisabethae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpene glycosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits TPA induced oedema in mouse, MPO release in human PMNs and, NO production in J774 macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-17-00282" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stichodactyla helianthus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peptide ShK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulates the function of effector-memory T cells and class-switched memory B cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B179-marinedrugs-17-00282" ref-type="bibr">179</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mytilus coruscus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D-Glucan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the production of LPS-induced TNF-<italic>&#x003b1;</italic>, NO, and PEG2.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Halocynthia aurantium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatty acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increases production of NO and PGE2 in RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B182-marinedrugs-17-00282" ref-type="bibr">182</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lepeophtheirus salmonis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trypsins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Causes an inhibitory effect on central inflammatory gene (<italic>IL-1&#x003b2;</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B192-marinedrugs-17-00282" ref-type="bibr">192</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Litopenaeus vannamei</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits immunomodulatory action of superoxide dismutase and its possible use as an indicator of immune responses.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B193-marinedrugs-17-00282" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nematopaleamon tenuipes</italic><break/><italic>Hemifusus pugilinus</italic><break/><italic>Euchelus asper</italic> &#x00026;<break/><italic>Rastrelliger kanagurta</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fractions of Petroleum ether:ethyl acetate (1:1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits immunosuppressive activity in the plaque forming cell assay.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B180-marinedrugs-17-00282" ref-type="bibr">180</xref>,<xref rid="B194-marinedrugs-17-00282" ref-type="bibr">194</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Crenomytilus grayanus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mytilan (Bioglycan)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mytilan isolated from the mussel mantle <italic>Crenomytilus grayanus</italic> is highly immunomodulating.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B195-marinedrugs-17-00282" ref-type="bibr">195</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bryozoans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Convolutamydine A (Oxindole alkaloid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits COX-2, iNOS, IL-6, PGE2 and TNF-<italic>&#x003b1;</italic> production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B196-marinedrugs-17-00282" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Seleronephthya gracillimum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnane-type steroids (Sclerosteroid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the expression of both iNOS and COX-2 proteins in LPS induced macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B197-marinedrugs-17-00282" ref-type="bibr">197</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Marthasterias glacialis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ergosta-7,22-dien-3-ol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory. Effective against iNOS, CHOP and I<italic>&#x003ba;</italic>B-<italic>&#x003b1;</italic> expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B198-marinedrugs-17-00282" ref-type="bibr">198</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Astropecten polyacanthus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Steroids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits pro-inflammatory cytokine secretion, including IL-12, p40, IL-6 and TNF-<italic>&#x003b1;</italic>.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B199-marinedrugs-17-00282" ref-type="bibr">199</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophytum micchaelae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Michosterols (Polyoxygenated steroids)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the generation of superoxide anion and elastase release in human neutrophils stimulated by N-formyl-methionyl-leucyl-phenylalanine /cytochaslasine B.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B200-marinedrugs-17-00282" ref-type="bibr">200</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Paralemnalia thyrsoides</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoparalemmone (Sesquiterpenoid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS protein expression in activated RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B201-marinedrugs-17-00282" ref-type="bibr">201</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cladiella hirsuta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hirsutalins (Diterpenes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits LPS-stimulated iNOS protein production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B202-marinedrugs-17-00282" ref-type="bibr">202</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophytum leavigatum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laevigatol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitory effects on NF-<italic>&#x003ba;</italic>B-induced transcriptional activity in Hep-G2 cells. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B203-marinedrugs-17-00282" ref-type="bibr">203</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sinularia gibberosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gibberoketosterol (Steroids)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of iNOS and COX-2 proteins in LPS-stimulated RWA 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B204-marinedrugs-17-00282" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Pseudopterogorgia elisabethae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pseudopterosins (Diterpene glycosides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocks zymosan-induced eicosanoid release in RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-marinedrugs-17-00282" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eunicea fusca</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucosides (Diterpene arabinose glycosides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits inflammation in the oedema model induced by 12-O- tetradecanoylphorbol-13-acetate.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B205-marinedrugs-17-00282" ref-type="bibr">205</xref>,<xref rid="B206-marinedrugs-17-00282" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hexaplex trunculus, Charonia tritonis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flesh and ashes of burned shell</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strengthens body&#x02019;s immune system; sore and wound healing property.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B207-marinedrugs-17-00282" ref-type="bibr">207</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Potamididae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shell and flesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the inflammation of the mouth, recurrent aphthous ulcer, and gingivitis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B208-marinedrugs-17-00282" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Eudistoma toealensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staurosporine &#x00026; Enzastaurin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ameliorates neuroinflammation by reducing demyelination and axonal damage.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-marinedrugs-17-00282" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haliotis discus hannai</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extracts fermented with C.<break/>militaris mycelia (HFCM-5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of NO in RAW 264.7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B209-marinedrugs-17-00282" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Capnella imbricate</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Capnellene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS and COX-2 in IFN-<italic>&#x003b3;</italic>-stimulated microglial cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B210-marinedrugs-17-00282" ref-type="bibr">210</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Haliotis diversicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shell powder</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreases iNOS expression and enhances the function of macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B211-marinedrugs-17-00282" ref-type="bibr">211</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Filopaludina bengalensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Footpad lipid extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits ROS, TNF-<italic>&#x003b1;</italic>, and NO production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B212-marinedrugs-17-00282" ref-type="bibr">212</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dicathais orbita Gmelin</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroform extract of the hypobranchial gland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the production of NO, downregulated the production of<break/>TNF&#x003b1; in RAW 264.7.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-marinedrugs-17-00282" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Perna canaliculus</italic>
<break/>
<italic>Gmelin</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Novel omega 3<break/>polyunsaturated fatty acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the biosynthesis of cholesterol, COX-2, TNF-&#x003b1; and PGE. Inhibits TNF-<italic>&#x003b1;</italic> and IL-12p40 production in THP-I.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-marinedrugs-17-00282" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Anadara kagoshimensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polypeptide fraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits NO in LPS-stimulated macrophage RAW 264.7cells. Inhibit IL-6, TNF-<italic>&#x003b1;</italic>, and IL-8 in human cervical cancer HeLa cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-marinedrugs-17-00282" ref-type="bibr">215</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Fissurella</italic>
<break/>
<italic>Latimarginata Sowerby</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemocyanin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increases IFN-<italic>&#x003b3;</italic> and higher numbers of tumor-infiltrating CD4+ lymphocytes.<break/>The generation of IL-6, IL-12, IL-23 and TNF-<italic>&#x003b1;</italic> in dendritic cells increases rapidly.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B216-marinedrugs-17-00282" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Perna canaliculu Mytilus unguiculatus s,</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipid extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduces the swelling of paw oedema. Inflammatory mediators (LTB4, PGE 2, and TXB2) and pro-inflammatory cytokines (IL-1, IL-6, INF-<italic>&#x003b3;</italic>, and TNF-<italic>&#x003b1;</italic>) have been suppressed.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B217-marinedrugs-17-00282" ref-type="bibr">217</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sepiella inermis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhikang Capsule</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses TNF-<italic>&#x003b1;</italic>, IFN-<italic>&#x003b3;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-12. Anti-inflammatory mediators (IL-4 and IL-10) have been promoted.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B218-marinedrugs-17-00282" ref-type="bibr">218</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Oily fishes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine n-3 polyunsaturated fatty acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreases human T cell spread, slows onset of arthritis, reduces paw swelling, reduces knee joint pathology, modulates a range of immunological reactions associated with RA.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B219-marinedrugs-17-00282" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sinularia kavarattiensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sinuleptolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1<italic>&#x003b2;</italic>, IL-6, IL-8, IL-18, and TNF-&#x003b1; inhibition.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B220-marinedrugs-17-00282" ref-type="bibr">220</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Carijoa</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Steroid glycoside carijoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutrophil superoxide and elastase inhibition.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B221-marinedrugs-17-00282" ref-type="bibr">221</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sinularia gyrosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpene gyrosanolides B &#x00026; C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B222-marinedrugs-17-00282" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sinularia flexibilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11-Dehydrosinulariolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Attenuates 6-OHDA-induced downregulation of TH-immunoreactivity and 6-OHDA-induced upregulation of DJ-1 protein in rat and zebrafish models.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-marinedrugs-17-00282" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Klyxum simplex</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Klysimplexin sulfoxide (Terpene) &#x00026; simplexin E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits expression of COX-2 and iNOS in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B224-marinedrugs-17-00282" ref-type="bibr">224</xref>,<xref rid="B225-marinedrugs-17-00282" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophytum crassum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits NO release and iNOS expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B226-marinedrugs-17-00282" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nephthea chabroli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nebrosteroid I (Steroid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-marinedrugs-17-00282" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Hyriopsis cumingii lea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activates adaptive immune response including T and B cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-marinedrugs-17-00282" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Styela plicata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatan sulfate (Polysaccharide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymphocyte and macrophage, as well as TNF-<italic>&#x003b1;</italic>, TGF-<italic>&#x003b2;</italic> and VEGF, have significantly decreased in inflamed colon of the rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B228-marinedrugs-17-00282" ref-type="bibr">228</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lobophytum durum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Durumhemiketalolide (Terpene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits expression of macrophage COX-2 and iNOS.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-marinedrugs-17-00282" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Lemnalia cervicorni</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lemnalol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits spinal TNF-<italic>&#x003b1;</italic> in microglial cells and astrocytes in neurophathic rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B230-marinedrugs-17-00282" ref-type="bibr">230</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sarcophyton ehrenbergi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycolipid &#x00026; sarcoehrenosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-marinedrugs-17-00282" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sarcophyton crassocaule</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sarcocrassocolides A &#x00026; B (Terpene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B231-marinedrugs-17-00282" ref-type="bibr">231</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplidium species</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rossinones A &#x00026; B (Terpene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits neutrophil superoxide.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B232-marinedrugs-17-00282" ref-type="bibr">232</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nephthea erecta</italic> &#x00026; <italic>Nephthea chabroli</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chabrosterol (Steroid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits iNOS and COX-2 expression in macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B233-marinedrugs-17-00282" ref-type="bibr">233</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mastigias papua</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Symbiopolyol (Polyketide sulfate)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited expression of inducible vascular cell adhesion molecule-1, which binds to leukocytes in early inflammation stages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B234-marinedrugs-17-00282" ref-type="bibr">234</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shellfish &#x00026; finfish sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docosahexaenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits carrageenan-induced microglial activation, p38 MAPK phosphorylation, and <italic>TNF- &#x003b1;</italic> and <italic>IL-1&#x003b2;</italic> mRNA expression in spinal cord.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-marinedrugs-17-00282" ref-type="bibr">235</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CHOP, C/EBP homologous protein; COX, cyclooxygenase; HIV, human immunodeficiency virus; IgE, immunoglobulin E; IL, interleukin; iNOS, inducible nitric oxide synthase; LKB4; leukotriene B4; MAPK; mitogen-activated protein kinase; MHC, major histocompatibility complex; NF-<italic>k</italic>B, nuclear factor-<italic>&#x003ba;</italic>B; NO, nitric oxide; PGE2, prostaglandin E2; PMNs, polymorphonuclear neutrophils; PLA2, phospholipase A; TLR, toll-like receptor; TNF, tumor necrosis factor; TPA, 12-O-tetradecanoylphorbol13-acetate; TXB2, thromboxane B2.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="sec3-marinedrugs-17-00282"><title>3. Anti-inflammatory and Immunomodulatory Effects of the Chemical Constituents of Marine Flora </title><p>Marine organisms are not only adapted to life in water with high salt concentrations, but have incorporated halogens into their chemical constituents, since ocean water contains chloride, bromide and iodide [<xref rid="B194-marinedrugs-17-00282" ref-type="bibr">194</xref>]. The extensive utilization of halogen ions by various marine organisms has important consequences for their overall composition. A plethora of chemical compounds have been discovered from this source. The chemical uniqueness of marine organism-derived compounds has accelerated drug discovery from those marine sources which have the highest probability of having novel molecules and interesting biological activity [<xref rid="B236-marinedrugs-17-00282" ref-type="bibr">236</xref>]. Marine flora is a prolific source of bioactive constituents including polysaccharides, oligosaccharides, terpenoids, steroids, alkaloids, polyphenols and antioxidants.</p><sec id="sec3dot1-marinedrugs-17-00282"><title>3.1. Polysaccharides</title><p>The most abundant and chemically complex organic molecules in the oceans are polysaccharides (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>19</bold>) [<xref rid="B237-marinedrugs-17-00282" ref-type="bibr">237</xref>]. Polysaccharides (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>19</bold>) of marine origin are a class of biochemical compounds that has been shown to have valuable therapeutic properties. These compounds are considered to be biocompatible and to have little or no toxicity. Marine algae and bacteria possess an extensive and valuable chemical library of unique polysaccharides. Sulphated polysaccharides can enhance the innate immune response by promoting the tumoricidal activities of macrophages and natural killer cells [<xref rid="B136-marinedrugs-17-00282" ref-type="bibr">136</xref>,<xref rid="B238-marinedrugs-17-00282" ref-type="bibr">238</xref>,<xref rid="B239-marinedrugs-17-00282" ref-type="bibr">239</xref>,<xref rid="B240-marinedrugs-17-00282" ref-type="bibr">240</xref>]. Polysaccharides (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>19</bold>) from macro- and microalgae have anti-inflammatory and immunomodulatory properties [<xref rid="B241-marinedrugs-17-00282" ref-type="bibr">241</xref>,<xref rid="B242-marinedrugs-17-00282" ref-type="bibr">242</xref>]. Among the marine algal polysaccharides, fucoidans, which are fucose-containing sulphated polysaccharides from brown seaweeds, have immunomodulatory effects [<xref rid="B243-marinedrugs-17-00282" ref-type="bibr">243</xref>,<xref rid="B244-marinedrugs-17-00282" ref-type="bibr">244</xref>]. EPCP1-2, a marine EPS extracted from <italic>Crypthecodinium cohnii, e</italic>xhibits anti-inflammatory activity achieved by regulating the TLR4 pathway [<xref rid="B245-marinedrugs-17-00282" ref-type="bibr">245</xref>]. P-KG03 sulphated polysaccharide, derived from marine microalgae <italic>Gyrodinium impudium</italic> strain KG03, activates the production of NO in a JNK-dependent manner and stimulates the production of cytokines IL-1<italic>&#x003b2;</italic> and 6 and TNF-<italic>&#x003b1;</italic> in macrophages, and prevents the growth of tumor cells in vitro and in vivo [<xref rid="B136-marinedrugs-17-00282" ref-type="bibr">136</xref>,<xref rid="B150-marinedrugs-17-00282" ref-type="bibr">150</xref>]. Alginic acid, a colloidal polysaccharide from brown seaweed, inhibits the secretion of TNF-<italic>&#x003b1;</italic> and IL-1 [<xref rid="B246-marinedrugs-17-00282" ref-type="bibr">246</xref>]. Several bacteria found in the deep-sea, in shallow hydrothermal vents, the Antarctic, and hypersaline lakes produce EPS [<xref rid="B247-marinedrugs-17-00282" ref-type="bibr">247</xref>,<xref rid="B248-marinedrugs-17-00282" ref-type="bibr">248</xref>,<xref rid="B249-marinedrugs-17-00282" ref-type="bibr">249</xref>,<xref rid="B250-marinedrugs-17-00282" ref-type="bibr">250</xref>,<xref rid="B251-marinedrugs-17-00282" ref-type="bibr">251</xref>]. EPS1 from a haloalkaliphilic, thermophilic strain of <italic>Bacillus licheniformis</italic> T14 hinders HSV-2 replication in hPBMCs. The non-cytotoxic exopolymer EPS1-T14 can stimulate the immune response and thus contribute to host defense against viruses [<xref rid="B23-marinedrugs-17-00282" ref-type="bibr">23</xref>].</p></sec><sec id="sec3dot2-marinedrugs-17-00282"><title>3.2. Alkaloids</title><p>Alkaloids, a structurally diverse group of secondary metabolites containing nitrogen, have a range of biological activities. Alkaloids are mostly found in higher plants, but many marine organisms also contain alkaloids [<xref rid="B252-marinedrugs-17-00282" ref-type="bibr">252</xref>,<xref rid="B253-marinedrugs-17-00282" ref-type="bibr">253</xref>]. Alkaloids from the marine sponges <italic>Axinella verrucosa</italic> and <italic>Acanthella aurantiaca</italic> have been characterized as NF-<italic>&#x003ba;</italic>B-specific inhibitors [<xref rid="B100-marinedrugs-17-00282" ref-type="bibr">100</xref>]. An oxindole alkaloid, convolutamydine A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>20</bold>) and its two analogs, ISA003 and ISA147 from marine bryozoans inhibits the formalin-induced licking behavior significantly in mice, migration of leucocytes, and expression of COX-2, PGE2, iNOS, IL-6, and TNF-<italic>&#x003b1;</italic> in RAW 264.7 cells [<xref rid="B196-marinedrugs-17-00282" ref-type="bibr">196</xref>]. Neoechinulins A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>21</bold>) and B, two diketopiperazine indole alkaloids from marine fungus <italic>Eurotium</italic> sp. SF-5989 exert in vitro anti-inflammatory activity on LPS-stimulated RAW 264.7 cells. Neoechinulin A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>21</bold>) was considered safe in vitro using a cell viability assay, but neoechinulin B exhibited toxicity. Neoechinulin A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>21</bold>) derived from <italic>Microsporum</italic> sp. downregulates the formation or expression of COX-2, PGE2, NO, ROS, iNOS, IL-1, IL-6, and TNF-<italic>&#x003b1;</italic> in oligomeric amyloid-<italic>&#x003b2;</italic> activated BV-2 microglial cells. This compound also downregulates apoptosis mediated by activated microglia in pheochromocytoma PC-12 cells and reduces the nuclear translocation of NF-<italic>&#x003ba;</italic>B p50 and p56 subunits. Neoechinulin A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>21</bold>) can also inhibit neuroinflammation in Alzheimer&#x02019;s disease [<xref rid="B254-marinedrugs-17-00282" ref-type="bibr">254</xref>]. Cytochalasan-based alkaloid chaetoglobosin Fex (Cha Fex) (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>22</bold>), isolated from the fungus <italic>Chaetomium globosum</italic>, suppresses IL-6, TNF-<italic>&#x003b1;</italic> and monocyte chemotactic protein-1 in LPS-stimulated peritoneal macrophages and RAW 264.7 cells. Cytokine mRNA expression is lowered, entry of the p65 subunit of NF-<italic>&#x003ba;</italic>B into the nucleus and LPS-elicited breakdown of I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> is impaired, and the levels of the extracellular-signal-related kinase (ERK1/2), p38, and c-Jun is reduced by Cha Fex (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>22</bold>) alkaloid. In addition, the upregulation of membrane-associated CD-14 expression induced by LPS on RAW 264.7 cells and human monocytes was suppressed [<xref rid="B188-marinedrugs-17-00282" ref-type="bibr">188</xref>]. Alkaloids have been used by humans for a variety of purposes for more than 4000 years. Alkaloids and alkaloid-containing taxa will undoubtedly continue to play an important role in modern drug development [<xref rid="B255-marinedrugs-17-00282" ref-type="bibr">255</xref>].</p></sec><sec id="sec3dot3-marinedrugs-17-00282"><title>3.3. Polyphenols</title><p>More than 8000 polyphenolic compounds are found in marine flora, including phlorotannins, flavonoids, anthocyanins, tannins, lignin, epigallocatechin, epicatechin, catechin, and hydroxylated polybrominated diphenyl ethers [<xref rid="B256-marinedrugs-17-00282" ref-type="bibr">256</xref>,<xref rid="B257-marinedrugs-17-00282" ref-type="bibr">257</xref>,<xref rid="B258-marinedrugs-17-00282" ref-type="bibr">258</xref>]. Polyphenols with multiple phenolic structural units are bioactive and are widely distributed in plants [<xref rid="B257-marinedrugs-17-00282" ref-type="bibr">257</xref>] and have a wide range of biological activities including antioxidant [<xref rid="B259-marinedrugs-17-00282" ref-type="bibr">259</xref>], cardiovascular protective, anti-cancer [<xref rid="B260-marinedrugs-17-00282" ref-type="bibr">260</xref>,<xref rid="B261-marinedrugs-17-00282" ref-type="bibr">261</xref>], anti-inflammatory and immune-modulatory effects [<xref rid="B262-marinedrugs-17-00282" ref-type="bibr">262</xref>,<xref rid="B263-marinedrugs-17-00282" ref-type="bibr">263</xref>]. Modern molecular and cellular biology techniques have led to a greater understanding of the benefits arising from polyphenols [<xref rid="B264-marinedrugs-17-00282" ref-type="bibr">264</xref>,<xref rid="B265-marinedrugs-17-00282" ref-type="bibr">265</xref>,<xref rid="B266-marinedrugs-17-00282" ref-type="bibr">266</xref>,<xref rid="B267-marinedrugs-17-00282" ref-type="bibr">267</xref>]. Cellular signaling and regulation of gene expression by polyphenols through modulation of NF-<italic>&#x003ba;</italic>B has a significant impact on cancer and chronic inflammation. For instance, resveratrol acts on the NF-<italic>&#x003ba;</italic>B pathway at multiple levels and is able to down-regulate its expression, phosphorylation and transcription activity [<xref rid="B268-marinedrugs-17-00282" ref-type="bibr">268</xref>,<xref rid="B269-marinedrugs-17-00282" ref-type="bibr">269</xref>,<xref rid="B270-marinedrugs-17-00282" ref-type="bibr">270</xref>,<xref rid="B271-marinedrugs-17-00282" ref-type="bibr">271</xref>]. Diphlorethohydroxycarmalol (DPHC) (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>23</bold>), a phlorotannin from <italic>Ishige okamuarae,</italic> exerts an anti-inflammatory effect by strongly inhibiting IL-6 production in LPS-stimulated RAW264.7 cells. In addition, DPHC inhibits the expression of signal transducer and activator of transcription 5 (STAT5) signaling and increases the production of suppressor of cytokine signaling 1 (SOCS1) [<xref rid="B151-marinedrugs-17-00282" ref-type="bibr">151</xref>]. A phlorotannin sub-fraction isolated from <italic>Fucus distichus</italic> reduces TNF-<italic>&#x003b1;</italic>, IL-10, MCP-1 and COX-2 expression. The sub-fraction also lowers downstream TLR activation and expression of inflammatory biomarkers. In view of the potential cellular signaling capabilities of polyphenols, phlorotannin is beneficial because it acts as a free radical scavenger, and can also modulate inflammatory signaling receptors such as TLRs and downstream protein pathways, including NF-<italic>&#x003ba;</italic>B, JNK and p38 MAPKs [<xref rid="B152-marinedrugs-17-00282" ref-type="bibr">152</xref>]. </p></sec><sec id="sec3dot4-marinedrugs-17-00282"><title>3.4. Steroids/Sterols</title><p>Steroids are lipophilic compounds derived from cholesterol, and have a variety of marine, terrestrial, and synthetic sources. Steroids and their metabolites play an important role in the physiology and biochemistry of living organisms. For example they are used as hormone antagonists [<xref rid="B272-marinedrugs-17-00282" ref-type="bibr">272</xref>], contraceptives [<xref rid="B273-marinedrugs-17-00282" ref-type="bibr">273</xref>], cardiovascular therapeutic agents [<xref rid="B274-marinedrugs-17-00282" ref-type="bibr">274</xref>], anti-cancer agents [<xref rid="B275-marinedrugs-17-00282" ref-type="bibr">275</xref>], osteoporosis treatments [<xref rid="B276-marinedrugs-17-00282" ref-type="bibr">276</xref>], anesthetics, antibiotics, anti-asthmatics, and anti-inflammatories [<xref rid="B277-marinedrugs-17-00282" ref-type="bibr">277</xref>]. </p><p>Steroidal compounds isolated from sponges that modulate the pregnane X receptors (PXRs) are effective in reducing intestinal inflammation by manipulating NF-<italic>&#x003ba;</italic>B activity [<xref rid="B278-marinedrugs-17-00282" ref-type="bibr">278</xref>,<xref rid="B279-marinedrugs-17-00282" ref-type="bibr">279</xref>]. Solomonsterol A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>24</bold>) from the marine sponge <italic>Theonella swinhoei</italic> is a selective PXR agonist and has been shown to mitigate systemic inflammation and immune system disturbances in a RA mouse model. Solomonsterol A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>24</bold>) inhibits the development of arthritis caused by anti-collagen antibodies in transgenic mice harboring a humanized PXR2. Solomonsterol A (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>24</bold>) reduces the expression of the inflammatory markers TNF-<italic>&#x003b1;</italic>, IFN-<italic>&#x003b3;</italic> and IL-17 and chemokines MIP1-<italic>&#x003b1;</italic> and RANTES, which reduces the inflammatory response [<xref rid="B280-marinedrugs-17-00282" ref-type="bibr">280</xref>]. Pregnane-type steroids derived from the soft coral <italic>Seleronephthya gracillimum</italic> show in vitro anti-inflammatory activity by reducing the accumulation of the pro-inflammatory proteins iNOS and COX-2. Sclerosteroid K (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>25</bold>) and M (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>27</bold>) reduce iNOS accumulation, while LPS-stimulated COX-2 accumulation in RAW 264.7 macrophages is prevented by these sclerosteriods [<xref rid="B197-marinedrugs-17-00282" ref-type="bibr">197</xref>]. Ergosta-7, 22-dien-3-ol (<xref ref-type="fig" rid="marinedrugs-17-00282-f001">Figure 1</xref>, <bold>28</bold>), an unsaturated sterol from the spiny sea star <italic>Marthasterias glacialis</italic> has anti-inflammatory activity on RAW 264.7 cells in vitro. The inflammatory markers NF-<italic>&#x003ba;</italic>B, iNOS, IL-6, and COX-2 are downregulated. Sterol ergosta-7, 22-dien-3-ol is most effective, but a potentially synergistic effect was obtained when this compound was administered with other compounds [<xref rid="B198-marinedrugs-17-00282" ref-type="bibr">198</xref>]. Steroids isolated from the starfish <italic>Astropecten polyacanthus,</italic> downregulate the generation of IL-6, IL-12 p40, and TNF-<italic>&#x003b1;</italic> in LPS-stimulated bone marrow-derived dendritic cells [<xref rid="B199-marinedrugs-17-00282" ref-type="bibr">199</xref>]. Polyoxygenated steroids michosterols A-C extracted from the soft coral <italic>Lobophytum micchaelae</italic> exhibit potent anti-inflammatory activity in stimulated neutrophils by suppressing the superoxide anion generation and elastase release in N-formyl-methionyl-leucyl-phenylalanine/cytochaslasine B <italic>(</italic>fMLP/CB) [<xref rid="B200-marinedrugs-17-00282" ref-type="bibr">200</xref>].</p></sec><sec id="sec3dot5-marinedrugs-17-00282"><title>3.5. Miscellaneous Compounds with Anti-oxidant Activities</title><p>Antioxidants are agents which modulate the levels of highly reactive oxygen species (ROS), which cause damage by binding to biomolecules such as DNA. Antioxidants act by neutralizing ROS produced during biochemical reactions. In diseases such as Alzheimer&#x02019;s, Parkinson&#x02019;s, atherosclerosis, stroke, cancer, diabetes, RA, and IBD the antioxidant potential of bio-modulators has been studied and the underlying prophylactic and therapeutic aspects investigated [<xref rid="B281-marinedrugs-17-00282" ref-type="bibr">281</xref>,<xref rid="B282-marinedrugs-17-00282" ref-type="bibr">282</xref>,<xref rid="B283-marinedrugs-17-00282" ref-type="bibr">283</xref>,<xref rid="B284-marinedrugs-17-00282" ref-type="bibr">284</xref>,<xref rid="B285-marinedrugs-17-00282" ref-type="bibr">285</xref>,<xref rid="B286-marinedrugs-17-00282" ref-type="bibr">286</xref>]. Antioxidants can function as immune modulators and are used in conjunction with mainstream therapy in some diseases. Antioxidants have been used in disease prevention, where they serve as free radical scavengers. Tocopherols in humans and mice suppress PGE2 synthesis and enhance cell-mediated immunity [<xref rid="B287-marinedrugs-17-00282" ref-type="bibr">287</xref>,<xref rid="B288-marinedrugs-17-00282" ref-type="bibr">288</xref>,<xref rid="B289-marinedrugs-17-00282" ref-type="bibr">289</xref>]. Selenium augments the phagocytic abilities of macrophages and prevents CD8+ T lymphocyte damage [<xref rid="B290-marinedrugs-17-00282" ref-type="bibr">290</xref>]. Astaxanthin and fucoxanthin, marine carotenoids, appear to be biologically more effective than terrestrial carotenoids [<xref rid="B291-marinedrugs-17-00282" ref-type="bibr">291</xref>,<xref rid="B292-marinedrugs-17-00282" ref-type="bibr">292</xref>,<xref rid="B293-marinedrugs-17-00282" ref-type="bibr">293</xref>,<xref rid="B294-marinedrugs-17-00282" ref-type="bibr">294</xref>,<xref rid="B295-marinedrugs-17-00282" ref-type="bibr">295</xref>]. Astaxanthin decreases the production of NO, iNOS activity, and the production of PGE2 and TNF-<italic>&#x003b1;</italic> in RAW 264.7 cells in a dose-dependent manner [<xref rid="B296-marinedrugs-17-00282" ref-type="bibr">296</xref>]. Fucoxanthin prevents inflammation by inhibiting inflammatory cytokines TNF-<italic>&#x003b1;</italic> and IL-1, and limits the expression of COX-2 and iNOS, as well as eliminating excess ROS [<xref rid="B297-marinedrugs-17-00282" ref-type="bibr">297</xref>]. </p><p>Vitamin C is an electron donor and acts as potent water-soluble antioxidant helping to prevent protein, lipid and DNA oxidation. Supplementation with vitamin C reduces IgE and histamine levels by increasing IFN-<italic>&#x003b3;</italic> and deceasing IL-4, an observation which indicates the suppression of immune response of type Th2-type cytokines [<xref rid="B298-marinedrugs-17-00282" ref-type="bibr">298</xref>]. Trace elements such as iron, copper, selenium and antioxidants are found in eight species of red (<italic>Hypnea spinella, Gracilaria textorii, Gracilaria vermicullophyla),</italic> green (<italic>Caulerpa sertularioides, Codium simulans, Codium amplivesiculatum Ulva lactuca</italic>) and brown (<italic>Dictyota flabellata</italic>) microalgae [<xref rid="B299-marinedrugs-17-00282" ref-type="bibr">299</xref>]. Due to environmental conditions such as temperature and high levels of irradiation, microalgae and seaweeds have high levels of ROS, which seaweeds deactivate with their high intracellular amounts of antioxidant compounds such as polyphenols, phycobilins, carotenoids and vitamins [<xref rid="B300-marinedrugs-17-00282" ref-type="bibr">300</xref>].</p></sec></sec><sec id="sec4-marinedrugs-17-00282"><title>4. Metabolic Engineering and Genomic Approaches for Marine Compounds</title><p>Marine compounds that are used as drugs in microorganisms, plants and animals are synthesized in small amounts and are difficult to obtain in large quantities. This is where metabolic engineering comes into play. Using metabolic engineering, we can model organisms using existing metabolic reconstructions to discover gene knockouts which could improve the yield of products of interest. Genome-scale metabolic constraint-based flux models have been constructed for <italic>Streptomyces coelicolor</italic> A3 strains with the aim of improving and optimizing the production of antibiotics [<xref rid="B301-marinedrugs-17-00282" ref-type="bibr">301</xref>]. The deletion of the <italic>gonCP</italic> gene in marine actinobacterium <italic>Streptomyces coniferous</italic> resulted in improved antitumor activity of two derivatives, PM100117 and PM100118 [<xref rid="B302-marinedrugs-17-00282" ref-type="bibr">302</xref>]. By combining metabolic engineering and mutagenesis, it was possible to produce a level of astaxanthin in <italic>Xanthophyllomyces dendrorhous</italic> that was 89 times higher than that of the wild-type strain [<xref rid="B303-marinedrugs-17-00282" ref-type="bibr">303</xref>]. Advances in the understanding of microbial metabolic pathways, together with the use of new combinatorial techniques and random mutagenesis, can increase product yield and enhance efficacy [<xref rid="B304-marinedrugs-17-00282" ref-type="bibr">304</xref>]. Genome-scale metabolic models have been developed for several non-marine organisms and several are currently used in industrial settings. Using genomic proteomic transcriptomic and other omics data across various conditions from in-vivo experiments and literature of marine organisms the genome-scale metabolic model can be developed to produce overproducing strains of a target organism (<xref ref-type="fig" rid="marinedrugs-17-00282-f002">Figure 2</xref>) [<xref rid="B305-marinedrugs-17-00282" ref-type="bibr">305</xref>]. In many cases, the chemical structures of biomolecules can be predicted to a certain extent, based on the analysis and biosynthetic logic of the enzymes encoded in a biosynthetic gene cluster, and their similarity to known counterparts [<xref rid="B306-marinedrugs-17-00282" ref-type="bibr">306</xref>]. Genomic analysis provides new insights into marine biodiversity and can reveal new drug sources. Retrieval of genomic information from marine microorganisms can also be used for the discovery of new drug molecules from microorganisms that are yet to be cultivated [<xref rid="B307-marinedrugs-17-00282" ref-type="bibr">307</xref>]. The CRISPR-Cas9 gene editing technology has been used in large number of microorganisms for genome modulation [<xref rid="B308-marinedrugs-17-00282" ref-type="bibr">308</xref>]. Researchers assembled a multifunctional metabolic engineering system based on CRISPR, which makes use of an RNA-guided nuclease. This system allows metabolic engineers to modify microorganisms via gene modifications and substitutions, and provide a practical means to reduce metabolic flux through redundant metabolic pathways and direct energy towards production of the target compound [<xref rid="B309-marinedrugs-17-00282" ref-type="bibr">309</xref>].</p></sec><sec sec-type="conclusions" id="sec5-marinedrugs-17-00282"><title>5. Conclusions</title><p>Chemical substances derived from marine organisms have proven to be a very effective in the prevention and treatment of disease. The recent development of new marine-derived treatments for cancer, inflammation and infectious diseases suggest that a focus on the development of marine medicines could be very valuable. The discovery of novel chemicals with therapeutic potential from marine sources requires the exploration of unique habitats such as deep-sea environments, as well as isolation and culturing of marine microorganisms. The traditional pharmaceutical fit of marine microorganisms as model natural product drug sources makes them more attractive. The production of bulk quantities of microbe-derived drugs is still challenging and can be addressed using metabolic engineering, in order to meet the growing need for a wide range of pharmaceuticals. Marine organisms both known and as yet undiscovered, may hold answers to some of our most pressing medical problems. </p></sec></body><back><notes><title>Author Contributions</title><p>B.A. and S.C. conceived the idea. B.A. and M.S. collected the data and literature. B.A. and M.S. wrote the manuscript. S.C. coordinated the project and wrote the manuscript. All authors have given their approval to the final version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by the National Research Foundation of Korea (2019R1H1A2039674) and the Commercializations Promotion Agency for R&#x00026;D Outcomes funded by the Ministry of Science and ICT (2018K000369).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there are no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-17-00282"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franks</surname><given-names>A.L.</given-names></name><name><surname>Slansky</surname><given-names>J.E.</given-names></name></person-group><article-title>Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer</article-title><source>Anticancer Res.</source><year>2012</year><volume>32</volume><fpage>1119</fpage><lpage>1136</lpage><?supplied-pmid 22493341?><pub-id pub-id-type="pmid">22493341</pub-id></element-citation></ref><ref id="B2-marinedrugs-17-00282"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suurmond</surname><given-names>J.</given-names></name><name><surname>Diamond</surname><given-names>B.</given-names></name></person-group><article-title>Autoantibodies in systemic autoimmune diseases: Specificity and pathogenicity</article-title><source>J. Clin. Invest.</source><year>2015</year><volume>125</volume><fpage>2194</fpage><lpage>2202</lpage><pub-id pub-id-type="doi">10.1172/JCI78084</pub-id><pub-id pub-id-type="pmid">25938780</pub-id></element-citation></ref><ref id="B3-marinedrugs-17-00282"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedby</surname><given-names>K.E.</given-names></name><name><surname>Askling</surname><given-names>J.</given-names></name><name><surname>Mariette</surname><given-names>X.</given-names></name><name><surname>Baecklund</surname><given-names>E.</given-names></name></person-group><article-title>Autoimmune and inflammatory disorders and risk of malignant lymphomas&#x02014;An update</article-title><source>J. Intern. Med.</source><year>2008</year><volume>264</volume><fpage>514</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2008.02029.x</pub-id><?supplied-pmid 19017176?><pub-id pub-id-type="pmid">19017176</pub-id></element-citation></ref><ref id="B4-marinedrugs-17-00282"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubtsova</surname><given-names>K.</given-names></name><name><surname>Rubtsov</surname><given-names>A.V.</given-names></name><name><surname>Thurman</surname><given-names>J.M.</given-names></name><name><surname>Mennona</surname><given-names>J.M.</given-names></name><name><surname>Kappler</surname><given-names>J.W.</given-names></name><name><surname>Marrack</surname><given-names>P.</given-names></name></person-group><article-title>B cells expressing the transcription factor T-bet drive lupus-like autoimmunity</article-title><source>J. Clin. Invest.</source><year>2017</year><volume>127</volume><fpage>1392</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1172/JCI91250</pub-id><pub-id pub-id-type="pmid">28240602</pub-id></element-citation></ref><ref id="B5-marinedrugs-17-00282"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>S.J.</given-names></name><name><surname>Rau</surname><given-names>L.M.</given-names></name></person-group><article-title>Autoimmune diseases: A leading cause of death among young and middle-aged women in the United States</article-title><source>Am. J. Public Health</source><year>2000</year><volume>90</volume><fpage>1463</fpage><lpage>1466</lpage><?supplied-pmid 10983209?><pub-id pub-id-type="pmid">10983209</pub-id></element-citation></ref><ref id="B6-marinedrugs-17-00282"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>A.</given-names></name><name><surname>Jeremias</surname><given-names>P.</given-names></name><name><surname>Matthias</surname><given-names>T.</given-names></name></person-group><article-title>The world incidence and prevalence of autoimmune diseases is increasing</article-title><source>Int. J. Celiac Dis.</source><year>2015</year><volume>3</volume><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.12691/ijcd-3-4-8</pub-id></element-citation></ref><ref id="B7-marinedrugs-17-00282"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohi</surname><given-names>S.</given-names></name><name><surname>Mustalahti</surname><given-names>K.</given-names></name><name><surname>Kaukinen</surname><given-names>K.</given-names></name><name><surname>Laurila</surname><given-names>K.</given-names></name><name><surname>Collin</surname><given-names>P.</given-names></name><name><surname>Rissanen</surname><given-names>H.</given-names></name><name><surname>Lohi</surname><given-names>O.</given-names></name><name><surname>Bravi</surname><given-names>E.</given-names></name><name><surname>Gasparin</surname><given-names>M.</given-names></name><name><surname>Reunanen</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Increasing prevalence of coeliac disease over time</article-title><source>Aliment. Pharmacol. Ther.</source><year>2007</year><volume>26</volume><fpage>1217</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2007.03502.x</pub-id><pub-id pub-id-type="pmid">17944736</pub-id></element-citation></ref><ref id="B8-marinedrugs-17-00282"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.W.</given-names></name><name><surname>Vederas</surname><given-names>J.C.</given-names></name></person-group><article-title>Drug discovery and natural products: End of era or an endless frontier</article-title><source>Biomed Khim</source><year>2011</year><volume>57</volume><fpage>148</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.18097/pbmc20115702148</pub-id><pub-id pub-id-type="pmid">21870600</pub-id></element-citation></ref><ref id="B9-marinedrugs-17-00282"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>M.H.</given-names></name><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Dumdei</surname><given-names>E.J.</given-names></name><name><surname>Hickford</surname><given-names>S.J.</given-names></name><name><surname>Lill</surname><given-names>R.E.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Battershill</surname><given-names>C.N.</given-names></name><name><surname>Duckworth</surname><given-names>A.R.</given-names></name></person-group><article-title>The discovery and development of marine compounds with pharmaceutical potential</article-title><source>J. Biotechnol.</source><year>1999</year><volume>70</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0168-1656(99)00052-8</pub-id><pub-id pub-id-type="pmid">10412202</pub-id></element-citation></ref><ref id="B10-marinedrugs-17-00282"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeuf</surname><given-names>G.</given-names></name></person-group><article-title>Marine biodiversity characteristics</article-title><source>C. R. Biol.</source><year>2011</year><volume>334</volume><fpage>435</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.crvi.2011.02.009</pub-id><pub-id pub-id-type="pmid">21640952</pub-id></element-citation></ref><ref id="B11-marinedrugs-17-00282"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowler</surname><given-names>C.</given-names></name><name><surname>Karl</surname><given-names>D.M.</given-names></name><name><surname>Colwell</surname><given-names>R.R.</given-names></name></person-group><article-title>Microbial oceanography in a sea of opportunity</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nature08056</pub-id><pub-id pub-id-type="pmid">19444203</pub-id></element-citation></ref><ref id="B12-marinedrugs-17-00282"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Natural products: A continuing source of novel drug leads</article-title><source>Biochim. Biophys. Acta</source><year>2013</year><volume>1830</volume><fpage>3670</fpage><lpage>3695</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2013.02.008</pub-id><?supplied-pmid 23428572?><pub-id pub-id-type="pmid">23428572</pub-id></element-citation></ref><ref id="B13-marinedrugs-17-00282"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Weiss</surname><given-names>R.B.</given-names></name></person-group><article-title>Coral reefs, forests, and thermal vents: The worldwide exploration of nature for novel antitumor agents</article-title><source>Semin. Oncol.</source><year>1997</year><volume>24</volume><fpage>156</fpage><lpage>163</lpage><?supplied-pmid 9129686?><pub-id pub-id-type="pmid">9129686</pub-id></element-citation></ref><ref id="B14-marinedrugs-17-00282"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>G.</given-names></name></person-group><source>Underwater Robots</source><edition>4th ed.</edition><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Berlin, Germany</publisher-loc><year>2018</year><fpage>350</fpage></element-citation></ref><ref id="B15-marinedrugs-17-00282"><label>15.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Elvander</surname><given-names>J.</given-names></name><name><surname>Hawkes</surname><given-names>G.</given-names></name></person-group><article-title>ROVs and AUVs in support of marine renewable technologies</article-title><source>Proceedings of the 2012 Oceans</source><conf-loc>Hampton Roads, VA, USA</conf-loc><conf-date>14&#x02013;19 October 2012</conf-date><fpage>1</fpage></element-citation></ref><ref id="B16-marinedrugs-17-00282"><label>16.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Ridolfi</surname><given-names>A.</given-names></name><name><surname>Costanzi</surname><given-names>R.</given-names></name><name><surname>Fanelli</surname><given-names>F.</given-names></name><name><surname>Monni</surname><given-names>N.</given-names></name><name><surname>Allotta</surname><given-names>B.</given-names></name><name><surname>Bianchi</surname><given-names>S.</given-names></name><name><surname>Conti</surname><given-names>R.</given-names></name><name><surname>Gelli</surname><given-names>J.</given-names></name><name><surname>Gori</surname><given-names>L.</given-names></name><name><surname>Pugi</surname><given-names>L.</given-names></name><etal/></person-group><article-title>FeelHippo: A low-cost autonomous underwater vehicle for subsea monitoring and inspection</article-title><source>Proceedings of the 2016 IEEE 16th International Conference on Environment and Electrical Engineering (EEEIC)</source><conf-loc>Florence, Italy</conf-loc><conf-date>7&#x02013;10 June 2016</conf-date></element-citation></ref><ref id="B17-marinedrugs-17-00282"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Gustafson</surname><given-names>K.R.</given-names></name></person-group><article-title>Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds</article-title><source>Eur. J. Cancer</source><year>2008</year><volume>44</volume><fpage>2357</fpage><lpage>2387</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2008.07.001</pub-id><?supplied-pmid 18701274?><pub-id pub-id-type="pmid">18701274</pub-id></element-citation></ref><ref id="B18-marinedrugs-17-00282"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Rodriguez</surname><given-names>A.D.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action</article-title><source>Biochim. Biophys. Acta</source><year>2009</year><volume>1790</volume><fpage>283</fpage><lpage>308</lpage><?supplied-pmid 19303911?><pub-id pub-id-type="pmid">19303911</pub-id></element-citation></ref><ref id="B19-marinedrugs-17-00282"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulder</surname><given-names>T.A.</given-names></name><name><surname>Moore</surname><given-names>B.S.</given-names></name></person-group><article-title>Chasing the treasures of the sea&#x02014;Bacterial marine natural products</article-title><source>Curr. Opin. Microbiol.</source><year>2009</year><volume>12</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2009.05.002</pub-id><?supplied-pmid 19481972?><pub-id pub-id-type="pmid">19481972</pub-id></element-citation></ref><ref id="B20-marinedrugs-17-00282"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>A.L.</given-names></name><name><surname>Hill</surname><given-names>R.T.</given-names></name><name><surname>Place</surname><given-names>A.R.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>The expanding role of marine microbes in pharmaceutical development</article-title><source>Curr. Opin. Biotechnol.</source><year>2010</year><volume>21</volume><fpage>780</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2010.09.013</pub-id><?supplied-pmid 20956080?><pub-id pub-id-type="pmid">20956080</pub-id></element-citation></ref><ref id="B21-marinedrugs-17-00282"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devine</surname><given-names>D.A.</given-names></name><name><surname>Marsh</surname><given-names>P.D.</given-names></name></person-group><article-title>Prospects for the development of probiotics and prebiotics for oral applications</article-title><source>J. Oral Microbiol.</source><year>2009</year><volume>1</volume><fpage>1949</fpage><pub-id pub-id-type="doi">10.3402/jom.v1i0.1949</pub-id><?supplied-pmid 21523212?><pub-id pub-id-type="pmid">21523212</pub-id></element-citation></ref><ref id="B22-marinedrugs-17-00282"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>S.</given-names></name><name><surname>Ku</surname><given-names>S.K.</given-names></name><name><surname>Min</surname><given-names>G.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>D.H.</given-names></name><name><surname>Bae</surname><given-names>J.S.</given-names></name></person-group><article-title>Suppressive effects of three diketopiperazines from marine-derived bacteria on polyphosphate-mediated septic responses</article-title><source>Chem. Biol. Interact.</source><year>2016</year><volume>257</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2016.07.032</pub-id><?supplied-pmid 27481191?><pub-id pub-id-type="pmid">27481191</pub-id></element-citation></ref><ref id="B23-marinedrugs-17-00282"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gugliandolo</surname><given-names>C.</given-names></name><name><surname>Spano</surname><given-names>A.</given-names></name><name><surname>Lentini</surname><given-names>V.</given-names></name><name><surname>Arena</surname><given-names>A.</given-names></name><name><surname>Maugeri</surname><given-names>T.L.</given-names></name></person-group><article-title>Antiviral and immunomodulatory effects of a novel bacterial exopolysaccharide of shallow marine vent origin</article-title><source>J. Appl. Microbiol.</source><year>2014</year><volume>116</volume><fpage>1028</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1111/jam.12422</pub-id><?supplied-pmid 24354946?><pub-id pub-id-type="pmid">24354946</pub-id></element-citation></ref><ref id="B24-marinedrugs-17-00282"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.H.</given-names></name><name><surname>Yang</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>Y.P.</given-names></name><name><surname>Hua</surname><given-names>K.F.</given-names></name><name><surname>Lu</surname><given-names>C.P.</given-names></name><name><surname>Sheu</surname><given-names>F.</given-names></name><name><surname>Lin</surname><given-names>G.H.</given-names></name><name><surname>Tsay</surname><given-names>S.S.</given-names></name><name><surname>Liang</surname><given-names>S.M.</given-names></name><name><surname>Wu</surname><given-names>S.H.</given-names></name></person-group><article-title>A novel exopolysaccharide from the biofilm of Thermus aquaticus YT-1 induces the immune response through Toll-like receptor 2</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>17736</fpage><lpage>17745</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.200113</pub-id><pub-id pub-id-type="pmid">21454596</pub-id></element-citation></ref><ref id="B25-marinedrugs-17-00282"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>C.D.</given-names></name><name><surname>Patil</surname><given-names>S.V.</given-names></name><name><surname>Salunke</surname><given-names>B.K.</given-names></name><name><surname>Salunkhe</surname><given-names>R.B.</given-names></name></person-group><article-title>Prodigiosin produced by Serratia marcescens NMCC46 as a mosquito larvicidal agent against Aedes aegypti and Anopheles stephensi</article-title><source>Parasitol. Res.</source><year>2011</year><volume>109</volume><fpage>1179</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1007/s00436-011-2365-9</pub-id><pub-id pub-id-type="pmid">21451991</pub-id></element-citation></ref><ref id="B26-marinedrugs-17-00282"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaramoorthy</surname><given-names>N.</given-names></name><name><surname>Yogesh</surname><given-names>P.</given-names></name><name><surname>Dhandapani</surname><given-names>R.</given-names></name></person-group><article-title>Production of prodigiosin from Serratia marcescens isolated from soil</article-title><source>Indian J. Sci. Technol.</source><year>2009</year><volume>2</volume><fpage>32</fpage><lpage>34</lpage></element-citation></ref><ref id="B27-marinedrugs-17-00282"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Shibata</surname><given-names>Y.</given-names></name><name><surname>Wataya</surname><given-names>Y.</given-names></name><name><surname>Mitamura</surname><given-names>T.</given-names></name><name><surname>Horii</surname><given-names>T.</given-names></name><name><surname>Kawauchi</surname><given-names>K.</given-names></name><name><surname>Hirata</surname><given-names>H.</given-names></name><name><surname>Tsuboi</surname><given-names>S.</given-names></name><name><surname>Moriyama</surname><given-names>Y.</given-names></name></person-group><article-title>Cycloprodigiosin hydrochloride obtained from Pseudoalteromonas denitrificans is a potent antimalarial agent</article-title><source>Biol. Pharm. Bull.</source><year>1999</year><volume>22</volume><fpage>532</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1248/bpb.22.532</pub-id><pub-id pub-id-type="pmid">10375177</pub-id></element-citation></ref><ref id="B28-marinedrugs-17-00282"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawauchi</surname><given-names>K.</given-names></name><name><surname>Okamoto</surname><given-names>S.</given-names></name><name><surname>Oka</surname><given-names>S.-I.</given-names></name><name><surname>Kamata</surname><given-names>H.</given-names></name><name><surname>Yagisawa</surname><given-names>H.</given-names></name><name><surname>Hirata</surname><given-names>H.</given-names></name></person-group><article-title>Cycloprodigiosin hydrocloride suppresses tumor necrosis factor (TNF) &#x003b1;-induced transcriptional activation by NF-&#x003ba;B</article-title><source>Febs Lett.</source><year>2001</year><volume>507</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11682062</pub-id></element-citation></ref><ref id="B29-marinedrugs-17-00282"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terracciano</surname><given-names>S.</given-names></name><name><surname>Aquino</surname><given-names>M.</given-names></name><name><surname>Rodriquez</surname><given-names>M.</given-names></name><name><surname>Monti</surname><given-names>M.C.</given-names></name><name><surname>Casapullo</surname><given-names>A.</given-names></name><name><surname>Riccio</surname><given-names>R.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name></person-group><article-title>Chemistry and biology of anti-inflammatory marine natural products: Molecules interfering with cyclooxygenase, NF-kappaB and other unidentified targets</article-title><source>Curr. Med. Chem.</source><year>2006</year><volume>13</volume><fpage>1947</fpage><lpage>1969</lpage><pub-id pub-id-type="doi">10.2174/092986706777585095</pub-id><pub-id pub-id-type="pmid">16842204</pub-id></element-citation></ref><ref id="B30-marinedrugs-17-00282"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsiades</surname><given-names>C.S.</given-names></name><name><surname>Ocio</surname><given-names>E.M.</given-names></name><name><surname>Pandiella</surname><given-names>A.</given-names></name><name><surname>Maiso</surname><given-names>P.</given-names></name><name><surname>Gajate</surname><given-names>C.</given-names></name><name><surname>Garayoa</surname><given-names>M.</given-names></name><name><surname>Vilanova</surname><given-names>D.</given-names></name><name><surname>Carlos Montero</surname><given-names>J.</given-names></name><name><surname>Mitsiades</surname><given-names>N.</given-names></name><name><surname>McMullan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>5216</fpage><lpage>5225</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5725</pub-id><pub-id pub-id-type="pmid">18593922</pub-id></element-citation></ref><ref id="B31-marinedrugs-17-00282"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.-M.D.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Chang</surname><given-names>Y.-C.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.-Y.</given-names></name></person-group><article-title>Marine-derived protein kinase inhibitors for neuroinflammatory diseases</article-title><source>Biomed. Eng. Online</source><year>2018</year><volume>17</volume><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/s12938-018-0477-5</pub-id><pub-id pub-id-type="pmid">29690896</pub-id></element-citation></ref><ref id="B32-marinedrugs-17-00282"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalechman</surname><given-names>Y.</given-names></name><name><surname>Albeck</surname><given-names>M.</given-names></name><name><surname>Sredni</surname><given-names>B.</given-names></name></person-group><article-title>In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin</article-title><source>Cell. Immunol.</source><year>1992</year><volume>143</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/0008-8749(92)90012-E</pub-id><pub-id pub-id-type="pmid">1623562</pub-id></element-citation></ref><ref id="B33-marinedrugs-17-00282"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname><given-names>P.A.</given-names></name><name><surname>Rea</surname><given-names>D.</given-names></name><name><surname>Thavasu</surname><given-names>P.</given-names></name><name><surname>Carmichael</surname><given-names>J.</given-names></name><name><surname>Stuart</surname><given-names>N.S.</given-names></name><name><surname>Rockett</surname><given-names>H.</given-names></name><name><surname>Talbot</surname><given-names>D.C.</given-names></name><name><surname>Ganesan</surname><given-names>T.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Balkwill</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Phase I study of bryostatin 1: Assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee</article-title><source>J. Natl. Cancer Inst.</source><year>1993</year><volume>85</volume><fpage>1812</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.1093/jnci/85.22.1812</pub-id><pub-id pub-id-type="pmid">8230261</pub-id></element-citation></ref><ref id="B34-marinedrugs-17-00282"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaeck</surname><given-names>M.</given-names></name><name><surname>Grooten</surname><given-names>J.</given-names></name><name><surname>Hamers</surname><given-names>R.</given-names></name><name><surname>De Baetselier</surname><given-names>P.</given-names></name></person-group><article-title>The immunomodulatory effect of anti-Micrococcus luteus antibodies. I. Effect on in vitro rabbit T cell functions</article-title><source>Eur. J. Immunol.</source><year>1983</year><volume>13</volume><fpage>772</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1002/eji.1830130914</pub-id><pub-id pub-id-type="pmid">6604636</pub-id></element-citation></ref><ref id="B35-marinedrugs-17-00282"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kijjoa</surname><given-names>A.</given-names></name><name><surname>Sawangwong</surname><given-names>P.</given-names></name></person-group><article-title>Drugs and Cosmetics from the Sea</article-title><source>Mar. Drugs</source><year>2004</year><volume>2</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.3390/md202073</pub-id></element-citation></ref><ref id="B36-marinedrugs-17-00282"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ankisetty</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>S.I.</given-names></name><name><surname>Avula</surname><given-names>B.</given-names></name><name><surname>Gochfeld</surname><given-names>D.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name><name><surname>Slattery</surname><given-names>M.</given-names></name></person-group><article-title>Chlorinated didemnins from the tunicate Trididemnum solidum</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>4478</fpage><lpage>4486</lpage><pub-id pub-id-type="doi">10.3390/md11114478</pub-id><pub-id pub-id-type="pmid">24284424</pub-id></element-citation></ref><ref id="B37-marinedrugs-17-00282"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000fc;rstner</surname><given-names>A.</given-names></name></person-group><article-title>Chemistry and Biology of Roseophilin and the Prodigiosin Alkaloids: A Survey of the Last 2500 Years</article-title><source>Angew. Chem. Int. Ed.</source><year>2003</year><volume>42</volume><fpage>3582</fpage><lpage>3603</lpage><pub-id pub-id-type="doi">10.1002/anie.200300582</pub-id></element-citation></ref><ref id="B38-marinedrugs-17-00282"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asolkar</surname><given-names>R.N.</given-names></name><name><surname>Freel</surname><given-names>K.C.</given-names></name><name><surname>Jensen</surname><given-names>P.R.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Kondratyuk</surname><given-names>T.P.</given-names></name><name><surname>Park</surname><given-names>E.J.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name></person-group><article-title>Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1021/np800617a</pub-id><?supplied-pmid 19117399?><pub-id pub-id-type="pmid">19117399</pub-id></element-citation></ref><ref id="B39-marinedrugs-17-00282"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name></person-group><article-title>Targeting cellular apoptotic pathway with peptides from marine organisms</article-title><source>Biochim. Biophys. Acta</source><year>2013</year><volume>1836</volume><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2013.02.006</pub-id><?supplied-pmid 23470652?><pub-id pub-id-type="pmid">23470652</pub-id></element-citation></ref><ref id="B40-marinedrugs-17-00282"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>M.-A.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Ijuin</surname><given-names>Y.</given-names></name><name><surname>Tsuji</surname><given-names>T.</given-names></name><name><surname>Yazawa</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Aburatubolactam A, a novel inhibitor of superoxide anion generation from a marine microorganism</article-title><source>Heterocycl. Commun.</source><year>1996</year><volume>2</volume><fpage>315</fpage><pub-id pub-id-type="doi">10.1515/HC.1996.2.4.315</pub-id></element-citation></ref><ref id="B41-marinedrugs-17-00282"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>M.K.</given-names></name><name><surname>Shen</surname><given-names>Y.-C.</given-names></name><name><surname>Cheng</surname><given-names>X.-C.</given-names></name><name><surname>Jensen</surname><given-names>P.R.</given-names></name><name><surname>Frankmoelle</surname><given-names>W.</given-names></name><name><surname>Kauffman</surname><given-names>C.A.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Lobkovsky</surname><given-names>E.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Cyclomarins A&#x02212;C, New Antiinflammatory Cyclic Peptides Produced by a Marine Bacterium (Streptomyces sp.)</article-title><source>J. Am. Chem. Soc.</source><year>1999</year><volume>121</volume><fpage>11273</fpage><lpage>11276</lpage><pub-id pub-id-type="doi">10.1021/ja992482o</pub-id></element-citation></ref><ref id="B42-marinedrugs-17-00282"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trischman</surname><given-names>J.A.</given-names></name><name><surname>Tapiolas</surname><given-names>D.M.</given-names></name><name><surname>Jensen</surname><given-names>P.R.</given-names></name><name><surname>Dwight</surname><given-names>R.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>McKee</surname><given-names>T.C.</given-names></name><name><surname>Ireland</surname><given-names>C.M.</given-names></name><name><surname>Stout</surname><given-names>T.J.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name></person-group><article-title>Salinamides A and B: Anti-inflammatory depsipeptides from a marine streptomycete</article-title><source>J. Am. Chem. Soc.</source><year>1994</year><volume>116</volume><fpage>757</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1021/ja00081a042</pub-id></element-citation></ref><ref id="B43-marinedrugs-17-00282"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strangman</surname><given-names>W.K.</given-names></name><name><surname>Kwon</surname><given-names>H.C.</given-names></name><name><surname>Broide</surname><given-names>D.</given-names></name><name><surname>Jensen</surname><given-names>P.R.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>2317</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1021/jm801110j</pub-id><pub-id pub-id-type="pmid">19323483</pub-id></element-citation></ref><ref id="B44-marinedrugs-17-00282"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.K.</given-names></name><name><surname>Tiwari</surname><given-names>S.P.</given-names></name><name><surname>Rai</surname><given-names>A.K.</given-names></name><name><surname>Mohapatra</surname><given-names>T.M.</given-names></name></person-group><article-title>Cyanobacteria: An emerging source for drug discovery</article-title><source>J. Antibiot. (Tokyo)</source><year>2011</year><volume>64</volume><fpage>401</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/ja.2011.21</pub-id><pub-id pub-id-type="pmid">21468079</pub-id></element-citation></ref><ref id="B45-marinedrugs-17-00282"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durai</surname><given-names>P.</given-names></name><name><surname>Batool</surname><given-names>M.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name></person-group><article-title>Structure and effects of cyanobacterial lipopolysaccharides</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>4217</fpage><lpage>4230</lpage><pub-id pub-id-type="doi">10.3390/md13074217</pub-id><?supplied-pmid 26198237?><pub-id pub-id-type="pmid">26198237</pub-id></element-citation></ref><ref id="B46-marinedrugs-17-00282"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorgersen</surname><given-names>E.B.</given-names></name><name><surname>Macagno</surname><given-names>A.</given-names></name><name><surname>Rossetti</surname><given-names>C.</given-names></name><name><surname>Mollnes</surname><given-names>T.E.</given-names></name></person-group><article-title>Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig</article-title><source>Mol. Immunol.</source><year>2008</year><volume>45</volume><fpage>3553</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2008.05.005</pub-id><?supplied-pmid 18571239?><pub-id pub-id-type="pmid">18571239</pub-id></element-citation></ref><ref id="B47-marinedrugs-17-00282"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macagno</surname><given-names>A.</given-names></name><name><surname>Molteni</surname><given-names>M.</given-names></name><name><surname>Rinaldi</surname><given-names>A.</given-names></name><name><surname>Bertoni</surname><given-names>F.</given-names></name><name><surname>Lanzavecchia</surname><given-names>A.</given-names></name><name><surname>Rossetti</surname><given-names>C.</given-names></name><name><surname>Sallusto</surname><given-names>F.</given-names></name></person-group><article-title>A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression</article-title><source>J. Exp. Med.</source><year>2006</year><volume>203</volume><fpage>1481</fpage><lpage>1492</lpage><pub-id pub-id-type="doi">10.1084/jem.20060136</pub-id><?supplied-pmid 16717116?><pub-id pub-id-type="pmid">16717116</pub-id></element-citation></ref><ref id="B48-marinedrugs-17-00282"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molteni</surname><given-names>M.</given-names></name><name><surname>Bosi</surname><given-names>A.</given-names></name><name><surname>Rossetti</surname><given-names>C.</given-names></name></person-group><article-title>The effect of cyanobacterial LPS antagonist (CyP) on cytokines and micro-RNA expression Induced by Porphyromonas gingivalis LPS</article-title><source>Toxins (Basel)</source><year>2018</year><volume>10</volume><elocation-id>290</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10070290</pub-id><?supplied-pmid 30012943?><pub-id pub-id-type="pmid">30012943</pub-id></element-citation></ref><ref id="B49-marinedrugs-17-00282"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>F.A.</given-names></name><name><surname>Lieske</surname><given-names>K.</given-names></name><name><surname>Gerwick</surname><given-names>L.</given-names></name></person-group><article-title>Selective MyD88-dependent pathway inhibition by the cyanobacterial natural product malyngamide F acetate</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>629</volume><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.12.002</pub-id><pub-id pub-id-type="pmid">20006962</pub-id></element-citation></ref><ref id="B50-marinedrugs-17-00282"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appel</surname><given-names>K.</given-names></name><name><surname>Munoz</surname><given-names>E.</given-names></name><name><surname>Navarrete</surname><given-names>C.</given-names></name><name><surname>Cruz-Teno</surname><given-names>C.</given-names></name><name><surname>Biller</surname><given-names>A.</given-names></name><name><surname>Thiemann</surname><given-names>E.</given-names></name></person-group><article-title>Immunomodulatory and inhibitory effect of immulina((R)), and immunloges((R)) in the Ig-E mediated activation of RBL-2H3 Cells. A new role in allergic inflammatory responses</article-title><source>Plants (Basel)</source><year>2018</year><volume>7</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3390/plants7010013</pub-id></element-citation></ref><ref id="B51-marinedrugs-17-00282"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.N.</given-names></name><name><surname>Lee</surname><given-names>E.H.</given-names></name><name><surname>Kim</surname><given-names>H.M.</given-names></name></person-group><article-title>Spirulina platensis inhibits anaphylactic reaction</article-title><source>Life Sci.</source><year>1997</year><volume>61</volume><fpage>1237</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(97)00668-1</pub-id><pub-id pub-id-type="pmid">9324065</pub-id></element-citation></ref><ref id="B52-marinedrugs-17-00282"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>J.C.</given-names></name><name><surname>Eksioglu</surname><given-names>E.A.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>5732</fpage><lpage>5747</lpage><pub-id pub-id-type="doi">10.1021/jm9009394</pub-id><pub-id pub-id-type="pmid">19715320</pub-id></element-citation></ref><ref id="B53-marinedrugs-17-00282"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Carroll</surname><given-names>A.R.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2018</year><volume>35</volume><fpage>8</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1039/C7NP00052A</pub-id><pub-id pub-id-type="pmid">29335692</pub-id></element-citation></ref><ref id="B54-marinedrugs-17-00282"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjum</surname><given-names>K.</given-names></name><name><surname>Abbas</surname><given-names>S.Q.</given-names></name><name><surname>Shah</surname><given-names>S.A.</given-names></name><name><surname>Akhter</surname><given-names>N.</given-names></name><name><surname>Batool</surname><given-names>S.</given-names></name><name><surname>Hassan</surname><given-names>S.S.</given-names></name></person-group><article-title>Marine sponges as a drug treasure</article-title><source>Biomol. Ther. (Seoul)</source><year>2016</year><volume>24</volume><fpage>347</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2016.067</pub-id><?supplied-pmid 27350338?><pub-id pub-id-type="pmid">27350338</pub-id></element-citation></ref><ref id="B55-marinedrugs-17-00282"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T.R.</given-names></name><name><surname>Kavlekar</surname><given-names>D.P.</given-names></name><name><surname>LokaBharathi</surname><given-names>P.A.</given-names></name></person-group><article-title>Marine drugs from sponge-microbe association&#x02014;A review</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>1417</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.3390/md8041417</pub-id><pub-id pub-id-type="pmid">20479984</pub-id></element-citation></ref><ref id="B56-marinedrugs-17-00282"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinehart</surname><given-names>K.L.</given-names></name><name><surname>Gloer</surname><given-names>J.B.</given-names></name><name><surname>Cook</surname><given-names>J.C.</given-names></name><name><surname>Mizsak</surname><given-names>S.A.</given-names></name><name><surname>Scahill</surname><given-names>T.A.</given-names></name></person-group><article-title>Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate</article-title><source>J. Am. Chem. Soc.</source><year>1981</year><volume>103</volume><fpage>1857</fpage><lpage>1859</lpage><pub-id pub-id-type="doi">10.1021/ja00397a055</pub-id></element-citation></ref><ref id="B57-marinedrugs-17-00282"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuijen</surname><given-names>B.</given-names></name><name><surname>Bouma</surname><given-names>M.</given-names></name><name><surname>Manada</surname><given-names>C.</given-names></name><name><surname>Jimeno</surname><given-names>J.M.</given-names></name><name><surname>Schellens</surname><given-names>J.H.</given-names></name><name><surname>Bult</surname><given-names>A.</given-names></name><name><surname>Beijnen</surname><given-names>J.H.</given-names></name></person-group><article-title>Pharmaceutical development of anticancer agents derived from marine sources</article-title><source>Anticancer Drugs</source><year>2000</year><volume>11</volume><fpage>793</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1097/00001813-200011000-00003</pub-id><?supplied-pmid 11142687?><pub-id pub-id-type="pmid">11142687</pub-id></element-citation></ref><ref id="B58-marinedrugs-17-00282"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Currano</surname><given-names>J.N.</given-names></name><name><surname>Carroll</surname><given-names>P.J.</given-names></name><name><surname>Joullie</surname><given-names>M.M.</given-names></name></person-group><article-title>Didemnins, tamandarins and related natural products</article-title><source>Nat. Prod. Rep.</source><year>2012</year><volume>29</volume><fpage>404</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1039/c2np00065b</pub-id><?supplied-pmid 22270031?><pub-id pub-id-type="pmid">22270031</pub-id></element-citation></ref><ref id="B59-marinedrugs-17-00282"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>M.D.</given-names></name><name><surname>Joullie</surname><given-names>M.M.</given-names></name></person-group><article-title>Natural products as probes of cell biology: 20 years of didemnin research</article-title><source>Med. Res. Rev.</source><year>2002</year><volume>22</volume><fpage>102</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1002/med.10003</pub-id><pub-id pub-id-type="pmid">11857636</pub-id></element-citation></ref><ref id="B60-marinedrugs-17-00282"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action</article-title><source>Mar. Biotechnol. (N. Y.)</source><year>2004</year><volume>6</volume><fpage>37</fpage><lpage>52</lpage></element-citation></ref><ref id="B61-marinedrugs-17-00282"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Rodriguez</surname><given-names>A.D.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action</article-title><source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source><year>2011</year><volume>153</volume><fpage>191</fpage><lpage>222</lpage><?supplied-pmid 20826228?><pub-id pub-id-type="pmid">20826228</pub-id></element-citation></ref><ref id="B62-marinedrugs-17-00282"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida Leone</surname><given-names>P.</given-names></name><name><surname>Redburn</surname><given-names>J.</given-names></name><name><surname>Hooper</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>R.</given-names></name></person-group><article-title>Polyoxygenated Dysidea sterols that inhibit the binding of [I125] IL-8 to the human recombinant IL-8 receptor type A</article-title><source>J. Nat. Prod.</source><year>2000</year><volume>63</volume><fpage>694</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1021/np9904657</pub-id><?supplied-pmid 10843593?><pub-id pub-id-type="pmid">10843593</pub-id></element-citation></ref><ref id="B63-marinedrugs-17-00282"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romo</surname><given-names>D.</given-names></name><name><surname>Rzasa</surname><given-names>R.M.</given-names></name><name><surname>Shea</surname><given-names>H.A.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Langenhan</surname><given-names>J.M.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Akhiezer</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>J.O.</given-names></name></person-group><article-title>Total Synthesis and Immunosuppressive Activity of (&#x02212;)-Pateamine A and Related Compounds:&#x02009; Implementation of a &#x003b2;-Lactam-Based Macrocyclization</article-title><source>J. Am. Chem. Soc.</source><year>1998</year><volume>120</volume><fpage>12237</fpage><lpage>12254</lpage><pub-id pub-id-type="doi">10.1021/ja981846u</pub-id></element-citation></ref><ref id="B64-marinedrugs-17-00282"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattenden</surname><given-names>G.</given-names></name><name><surname>Critcher</surname><given-names>D.</given-names></name><name><surname>Remui&#x000f1;&#x000e1;n</surname><given-names>M.</given-names></name></person-group><article-title>Total synthesis of (-)-pateamine A, a novel immunosuppressive agent from Mycale sp.</article-title><source>Can. J. Chem.</source><year>2011</year><volume>82</volume><fpage>353</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1139/v03-199</pub-id></element-citation></ref><ref id="B65-marinedrugs-17-00282"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekera</surname><given-names>S.P.</given-names></name><name><surname>Gunasekera</surname><given-names>M.</given-names></name><name><surname>Longley</surname><given-names>R.E.</given-names></name><name><surname>Schulte</surname><given-names>G.K.</given-names></name></person-group><article-title>Discodermolide: A new bioactive polyhydroxylated lactone from the marine sponge Discodermia dissoluta [Erratum to document cited in CA113(9):75187b]</article-title><source>J. Org. Chem.</source><year>1991</year><volume>56</volume><fpage>1346</fpage><pub-id pub-id-type="doi">10.1021/jo00003a090</pub-id></element-citation></ref><ref id="B66-marinedrugs-17-00282"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arefolov</surname><given-names>A.</given-names></name><name><surname>Panek</surname><given-names>J.S.</given-names></name></person-group><article-title>Studies directed toward the total synthesis of discodermolide: Asymmetric synthesis of the C1-C14 fragment</article-title><source>Org. Lett.</source><year>2002</year><volume>4</volume><fpage>2397</fpage><lpage>2400</lpage><pub-id pub-id-type="doi">10.1021/ol026139r</pub-id><?supplied-pmid 12098256?><pub-id pub-id-type="pmid">12098256</pub-id></element-citation></ref><ref id="B67-marinedrugs-17-00282"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamatsu</surname><given-names>S.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Secondary metabolites from marine cyanobacteria and algae inhibit LFA-1/ICAM-1 mediated cell adhesion</article-title><source>Planta Med.</source><year>2004</year><volume>70</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">14994189</pub-id></element-citation></ref><ref id="B68-marinedrugs-17-00282"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malloy</surname><given-names>K.L.</given-names></name><name><surname>Villa</surname><given-names>F.A.</given-names></name><name><surname>Engene</surname><given-names>N.</given-names></name><name><surname>Matainaho</surname><given-names>T.</given-names></name><name><surname>Gerwick</surname><given-names>L.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1021/np1005407</pub-id><pub-id pub-id-type="pmid">21155594</pub-id></element-citation></ref><ref id="B69-marinedrugs-17-00282"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silambarasan</surname><given-names>G.</given-names></name><name><surname>Ramanathan</surname><given-names>T.</given-names></name><name><surname>Nabeel</surname><given-names>M.A.</given-names></name><name><surname>Kalaichelvan</surname><given-names>V.K.</given-names></name><name><surname>Kathiresan</surname><given-names>K.</given-names></name><name><surname>Balasubramanian</surname><given-names>T.</given-names></name></person-group><article-title>Anti-Inflammatory Activity of the Marine Cyanobacterium Trichodesmium Erythraeum against Carrageenan-Induced Paw Oedema in Wistar Albino Rats</article-title><source>Eur. J. Inflam.</source><year>2011</year><volume>9</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1177/1721727X1100900108</pub-id></element-citation></ref><ref id="B70-marinedrugs-17-00282"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantino</surname><given-names>V.</given-names></name><name><surname>Fattorusso</surname><given-names>E.</given-names></name><name><surname>Mangoni</surname><given-names>A.</given-names></name><name><surname>Di Rosa</surname><given-names>M.</given-names></name><name><surname>Ianaro</surname><given-names>A.</given-names></name></person-group><article-title>Glycolipids from sponges. VII.1 simplexides, novel immunosuppressive glycolipids from the caribbean sponge Plakortis simplex</article-title><source>Bioorg. Med. Chem. Lett.</source><year>1999</year><volume>9</volume><fpage>271</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(98)00719-7</pub-id><pub-id pub-id-type="pmid">10021943</pub-id></element-citation></ref><ref id="B71-marinedrugs-17-00282"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loffredo</surname><given-names>S.</given-names></name><name><surname>Staiano</surname><given-names>R.I.</given-names></name><name><surname>Granata</surname><given-names>F.</given-names></name><name><surname>Costantino</surname><given-names>V.</given-names></name><name><surname>Borriello</surname><given-names>F.</given-names></name><name><surname>Frattini</surname><given-names>A.</given-names></name><name><surname>Lepore</surname><given-names>M.T.</given-names></name><name><surname>Mangoni</surname><given-names>A.</given-names></name><name><surname>Marone</surname><given-names>G.</given-names></name><name><surname>Triggiani</surname><given-names>M.</given-names></name></person-group><article-title>Simplexide induces CD1d-dependent cytokine and chemokine production from human monocytes</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e111326</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0111326</pub-id><pub-id pub-id-type="pmid">25390653</pub-id></element-citation></ref><ref id="B72-marinedrugs-17-00282"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busserolles</surname><given-names>J.</given-names></name><name><surname>Paya</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name><name><surname>Alcaraz</surname><given-names>M.J.</given-names></name></person-group><article-title>Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M</article-title><source>Biochem. Pharmacol.</source><year>2005</year><volume>69</volume><fpage>1433</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2005.01.020</pub-id><pub-id pub-id-type="pmid">15857607</pub-id></element-citation></ref><ref id="B73-marinedrugs-17-00282"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>M.</given-names></name><name><surname>Burgoyne</surname><given-names>D.L.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name></person-group><article-title>Effect of contignasterol on histamine release induced by anti-immunoglobulin E from rat peritoneal mast cells</article-title><source>J. Pharm. Sci.</source><year>1994</year><volume>83</volume><fpage>1234</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1002/jps.2600830909</pub-id><pub-id pub-id-type="pmid">7530301</pub-id></element-citation></ref><ref id="B74-marinedrugs-17-00282"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Rhee</surname><given-names>M.H.</given-names></name><name><surname>Kim</surname><given-names>A.R.</given-names></name><name><surname>Jung</surname><given-names>J.H.</given-names></name><name><surname>Chun</surname><given-names>T.</given-names></name><name><surname>Yoo</surname><given-names>E.S.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name></person-group><article-title>In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges</article-title><source>Naunyn Schmiedebergs Arch. Pharmacol.</source><year>2003</year><volume>368</volume><fpage>448</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1007/s00210-003-0848-7</pub-id><pub-id pub-id-type="pmid">14615882</pub-id></element-citation></ref><ref id="B75-marinedrugs-17-00282"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Munro</surname><given-names>M.H.G.</given-names></name></person-group><article-title>Pateamine: A potent cytotoxin from the New Zealand Marine sponge, mycale sp.</article-title><source>Tetrahedron Lett.</source><year>1991</year><volume>32</volume><fpage>6411</fpage><lpage>6414</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(91)80182-6</pub-id></element-citation></ref><ref id="B76-marinedrugs-17-00282"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>W.K.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><name><surname>Schneider-Poetsch</surname><given-names>T.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>N.S.</given-names></name><name><surname>Merrick</surname><given-names>W.C.</given-names></name><name><surname>Romo</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J.O.</given-names></name></person-group><article-title>Inhibition of eukaryotic translation initiation by the marine natural product pateamine A</article-title><source>Mol. Cell</source><year>2005</year><volume>20</volume><fpage>709</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.10.008</pub-id><pub-id pub-id-type="pmid">16337595</pub-id></element-citation></ref><ref id="B77-marinedrugs-17-00282"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname><given-names>M.</given-names></name><name><surname>Umeyama</surname><given-names>A.</given-names></name><name><surname>Shoji</surname><given-names>N.</given-names></name><name><surname>Hashimoto</surname><given-names>T.</given-names></name></person-group><article-title>Polyacetylenediols regulate the function of human monocyte-derived dendritic cells</article-title><source>Int. Immunopharmacol.</source><year>2010</year><volume>10</volume><fpage>913</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2010.05.002</pub-id><pub-id pub-id-type="pmid">20493278</pub-id></element-citation></ref><ref id="B78-marinedrugs-17-00282"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greve</surname><given-names>H.</given-names></name><name><surname>Meis</surname><given-names>S.</given-names></name><name><surname>Kassack</surname><given-names>M.U.</given-names></name><name><surname>Kehraus</surname><given-names>S.</given-names></name><name><surname>Krick</surname><given-names>A.</given-names></name><name><surname>Wright</surname><given-names>A.D.</given-names></name><name><surname>Konig</surname><given-names>G.M.</given-names></name></person-group><article-title>New iantherans from the marine sponge Ianthella quadrangulata: Novel agonists of the P2Y(11) receptor</article-title><source>J. Med. Chem.</source><year>2007</year><volume>50</volume><fpage>5600</fpage><lpage>5607</lpage><pub-id pub-id-type="doi">10.1021/jm070043r</pub-id><pub-id pub-id-type="pmid">17941622</pub-id></element-citation></ref><ref id="B79-marinedrugs-17-00282"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M.E.</given-names></name><name><surname>Johnson</surname><given-names>T.W.</given-names></name></person-group><article-title>First total synthesis of xestobergsterol A and active structural analogues of the xestobergsterols</article-title><source>Org. Lett.</source><year>1999</year><volume>1</volume><fpage>1671</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1021/ol991057x</pub-id><pub-id pub-id-type="pmid">10836028</pub-id></element-citation></ref><ref id="B80-marinedrugs-17-00282"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Berridge</surname><given-names>M.V.</given-names></name></person-group><article-title>Clathriol B, a New 14&#x003b2; Marine Sterol from the New Zealand Sponge Clathria lissosclera</article-title><source>ChemInform</source><year>2003</year><volume>34</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1002/chin.200336156</pub-id></element-citation></ref><ref id="B81-marinedrugs-17-00282"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>M.</given-names></name><name><surname>Cerella</surname><given-names>C.</given-names></name><name><surname>Eifes</surname><given-names>S.</given-names></name><name><surname>Chateauvieux</surname><given-names>S.</given-names></name><name><surname>Morceau</surname><given-names>F.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name><name><surname>Dicato</surname><given-names>M.</given-names></name><name><surname>Diederich</surname><given-names>M.</given-names></name></person-group><article-title>Heteronemin, a spongean sesterterpene, inhibits TNF&#x003b1;-induced NF-&#x003ba;B activation through proteasome inhibition and induces apoptotic cell death</article-title><source>Biochem. Pharmacol.</source><year>2010</year><volume>79</volume><fpage>610</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2009.09.027</pub-id><pub-id pub-id-type="pmid">19814997</pub-id></element-citation></ref><ref id="B82-marinedrugs-17-00282"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Shitany</surname><given-names>N.A.</given-names></name><name><surname>Shaala</surname><given-names>L.A.</given-names></name><name><surname>Abbas</surname><given-names>A.T.</given-names></name><name><surname>Abdel-Dayem</surname><given-names>U.A.</given-names></name><name><surname>Azhar</surname><given-names>E.I.</given-names></name><name><surname>Ali</surname><given-names>S.S.</given-names></name><name><surname>van Soest</surname><given-names>R.W.</given-names></name><name><surname>Youssef</surname><given-names>D.T.</given-names></name></person-group><article-title>Evaluation of the anti-Inflammatory, antioxidant and immunomodulatory effects of the organic extract of the red Sea marine sponge Xestospongia testudinaria against carrageenan induced rat paw inflammation</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0138917</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0138917</pub-id><pub-id pub-id-type="pmid">26422010</pub-id></element-citation></ref><ref id="B83-marinedrugs-17-00282"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kossuga</surname><given-names>M.</given-names></name><name><surname>Nascimento</surname><given-names>A.</given-names></name><name><surname>Reim&#x000e3;o</surname><given-names>J.</given-names></name><name><surname>Tempone</surname><given-names>A.</given-names></name><name><surname>Taniwaki</surname><given-names>N.</given-names></name><name><surname>Veloso</surname><given-names>K.</given-names></name><name><surname>Ferreira</surname><given-names>A.</given-names></name><name><surname>Cavalcanti</surname><given-names>B.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name><name><surname>Moraes</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Antiparasitic, Antineuroinflammatory, and Cytotoxic Polyketides from the Marine Sponge Plakortis angulospiculatus Collected in Brazil</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1021/np0705256</pub-id><pub-id pub-id-type="pmid">18177008</pub-id></element-citation></ref><ref id="B84-marinedrugs-17-00282"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname><given-names>S.</given-names></name><name><surname>Romano</surname><given-names>G.</given-names></name><name><surname>Rusolo</surname><given-names>F.</given-names></name><name><surname>Capone</surname><given-names>F.</given-names></name><name><surname>Guerriero</surname><given-names>E.</given-names></name><name><surname>Colonna</surname><given-names>G.</given-names></name><name><surname>Ianora</surname><given-names>A.</given-names></name><name><surname>Ciliberto</surname><given-names>G.</given-names></name><name><surname>Costantini</surname><given-names>M.</given-names></name></person-group><article-title>Anti-Inflammatory effects of a methanol extract from the marine sponge Geodia cydonium on the human breast cancer MCF-7 cell line</article-title><source>Mediators Inflamm.</source><year>2015</year><volume>2015</volume><fpage>204975</fpage><pub-id pub-id-type="doi">10.1155/2015/204975</pub-id><?supplied-pmid 26491222?><pub-id pub-id-type="pmid">26491222</pub-id></element-citation></ref><ref id="B85-marinedrugs-17-00282"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname><given-names>S.</given-names></name><name><surname>Guerriero</surname><given-names>E.</given-names></name><name><surname>Teta</surname><given-names>R.</given-names></name><name><surname>Capone</surname><given-names>F.</given-names></name><name><surname>Caso</surname><given-names>A.</given-names></name><name><surname>Sorice</surname><given-names>A.</given-names></name><name><surname>Romano</surname><given-names>G.</given-names></name><name><surname>Ianora</surname><given-names>A.</given-names></name><name><surname>Ruocco</surname><given-names>N.</given-names></name><name><surname>Budillon</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Evaluating the effects of an organic extract from the Mediterranean sponge Geodia cydonium on human breast cancer cell lines</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>2112</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18102112</pub-id><?supplied-pmid 28991212?><pub-id pub-id-type="pmid">28991212</pub-id></element-citation></ref><ref id="B86-marinedrugs-17-00282"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Marino</surname><given-names>S.</given-names></name><name><surname>Festa</surname><given-names>C.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>Bourguet-Kondracki</surname><given-names>M.-L.</given-names></name><name><surname>Petek</surname><given-names>S.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Andr&#x000e9;s</surname><given-names>R.M.</given-names></name><name><surname>Terencio</surname><given-names>M.C.</given-names></name><name><surname>Pay&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name></person-group><article-title>Coscinolactams A and B: New nitrogen-containing sesterterpenoids from the marine sponge Coscinoderma mathewsi exerting anti-inflammatory properties</article-title><source>Tetrahedron</source><year>2009</year><volume>65</volume><fpage>2905</fpage><lpage>2909</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2009.02.016</pub-id></element-citation></ref><ref id="B87-marinedrugs-17-00282"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><name><surname>Lu</surname><given-names>M.-C.</given-names></name><name><surname>Su</surname><given-names>J.-H.</given-names></name><name><surname>Chu</surname><given-names>C.-L.</given-names></name><name><surname>Shiuan</surname><given-names>D.</given-names></name><name><surname>Weng</surname><given-names>C.-F.</given-names></name><name><surname>Sung</surname><given-names>P.-J.</given-names></name><name><surname>Huang</surname><given-names>K.-J.</given-names></name></person-group><article-title>Immunomodulatory effect of marine cembrane-type diterpenoids on dendritic cells</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>1336</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.3390/md11041336</pub-id><pub-id pub-id-type="pmid">23609581</pub-id></element-citation></ref><ref id="B88-marinedrugs-17-00282"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Pastor</surname><given-names>P.</given-names></name><name><surname>Randazzo</surname><given-names>A.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name><name><surname>Alcaraz</surname><given-names>M.J.</given-names></name><name><surname>Paya</surname><given-names>M.</given-names></name></person-group><article-title>Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1999</year><volume>289</volume><fpage>166</fpage><pub-id pub-id-type="pmid">10087000</pub-id></element-citation></ref><ref id="B89-marinedrugs-17-00282"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourguet-Kondracki</surname><given-names>M.-L.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Guyot</surname><given-names>M.</given-names></name></person-group><article-title>Dipuupehedione, a cytotoxic new red dimer from a new caledonian marine sponge hyrtios sp.</article-title><source>Tetrahedron Lett.</source><year>1996</year><volume>37</volume><fpage>3861</fpage><lpage>3864</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(96)00700-9</pub-id></element-citation></ref><ref id="B90-marinedrugs-17-00282"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandraraj</surname><given-names>S.</given-names></name><name><surname>Prakash</surname><given-names>B.</given-names></name><name><surname>Navanath</surname><given-names>K.</given-names></name></person-group><article-title>Immunomodulatory activities of ethyl acetate extracts of two marine sponges Gelliodes fibrosa and Tedania anhelans and brown algae Sargassum ilicifolium with reference to phagocytosis</article-title><source>Res. J. Pharm. Biol. Chem. Sci.</source><year>2010</year><volume>1</volume><fpage>302</fpage><lpage>307</lpage></element-citation></ref><ref id="B91-marinedrugs-17-00282"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifai</surname><given-names>S.</given-names></name><name><surname>Fassouane</surname><given-names>A.</given-names></name><name><surname>Pinho</surname><given-names>P.M.</given-names></name><name><surname>Kijjoa</surname><given-names>A.</given-names></name><name><surname>Nazareth</surname><given-names>N.</given-names></name><name><surname>Nascimento</surname><given-names>M.S.J.</given-names></name><name><surname>Herz</surname><given-names>W.</given-names></name></person-group><article-title>Cytotoxicity and inhibition of lymphocyte proliferation of fasciculatin, a linear furanosesterterpene isolated from Ircinia variabilis collected from the Atlantic Coast of Morocco</article-title><source>Mar. Drugs</source><year>2005</year><volume>3</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3390/md301015</pub-id></element-citation></ref><ref id="B92-marinedrugs-17-00282"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvin</surname><given-names>J.</given-names></name><name><surname>Huxley</surname><given-names>A.J.</given-names></name><name><surname>Lipton</surname><given-names>A.P.</given-names></name></person-group><article-title>Immunomodulatory potential of marine secondary metabolites against bacterial diseases of shrimp</article-title><source>Aquaculture</source><year>2004</year><volume>230</volume><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/S0044-8486(03)00427-7</pub-id></element-citation></ref><ref id="B93-marinedrugs-17-00282"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.D.</given-names></name><name><surname>Nagle</surname><given-names>D.G.</given-names></name></person-group><article-title>Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1741</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.1021/np070206e</pub-id><pub-id pub-id-type="pmid">17958397</pub-id></element-citation></ref><ref id="B94-marinedrugs-17-00282"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festa</surname><given-names>C.</given-names></name><name><surname>De Marino</surname><given-names>S.</given-names></name><name><surname>Sepe</surname><given-names>V.</given-names></name><name><surname>Monti</surname><given-names>M.C.</given-names></name><name><surname>Luciano</surname><given-names>P.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>D&#x000e9;bitus</surname><given-names>C.</given-names></name><name><surname>Bucci</surname><given-names>M.</given-names></name><name><surname>Vellecco</surname><given-names>V.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name></person-group><article-title>Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei</article-title><source>Tetrahedron</source><year>2009</year><volume>65</volume><fpage>10424</fpage><lpage>10429</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2009.10.026</pub-id></element-citation></ref><ref id="B95-marinedrugs-17-00282"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>M.C.</given-names></name><name><surname>Ohtani</surname><given-names>I.I.</given-names></name><name><surname>Ichiba</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>J.</given-names></name><name><surname>Satari</surname><given-names>R.</given-names></name><name><surname>Higa</surname><given-names>T.</given-names></name></person-group><article-title>New Cyclic Peptides from the Indonesian Sponge Theonellaswinhoei</article-title><source>Tetrahedron</source><year>2000</year><volume>56</volume><fpage>9079</fpage><lpage>9092</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(00)00762-6</pub-id></element-citation></ref><ref id="B96-marinedrugs-17-00282"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekera</surname><given-names>S.P.</given-names></name><name><surname>Gunasekera</surname><given-names>M.</given-names></name><name><surname>Longley</surname><given-names>R.E.</given-names></name><name><surname>Schulte</surname><given-names>G.K.</given-names></name></person-group><article-title>Discodermolide: A new bioactive polyhydroxylated lactone from the marine sponge Discodermia dissoluta</article-title><source>J. Org. Chem.</source><year>1990</year><volume>55</volume><fpage>4912</fpage><lpage>4915</lpage><pub-id pub-id-type="doi">10.1021/jo00303a029</pub-id></element-citation></ref><ref id="B97-marinedrugs-17-00282"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciasullo</surname><given-names>L.</given-names></name><name><surname>Casapullo</surname><given-names>A.</given-names></name><name><surname>Cutignano</surname><given-names>A.</given-names></name><name><surname>Bifulco</surname><given-names>G.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Hooper</surname><given-names>J.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name><name><surname>Riccio</surname><given-names>R.</given-names></name></person-group><article-title>Renieramide, a cyclic tripeptide from the Vanuatu sponge Reniera n. sp.</article-title><source>J. Nat. Prod.</source><year>2002</year><volume>65</volume><fpage>407</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1021/np010383u</pub-id><?supplied-pmid 11908992?><pub-id pub-id-type="pmid">11908992</pub-id></element-citation></ref><ref id="B98-marinedrugs-17-00282"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>S.-Y.</given-names></name><name><surname>Sofiyev</surname><given-names>V.</given-names></name><name><surname>Schneiderman</surname><given-names>J.</given-names></name><name><surname>Hirschfeld</surname><given-names>A.F.</given-names></name><name><surname>Victor</surname><given-names>R.E.</given-names></name><name><surname>Woods</surname><given-names>K.</given-names></name><name><surname>Piotrowski</surname><given-names>J.S.</given-names></name><name><surname>Deshpande</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>S.C.</given-names></name><name><surname>de Voogd</surname><given-names>N.J.</given-names></name><etal/></person-group><article-title>Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis</article-title><source>ACS Chem. Biol.</source><year>2014</year><volume>9</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1021/cb400740c</pub-id><pub-id pub-id-type="pmid">24117378</pub-id></element-citation></ref><ref id="B99-marinedrugs-17-00282"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youssef</surname><given-names>D.T.</given-names></name><name><surname>Ibrahim</surname><given-names>A.K.</given-names></name><name><surname>Khalifa</surname><given-names>S.I.</given-names></name><name><surname>Mesbah</surname><given-names>M.K.</given-names></name><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>van Soest</surname><given-names>R.W.</given-names></name></person-group><article-title>New anti-inflammatory sterols from the Red Sea sponges Scalarispongia aqabaensis and Callyspongia siphonella</article-title><source>Nat. Prod. Commun.</source><year>2010</year><volume>5</volume><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">20184014</pub-id></element-citation></ref><ref id="B100-marinedrugs-17-00282"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimino</surname><given-names>G.</given-names></name><name><surname>De Rosa</surname><given-names>S.</given-names></name><name><surname>De Stefano</surname><given-names>S.</given-names></name><name><surname>Mazzarella</surname><given-names>L.</given-names></name><name><surname>Puliti</surname><given-names>R.</given-names></name><name><surname>Sodano</surname><given-names>G.</given-names></name></person-group><article-title>Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges</article-title><source>Tetrahedron Lett.</source><year>1982</year><volume>23</volume><fpage>767</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)86943-9</pub-id></element-citation></ref><ref id="B101-marinedrugs-17-00282"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantino</surname><given-names>V.</given-names></name><name><surname>Fattorusso</surname><given-names>E.</given-names></name><name><surname>Mangoni</surname><given-names>A.</given-names></name><name><surname>Perinu</surname><given-names>C.</given-names></name><name><surname>Cirino</surname><given-names>G.</given-names></name><name><surname>De Gruttola</surname><given-names>L.</given-names></name><name><surname>Roviezzo</surname><given-names>F.</given-names></name></person-group><article-title>Tedanol: A potent anti-inflammatory ent-pimarane diterpene from the Caribbean Sponge Tedania ignis</article-title><source>Biorg. Med. Chem.</source><year>2009</year><volume>17</volume><fpage>7542</fpage><lpage>7547</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2009.09.010</pub-id></element-citation></ref><ref id="B102-marinedrugs-17-00282"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castrillo</surname><given-names>A.</given-names></name><name><surname>de Las Heras</surname><given-names>B.</given-names></name><name><surname>Hortelano</surname><given-names>S.</given-names></name><name><surname>Rodriguez</surname><given-names>B.</given-names></name><name><surname>Villar</surname><given-names>A.</given-names></name><name><surname>Bosca</surname><given-names>L.</given-names></name></person-group><article-title>Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>15854</fpage><lpage>15860</lpage><pub-id pub-id-type="doi">10.1074/jbc.M100010200</pub-id><pub-id pub-id-type="pmid">11278990</pub-id></element-citation></ref><ref id="B103-marinedrugs-17-00282"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randazzo</surname><given-names>A.</given-names></name><name><surname>Bifulco</surname><given-names>G.</given-names></name><name><surname>Giannini</surname><given-names>C.</given-names></name><name><surname>Bucci</surname><given-names>M.</given-names></name><name><surname>Debitus</surname><given-names>C.</given-names></name><name><surname>Cirino</surname><given-names>G.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name></person-group><article-title>Halipeptins A and B: Two novel potent anti-inflammatory cyclic depsipeptides from the Vanuatu marine sponge Haliclona species</article-title><source>J. Am. Chem. Soc.</source><year>2001</year><volume>123</volume><fpage>10870</fpage><lpage>10876</lpage><pub-id pub-id-type="doi">10.1021/ja010015c</pub-id><pub-id pub-id-type="pmid">11686688</pub-id></element-citation></ref><ref id="B104-marinedrugs-17-00282"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2001</year><volume>18</volume><fpage>1R</fpage><lpage>49R</lpage><pub-id pub-id-type="doi">10.1039/b006897g</pub-id><pub-id pub-id-type="pmid">11245399</pub-id></element-citation></ref><ref id="B105-marinedrugs-17-00282"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitch</surname><given-names>A.E.</given-names></name><name><surname>Haslett</surname><given-names>C.</given-names></name><name><surname>Rossi</surname><given-names>A.G.</given-names></name></person-group><article-title>Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents</article-title><source>Br. J. Pharmacol.</source><year>2009</year><volume>158</volume><fpage>1004</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00402.x</pub-id><?supplied-pmid 19775281?><pub-id pub-id-type="pmid">19775281</pub-id></element-citation></ref><ref id="B106-marinedrugs-17-00282"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costantino</surname><given-names>V.</given-names></name><name><surname>Fattorusso</surname><given-names>E.</given-names></name><name><surname>Mangoni</surname><given-names>A.</given-names></name><name><surname>Teta</surname><given-names>R.</given-names></name><name><surname>Panza</surname><given-names>E.</given-names></name><name><surname>Ianaro</surname><given-names>A.</given-names></name></person-group><article-title>Terpioside B, a difucosyl GSL from the marine sponge Terpios sp. is a potent inhibitor of NO release</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>5310</fpage><lpage>5315</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2010.05.048</pub-id><?supplied-pmid 20624608?><pub-id pub-id-type="pmid">20624608</pub-id></element-citation></ref><ref id="B107-marinedrugs-17-00282"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ter Haar</surname><given-names>E.</given-names></name><name><surname>Kowalski</surname><given-names>R.J.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Lin</surname><given-names>C.M.</given-names></name><name><surname>Longley</surname><given-names>R.E.</given-names></name><name><surname>Gunasekera</surname><given-names>S.P.</given-names></name><name><surname>Rosenkranz</surname><given-names>H.S.</given-names></name><name><surname>Day</surname><given-names>B.W.</given-names></name></person-group><article-title>Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1021/bi9515127</pub-id><?supplied-pmid 8555181?><pub-id pub-id-type="pmid">8555181</pub-id></element-citation></ref><ref id="B108-marinedrugs-17-00282"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>D.T.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Schreiber</surname><given-names>S.L.</given-names></name></person-group><article-title>(+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest</article-title><source>Chem. Biol.</source><year>1996</year><volume>3</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(96)90108-8</pub-id><pub-id pub-id-type="pmid">8807856</pub-id></element-citation></ref><ref id="B109-marinedrugs-17-00282"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posadas</surname><given-names>I.</given-names></name><name><surname>Terencio</surname><given-names>M.C.</given-names></name><name><surname>Randazzo</surname><given-names>A.</given-names></name><name><surname>Gomez-Paloma</surname><given-names>L.</given-names></name><name><surname>Paya</surname><given-names>M.</given-names></name><name><surname>Alcaraz</surname><given-names>M.J.</given-names></name></person-group><article-title>Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M</article-title><source>Biochem. Pharmacol.</source><year>2003</year><volume>65</volume><fpage>887</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(02)01659-3</pub-id><pub-id pub-id-type="pmid">12628480</pub-id></element-citation></ref><ref id="B110-marinedrugs-17-00282"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacArtain</surname><given-names>P.</given-names></name><name><surname>Gill</surname><given-names>C.I.</given-names></name><name><surname>Brooks</surname><given-names>M.</given-names></name><name><surname>Campbell</surname><given-names>R.</given-names></name><name><surname>Rowland</surname><given-names>I.R.</given-names></name></person-group><article-title>Nutritional value of edible seaweeds</article-title><source>Nutr. Rev.</source><year>2007</year><volume>65</volume><fpage>535</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2007.tb00278.x</pub-id><?supplied-pmid 18236692?><pub-id pub-id-type="pmid">18236692</pub-id></element-citation></ref><ref id="B111-marinedrugs-17-00282"><label>111.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>&#x0010c;ern&#x000e1;</surname><given-names>M.</given-names></name></person-group><article-title>Seaweed Proteins and Amino Acids as Nutraceuticals</article-title><source>Advances in Food and Nutrition Research</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2011</year><volume>Volume 64</volume><fpage>297</fpage><lpage>312</lpage></element-citation></ref><ref id="B112-marinedrugs-17-00282"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misurcova</surname><given-names>L.</given-names></name><name><surname>Skrovankova</surname><given-names>S.</given-names></name><name><surname>Samek</surname><given-names>D.</given-names></name><name><surname>Ambrozova</surname><given-names>J.</given-names></name><name><surname>Machu</surname><given-names>L.</given-names></name></person-group><article-title>Health benefits of algal polysaccharides in human nutrition</article-title><source>Adv. Food Nutr. Res.</source><year>2012</year><volume>66</volume><fpage>75</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">22909979</pub-id></element-citation></ref><ref id="B113-marinedrugs-17-00282"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabarsa</surname><given-names>M.</given-names></name><name><surname>Rezaei</surname><given-names>M.</given-names></name><name><surname>Ramezanpour</surname><given-names>Z.</given-names></name><name><surname>Waaland</surname><given-names>J.R.</given-names></name></person-group><article-title>Chemical compositions of the marine algae Gracilaria salicornia (Rhodophyta) and Ulva lactuca (Chlorophyta) as a potential food source</article-title><source>J. Sci. Food Agric.</source><year>2012</year><volume>92</volume><fpage>2500</fpage><lpage>2506</lpage><pub-id pub-id-type="doi">10.1002/jsfa.5659</pub-id><pub-id pub-id-type="pmid">22467477</pub-id></element-citation></ref><ref id="B114-marinedrugs-17-00282"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajapakse</surname><given-names>N.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group><article-title>Nutritional and digestive health benefits of seaweed</article-title><source>Adv. Food Nutr. Res.</source><year>2011</year><volume>64</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">22054935</pub-id></element-citation></ref><ref id="B115-marinedrugs-17-00282"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.C.</given-names></name><name><surname>Hou</surname><given-names>M.F.</given-names></name><name><surname>Huang</surname><given-names>H.W.</given-names></name><name><surname>Chang</surname><given-names>F.R.</given-names></name><name><surname>Yeh</surname><given-names>C.C.</given-names></name><name><surname>Tang</surname><given-names>J.Y.</given-names></name><name><surname>Chang</surname><given-names>H.W.</given-names></name></person-group><article-title>Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties</article-title><source>Cancer Cell Int.</source><year>2013</year><volume>13</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/1475-2867-13-55</pub-id><?supplied-pmid 23724847?><pub-id pub-id-type="pmid">23724847</pub-id></element-citation></ref><ref id="B116-marinedrugs-17-00282"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makarenkova</surname><given-names>I.D.</given-names></name><name><surname>Logunov</surname><given-names>D.</given-names></name><name><surname>Tukhvatulin</surname><given-names>A.I.</given-names></name><name><surname>Semenova</surname><given-names>I.B.</given-names></name><name><surname>Zviagintheva</surname><given-names>T.N.</given-names></name><name><surname>Gorbach</surname><given-names>V.I.</given-names></name><name><surname>Ermakova</surname><given-names>S.P.</given-names></name><name><surname>Besednova</surname><given-names>N.N.</given-names></name></person-group><article-title>Sulfated polysaccharides of brown seaweeds-ligands of toll-like receptors</article-title><source>Biomed Khim</source><year>2012</year><volume>58</volume><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.18097/pbmc20125803318</pub-id><?supplied-pmid 22856137?><pub-id pub-id-type="pmid">22856137</pub-id></element-citation></ref><ref id="B117-marinedrugs-17-00282"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besednova</surname><given-names>N.N.</given-names></name><name><surname>Zaporozhets</surname><given-names>T.S.</given-names></name><name><surname>Somova</surname><given-names>L.M.</given-names></name><name><surname>Kuznetsova</surname><given-names>T.A.</given-names></name></person-group><article-title>Review: Prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori</article-title><source>Helicobacter</source><year>2015</year><volume>20</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1111/hel.12177</pub-id><?supplied-pmid 25660579?><pub-id pub-id-type="pmid">25660579</pub-id></element-citation></ref><ref id="B118-marinedrugs-17-00282"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Okamoto</surname><given-names>T.</given-names></name><name><surname>Kakinuma</surname><given-names>M.</given-names></name><name><surname>Amano</surname><given-names>H.</given-names></name></person-group><article-title>Anti-allergic effects of the brown alga Eisenia arborea on Brown Norway rats</article-title><source>Fish. Sci.</source><year>2008</year><volume>74</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1111/j.1444-2906.2007.01508.x</pub-id></element-citation></ref><ref id="B119-marinedrugs-17-00282"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Dang</surname><given-names>H.T.</given-names></name><name><surname>Kang</surname><given-names>G.J.</given-names></name><name><surname>Yang</surname><given-names>E.J.</given-names></name><name><surname>Park</surname><given-names>S.S.</given-names></name><name><surname>Yoon</surname><given-names>W.J.</given-names></name><name><surname>Jung</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Yoo</surname><given-names>E.S.</given-names></name></person-group><article-title>Two enone fatty acids isolated from Gracilaria verrucosa suppress the production of inflammatory mediators by down-regulating NF-kappaB and STAT1 activity in lipopolysaccharide-stimulated RAW 264.7 cells</article-title><source>Arch. Pharm. Res.</source><year>2009</year><volume>32</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1007/s12272-009-1320-0</pub-id><?supplied-pmid 19387591?><pub-id pub-id-type="pmid">19387591</pub-id></element-citation></ref><ref id="B120-marinedrugs-17-00282"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro Abreu</surname><given-names>T.</given-names></name><name><surname>Castelo Melo Silva</surname><given-names>L.M.</given-names></name><name><surname>Vanderlei</surname><given-names>E.S.</given-names></name><name><surname>de Melo</surname><given-names>C.M.</given-names></name><name><surname>Pereira</surname><given-names>V.R.</given-names></name><name><surname>Barros Benevides</surname><given-names>N.M.</given-names></name></person-group><article-title>Cytokine production induced by marine algae lectins in BALB/c mice splenocytes</article-title><source>Protein Pept. Lett.</source><year>2012</year><volume>19</volume><fpage>975</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.2174/092986612802084474</pub-id><pub-id pub-id-type="pmid">22486611</pub-id></element-citation></ref><ref id="B121-marinedrugs-17-00282"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overy</surname><given-names>D.P.</given-names></name><name><surname>Bayman</surname><given-names>P.</given-names></name><name><surname>Kerr</surname><given-names>R.G.</given-names></name><name><surname>Bills</surname><given-names>G.F.</given-names></name></person-group><article-title>An assessment of natural product discovery from marine (sensu strictu) and marine-derived fungi</article-title><source>Mycology</source><year>2014</year><volume>5</volume><fpage>145</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1080/21501203.2014.931308</pub-id><pub-id pub-id-type="pmid">25379338</pub-id></element-citation></ref><ref id="B122-marinedrugs-17-00282"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreyfuss</surname><given-names>M.</given-names></name><name><surname>H&#x000e4;rri</surname><given-names>E.</given-names></name><name><surname>Hofmann</surname><given-names>H.</given-names></name><name><surname>Kobel</surname><given-names>H.</given-names></name><name><surname>Pache</surname><given-names>W.</given-names></name><name><surname>Tscherter</surname><given-names>H.</given-names></name></person-group><article-title>Cyclosporin A and C</article-title><source>Eur. J. Appl. Microbiol. Biotechnol.</source><year>1976</year><volume>3</volume><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/BF00928431</pub-id></element-citation></ref><ref id="B123-marinedrugs-17-00282"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name></person-group><article-title>Optimization of cyclosporin A production by Beauveria nivea in continuous fed-batch fermentation</article-title><source>Arch. Biol. Sci. (Serbia)</source><year>2011</year><volume>63</volume><fpage>907</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.2298/ABS1103907D</pub-id></element-citation></ref><ref id="B124-marinedrugs-17-00282"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhosale</surname><given-names>S.H.</given-names></name><name><surname>Patil</surname><given-names>K.B.</given-names></name><name><surname>Parameswaran</surname><given-names>P.S.</given-names></name><name><surname>Naik</surname><given-names>C.G.</given-names></name><name><surname>Jagtap</surname><given-names>T.G.</given-names></name></person-group><article-title>Active pharmaceutical ingredient (api) from an estuarine fungus, Microdochium nivale (Fr.)</article-title><source>J. Environ. Biol.</source><year>2011</year><volume>32</volume><fpage>653</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">22319884</pub-id></element-citation></ref><ref id="B125-marinedrugs-17-00282"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borel</surname><given-names>J.F.</given-names></name><name><surname>Feurer</surname><given-names>C.</given-names></name><name><surname>Magnee</surname><given-names>C.</given-names></name><name><surname>Stahelin</surname><given-names>H.</given-names></name></person-group><article-title>Effects of the new anti-lymphocytic peptide cyclosporin A in animals</article-title><source>Immunology</source><year>1977</year><volume>32</volume><fpage>1017</fpage><lpage>1025</lpage><pub-id pub-id-type="pmid">328380</pub-id></element-citation></ref><ref id="B126-marinedrugs-17-00282"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederrecht</surname><given-names>G.</given-names></name><name><surname>Lam</surname><given-names>E.</given-names></name><name><surname>Hung</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>M.</given-names></name><name><surname>Sigal</surname><given-names>N.</given-names></name></person-group><article-title>The Mechanism of Action of FK-506 and Cyclosporin A</article-title><source>Ann. N. Y. Acad. Sci.</source><year>1993</year><volume>696</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1993.tb17137.x</pub-id><pub-id pub-id-type="pmid">7509138</pub-id></element-citation></ref><ref id="B127-marinedrugs-17-00282"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehgal</surname><given-names>S.N.</given-names></name></person-group><article-title>Sirolimus: Its discovery, biological properties, and mechanism of action</article-title><source>Transplant. Proc.</source><year>2003</year><volume>35</volume><fpage>7S</fpage><lpage>14S</lpage><pub-id pub-id-type="doi">10.1016/S0041-1345(03)00211-2</pub-id><pub-id pub-id-type="pmid">12742462</pub-id></element-citation></ref><ref id="B128-marinedrugs-17-00282"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehgal</surname><given-names>S.N.</given-names></name></person-group><article-title>Rapamune (Sirolimus, rapamycin): An overview and mechanism of action</article-title><source>Ther. Drug Monit.</source><year>1995</year><volume>17</volume><fpage>660</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1097/00007691-199512000-00019</pub-id><pub-id pub-id-type="pmid">8588237</pub-id></element-citation></ref><ref id="B129-marinedrugs-17-00282"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E.J.</given-names></name><name><surname>Albers</surname><given-names>M.W.</given-names></name><name><surname>Shin</surname><given-names>T.B.</given-names></name><name><surname>Ichikawa</surname><given-names>K.</given-names></name><name><surname>Keith</surname><given-names>C.T.</given-names></name><name><surname>Lane</surname><given-names>W.S.</given-names></name><name><surname>Schreiber</surname><given-names>S.L.</given-names></name></person-group><article-title>A mammalian protein targeted by G1-arresting rapamycin-receptor complex</article-title><source>Nature</source><year>1994</year><volume>369</volume><fpage>756</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/369756a0</pub-id><pub-id pub-id-type="pmid">8008069</pub-id></element-citation></ref><ref id="B130-marinedrugs-17-00282"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>H.-T.</given-names></name></person-group><article-title>Immunological properties of the marine brown alga endarachne binghamiae (Phaeophyceae)</article-title><source>Int. J. Appl. Sci. Eng.</source><year>2005</year><volume>3</volume><fpage>167</fpage><lpage>173</lpage></element-citation></ref><ref id="B131-marinedrugs-17-00282"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yende</surname><given-names>S.R.</given-names></name><name><surname>Harle</surname><given-names>U.N.</given-names></name><name><surname>Chaugule</surname><given-names>B.B.</given-names></name></person-group><article-title>Therapeutic potential and health benefits of Sargassum species</article-title><source>Pharmacogn Rev.</source><year>2014</year><volume>8</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4103/0973-7847.125514</pub-id><pub-id pub-id-type="pmid">24600190</pub-id></element-citation></ref><ref id="B132-marinedrugs-17-00282"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>Y.W.</given-names></name><name><surname>Kim</surname><given-names>H.B.</given-names></name><name><surname>Lee</surname><given-names>B.J.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name></person-group><article-title>Anti-apoptotic activity of laminarin polysaccharides and their enzymatically hydrolyzed oligosaccharides from Laminaria japonica</article-title><source>Biotechnol. Lett.</source><year>2006</year><volume>28</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1007/s10529-005-6177-9</pub-id><?supplied-pmid 16614911?><pub-id pub-id-type="pmid">16614911</pub-id></element-citation></ref><ref id="B133-marinedrugs-17-00282"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.Y.</given-names></name><name><surname>Hwang</surname><given-names>C.J.</given-names></name><name><surname>Lee</surname><given-names>H.P.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Han</surname><given-names>S.B.</given-names></name><name><surname>Hong</surname><given-names>J.T.</given-names></name></person-group><article-title>Inhibitory effect of ethanol extract of Nannochloropsis oceanica on lipopolysaccharide-induced neuroinflammation, oxidative stress, amyloidogenesis and memory impairment</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>45517</fpage><lpage>45530</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.17268</pub-id><?supplied-pmid 28489589?><pub-id pub-id-type="pmid">28489589</pub-id></element-citation></ref><ref id="B134-marinedrugs-17-00282"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnjanapratum</surname><given-names>S.</given-names></name><name><surname>You</surname><given-names>S.</given-names></name></person-group><article-title>Molecular characteristics of sulfated polysaccharides from Monostroma nitidum and their in vitro anticancer and immunomodulatory activities</article-title><source>Int. J. Biol. Macromol.</source><year>2011</year><volume>48</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2010.12.002</pub-id><?supplied-pmid 21145343?><pub-id pub-id-type="pmid">21145343</pub-id></element-citation></ref><ref id="B135-marinedrugs-17-00282"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okai</surname><given-names>Y.</given-names></name><name><surname>Higashi-Okai</surname><given-names>K.</given-names></name><name><surname>Ishizaka</surname><given-names>S.</given-names></name><name><surname>Ohtani</surname><given-names>K.</given-names></name><name><surname>Matsui-Yuasa</surname><given-names>I.</given-names></name><name><surname>Yamashita</surname><given-names>U.</given-names></name></person-group><article-title>Possible immunodulating activities in an extract of edible brown alga, Hijikia fusiforme (Hijiki)</article-title><source>J. Sci. Food Agric.</source><year>1998</year><volume>76</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0010(199801)76:1&#x0003c;56::AID-JSFA927&#x0003e;3.0.CO;2-L</pub-id></element-citation></ref><ref id="B136-marinedrugs-17-00282"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>J.H.</given-names></name><name><surname>Son</surname><given-names>E.</given-names></name><name><surname>Pyo</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name></person-group><article-title>Novel sulfated polysaccharide derived from red-tide microalga Gyrodinium impudicum strain KG03 with immunostimulating activity in vivo</article-title><source>Mar. Biotechnol. (N. Y.)</source><year>2005</year><volume>7</volume><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1007/s10126-004-0404-6</pub-id><?supplied-pmid 15976942?><pub-id pub-id-type="pmid">15976942</pub-id></element-citation></ref><ref id="B137-marinedrugs-17-00282"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>H.</given-names></name><name><surname>Noda</surname><given-names>H.</given-names></name><name><surname>Amano</surname><given-names>H.</given-names></name><name><surname>Zhuaug</surname><given-names>C.</given-names></name><name><surname>Mizuno</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name></person-group><article-title>Antitumor activity and immunological properties of marine algal polysaccharides, especially fucoidan, prepared from Sargassum thunbergii of Phaeophyceae</article-title><source>Anticancer Res.</source><year>1993</year><volume>13</volume><fpage>2045</fpage><lpage>2052</lpage><pub-id pub-id-type="pmid">8297113</pub-id></element-citation></ref><ref id="B138-marinedrugs-17-00282"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>B.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Kuroda</surname><given-names>E.</given-names></name><name><surname>Yamashita</surname><given-names>U.</given-names></name></person-group><article-title>Brief communication immunomodulating activity of seaweed extract on human lymphocytes in vitro</article-title><source>Int. J. Immunopharmacol.</source><year>1999</year><volume>21</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0192-0561(98)00063-0</pub-id><pub-id pub-id-type="pmid">10411282</pub-id></element-citation></ref><ref id="B139-marinedrugs-17-00282"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name></person-group><article-title>In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus</article-title><source>Pharmacol. Res.</source><year>2004</year><volume>50</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2003.12.002</pub-id><?supplied-pmid 15082028?><pub-id pub-id-type="pmid">15082028</pub-id></element-citation></ref><ref id="B140-marinedrugs-17-00282"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>S.</given-names></name><name><surname>Gato</surname><given-names>A.</given-names></name><name><surname>Lamela</surname><given-names>M.</given-names></name><name><surname>Freire-Garabal</surname><given-names>M.</given-names></name><name><surname>Calleja</surname><given-names>J.M.</given-names></name></person-group><article-title>Anti-inflammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum</article-title><source>Phytother. Res.</source><year>2003</year><volume>17</volume><fpage>665</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1002/ptr.1227</pub-id><?supplied-pmid 12820237?><pub-id pub-id-type="pmid">12820237</pub-id></element-citation></ref><ref id="B141-marinedrugs-17-00282"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname><given-names>M.</given-names></name><name><surname>Sabina</surname><given-names>E.P.</given-names></name></person-group><article-title>Appraisal of immunomodulatory potential of Spirulina fusiformis: An in vivo and in vitro study</article-title><source>J. Nat. Med.</source><year>2009</year><volume>63</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1007/s11418-008-0308-2</pub-id><pub-id pub-id-type="pmid">19093070</pub-id></element-citation></ref><ref id="B142-marinedrugs-17-00282"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname><given-names>M.</given-names></name><name><surname>Sabina</surname><given-names>E.P.</given-names></name><name><surname>Lavanya</surname><given-names>B.</given-names></name></person-group><article-title>Anti-inflammatory effect of Spirulina fusiformis on adjuvant-induced arthritis in mice</article-title><source>Biol. Pharm. Bull.</source><year>2006</year><volume>29</volume><fpage>2483</fpage><lpage>2487</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.2483</pub-id><pub-id pub-id-type="pmid">17142986</pub-id></element-citation></ref><ref id="B143-marinedrugs-17-00282"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.T.</given-names></name><name><surname>Williamson</surname><given-names>R.T.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Watts</surname><given-names>K.S.</given-names></name><name><surname>McGough</surname><given-names>K.</given-names></name><name><surname>Jacobs</surname><given-names>R.</given-names></name></person-group><article-title>cis,cis- and trans,trans-ceratospongamide, new bioactive cyclic heptapeptides from the Indonesian red alga Ceratodictyon spongiosum and symbiotic sponge Sigmadocia symbiotica</article-title><source>J. Org. Chem.</source><year>2000</year><volume>65</volume><fpage>419</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1021/jo991165x</pub-id><pub-id pub-id-type="pmid">10813950</pub-id></element-citation></ref><ref id="B144-marinedrugs-17-00282"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>T.</given-names></name><name><surname>Nagayama</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Yamaguchi</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory effects of brown algal phlorotannins on secretory phospholipase A2s, lipoxygenases and cyclooxygenases</article-title><source>J. Appl. Phycol.</source><year>2003</year><volume>15</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1023/A:1022972221002</pub-id></element-citation></ref><ref id="B145-marinedrugs-17-00282"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>H.A.</given-names></name><name><surname>Jin</surname><given-names>S.E.</given-names></name><name><surname>Ahn</surname><given-names>B.R.</given-names></name><name><surname>Lee</surname><given-names>C.M.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name></person-group><article-title>Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>59</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.05.061</pub-id><pub-id pub-id-type="pmid">23774261</pub-id></element-citation></ref><ref id="B146-marinedrugs-17-00282"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Le</surname><given-names>Q.-T.</given-names></name><name><surname>Kim</surname><given-names>M.-M.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name></person-group><article-title>Anti-allergic effects of phlorotannins on histamine release via binding inhibition between IgE and Fc epsilonRI</article-title><source>J. Agric. Food Chem.</source><year>2008</year><volume>56</volume><fpage>12073</fpage><lpage>12080</lpage><pub-id pub-id-type="doi">10.1021/jf802732n</pub-id><pub-id pub-id-type="pmid">19053379</pub-id></element-citation></ref><ref id="B147-marinedrugs-17-00282"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>Q.-T.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Z.-J.</given-names></name><name><surname>Kim</surname><given-names>M.-M.</given-names></name><name><surname>Kim</surname><given-names>S.-K.</given-names></name></person-group><article-title>Inhibitory effects of polyphenols isolated from marine alga Ecklonia cava on histamine release</article-title><source>Process Biochem.</source><year>2009</year><volume>44</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2008.10.002</pub-id></element-citation></ref><ref id="B148-marinedrugs-17-00282"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.S.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Norris</surname><given-names>J.N.</given-names></name><name><surname>de Carvalho</surname><given-names>M.S.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name></person-group><article-title>Phospholipase A2 inhibitors from marine algae</article-title><source>Hydrobiologia</source><year>1993</year><volume>260</volume><fpage>521</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1007/BF00049065</pub-id></element-citation></ref><ref id="B149-marinedrugs-17-00282"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name></person-group><article-title>The Anti-Inflammatory Effect and Structure of EPCP1-2 from Crypthecodinium cohnii via Modulation of TLR4-NF-&#x003ba;B Pathways in LPS-Induced RAW 264.7 Cells</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>376</elocation-id><pub-id pub-id-type="doi">10.3390/md15120376</pub-id></element-citation></ref><ref id="B150-marinedrugs-17-00282"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>S.Y.</given-names></name><name><surname>Yim</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name><name><surname>Pyo</surname><given-names>S.</given-names></name></person-group><article-title>Activation of murine peritoneal macrophages by sulfated exopolysaccharide from marine microalga Gyrodinium impudicum (strain KG03): Involvement of the NF-kappa B and JNK pathway</article-title><source>Int. Immunopharmacol.</source><year>2006</year><volume>6</volume><fpage>473</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2005.09.009</pub-id><?supplied-pmid 16428083?><pub-id pub-id-type="pmid">16428083</pub-id></element-citation></ref><ref id="B151-marinedrugs-17-00282"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N.J.</given-names></name><name><surname>Han</surname><given-names>S.C.</given-names></name><name><surname>Kang</surname><given-names>G.J.</given-names></name><name><surname>Koo</surname><given-names>D.H.</given-names></name><name><surname>Koh</surname><given-names>Y.S.</given-names></name><name><surname>Hyun</surname><given-names>J.W.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name><name><surname>Ko</surname><given-names>M.H.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Yoo</surname><given-names>E.S.</given-names></name></person-group><article-title>Diphlorethohydroxycarmalol inhibits interleukin-6 production by regulating NF-kappaB, STAT5 and SOCS1 in lipopolysaccharide-stimulated RAW264.7 cells</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>2141</fpage><lpage>2157</lpage><pub-id pub-id-type="doi">10.3390/md13042141</pub-id><?supplied-pmid 25871292?><pub-id pub-id-type="pmid">25871292</pub-id></element-citation></ref><ref id="B152-marinedrugs-17-00282"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellogg</surname><given-names>J.</given-names></name><name><surname>Esposito</surname><given-names>D.</given-names></name><name><surname>Grace</surname><given-names>M.</given-names></name><name><surname>Komarnytsky</surname><given-names>S.</given-names></name><name><surname>Ann Lila</surname><given-names>M.</given-names></name></person-group><article-title>Alaskan seaweeds lower inflammation in RAW 264.7 macrophages and decrease lipid accumulation in 3T3-L1 adipocytes</article-title><source>J. Funct. Foods</source><year>2015</year><volume>15</volume><fpage>396</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2015.03.049</pub-id></element-citation></ref><ref id="B153-marinedrugs-17-00282"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orsi</surname><given-names>C.F.</given-names></name><name><surname>Colombari</surname><given-names>B.</given-names></name><name><surname>Callegari</surname><given-names>F.</given-names></name><name><surname>Todaro</surname><given-names>A.M.</given-names></name><name><surname>Ardizzoni</surname><given-names>A.</given-names></name><name><surname>Rossini</surname><given-names>G.P.</given-names></name><name><surname>Blasi</surname><given-names>E.</given-names></name><name><surname>Peppoloni</surname><given-names>S.</given-names></name></person-group><article-title>Yessotoxin inhibits phagocytic activity of macrophages</article-title><source>Toxicon</source><year>2010</year><volume>55</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2009.07.033</pub-id><?supplied-pmid 19647763?><pub-id pub-id-type="pmid">19647763</pub-id></element-citation></ref><ref id="B154-marinedrugs-17-00282"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso</surname><given-names>A.</given-names></name><name><surname>Vieytes</surname><given-names>M.R.</given-names></name><name><surname>Botana</surname><given-names>L.M.</given-names></name></person-group><article-title>Yessotoxin, a Promising Therapeutic Tool</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3390/md14020030</pub-id><?supplied-pmid 26828502?><pub-id pub-id-type="pmid">26828502</pub-id></element-citation></ref><ref id="B155-marinedrugs-17-00282"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>San-Martin</surname><given-names>A.</given-names></name><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>Astudillo</surname><given-names>L.</given-names></name><name><surname>Sepulveda</surname><given-names>B.</given-names></name><name><surname>Ruiz</surname><given-names>D.</given-names></name><name><surname>San-Martin</surname><given-names>C.</given-names></name></person-group><article-title>Biotransformation of the marine sesquiterpene pacifenol by a facultative marine fungus</article-title><source>Nat. Prod. Res.</source><year>2008</year><volume>22</volume><fpage>1627</fpage><lpage>1632</lpage><pub-id pub-id-type="doi">10.1080/14786410701869440</pub-id><pub-id pub-id-type="pmid">19085420</pub-id></element-citation></ref><ref id="B156-marinedrugs-17-00282"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Qian</surname><given-names>Z.J.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group><article-title>Inhibitors of oxidation and matrix metalloproteinases, floridoside, and D-isofloridoside from marine red alga Laurencia undulata</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>578</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1021/jf902811j</pub-id><?supplied-pmid 20017487?><pub-id pub-id-type="pmid">20017487</pub-id></element-citation></ref><ref id="B157-marinedrugs-17-00282"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>B.</given-names></name><name><surname>Ferrandiz</surname><given-names>M.L.</given-names></name><name><surname>Sanz</surname><given-names>M.J.</given-names></name><name><surname>Terencio</surname><given-names>M.C.</given-names></name><name><surname>Ubeda</surname><given-names>A.</given-names></name><name><surname>Rovirosa</surname><given-names>J.</given-names></name><name><surname>San-Martin</surname><given-names>A.</given-names></name><name><surname>Alcaraz</surname><given-names>M.J.</given-names></name><name><surname>Paya</surname><given-names>M.</given-names></name></person-group><article-title>Inhibition of inflammatory responses by epitaondiol and other marine natural products</article-title><source>Life Sci.</source><year>1995</year><volume>57</volume><fpage>PL25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(95)00260-D</pub-id><pub-id pub-id-type="pmid">7603289</pub-id></element-citation></ref><ref id="B158-marinedrugs-17-00282"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llanio</surname><given-names>M.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>M.D.</given-names></name><name><surname>Cabrera</surname><given-names>B.</given-names></name><name><surname>Bermejo</surname><given-names>P.</given-names></name><name><surname>Abad</surname><given-names>M.</given-names></name><name><surname>Pay&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Alcaraz</surname><given-names>M.-J.</given-names></name></person-group><article-title>The marine plant thalassia testudinum possesses anti-inflammatory and analgesic properties</article-title><source>Pharmacologyonline</source><year>2006</year><volume>3</volume><fpage>594</fpage><lpage>600</lpage></element-citation></ref><ref id="B159-marinedrugs-17-00282"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>P.B.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name></person-group><article-title>Fuscoside: An anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part I: Physiological and biochemical studies in murine inflammatory models</article-title><source>J. Pharmacol. Exp. Ther.</source><year>1992</year><volume>262</volume><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">1501127</pub-id></element-citation></ref><ref id="B160-marinedrugs-17-00282"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folmer</surname><given-names>F.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name><name><surname>Schumacher</surname><given-names>M.</given-names></name><name><surname>Dicato</surname><given-names>M.</given-names></name><name><surname>Diederich</surname><given-names>M.</given-names></name></person-group><article-title>Marine natural products targeting phospholipases A2</article-title><source>Biochem. Pharmacol.</source><year>2010</year><volume>80</volume><fpage>1793</fpage><lpage>1800</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2010.08.024</pub-id><?supplied-pmid 20833149?><pub-id pub-id-type="pmid">20833149</pub-id></element-citation></ref><ref id="B161-marinedrugs-17-00282"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Davies-Coleman</surname><given-names>M.T.</given-names></name></person-group><article-title>Anti-inflammatory metabolites from marine sponges</article-title><source>Chem. Soc. Rev.</source><year>2005</year><volume>34</volume><fpage>355</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1039/b408600g</pub-id><?supplied-pmid 15778769?><pub-id pub-id-type="pmid">15778769</pub-id></element-citation></ref><ref id="B162-marinedrugs-17-00282"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>B.C.</given-names></name><name><surname>Faulkner</surname><given-names>D.J.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name></person-group><article-title>Phospholipase A2 inhibitors from marine organisms</article-title><source>J. Nat. Prod.</source><year>1992</year><volume>55</volume><fpage>1701</fpage><lpage>1717</lpage><pub-id pub-id-type="doi">10.1021/np50090a001</pub-id><?supplied-pmid 1294693?><pub-id pub-id-type="pmid">1294693</pub-id></element-citation></ref><ref id="B163-marinedrugs-17-00282"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.-Y.</given-names></name><name><surname>Cai</surname><given-names>S.-X.</given-names></name><name><surname>Zhang</surname><given-names>W.-J.</given-names></name><name><surname>Tang</surname><given-names>X.-L.</given-names></name><name><surname>Shin</surname><given-names>H.-Y.</given-names></name><name><surname>Lee</surname><given-names>J.-Y.</given-names></name><name><surname>Gu</surname><given-names>Q.-Q.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name></person-group><article-title>Semi-vioxanthin Isolated from marine-derived fungus regulates tumor necrosis factor-&#x003b1;, cluster of differentiation (CD) 80, CD86, and major histocompatibility complex class II expression in RAW264.7 cells via nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways</article-title><source>Biol. Pharm. Bull.</source><year>2008</year><volume>31</volume><fpage>2228</fpage><lpage>2233</lpage><?supplied-pmid 19043204?><pub-id pub-id-type="pmid">19043204</pub-id></element-citation></ref><ref id="B164-marinedrugs-17-00282"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Jung</surname><given-names>S.Y.</given-names></name><name><surname>Zheng</surname><given-names>B.</given-names></name><name><surname>Soh</surname><given-names>B.Y.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Gu</surname><given-names>Q.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name></person-group><article-title>Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-kappaB</article-title><source>J. Neuroimmunol.</source><year>2009</year><volume>216</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2009.09.004</pub-id><pub-id pub-id-type="pmid">19815299</pub-id></element-citation></ref><ref id="B165-marinedrugs-17-00282"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.X.</given-names></name><name><surname>Crews</surname><given-names>M.S.</given-names></name><name><surname>Draskovic</surname><given-names>M.</given-names></name><name><surname>Sohn</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>T.A.</given-names></name><name><surname>Tenney</surname><given-names>K.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name><name><surname>Yao</surname><given-names>X.J.</given-names></name><name><surname>Bjeldanes</surname><given-names>L.F.</given-names></name><name><surname>Crews</surname><given-names>P.</given-names></name></person-group><article-title>Azonazine, a novel dipeptide from a Hawaiian marine sediment-derived fungus, Aspergillus insulicola</article-title><source>Org. Lett.</source><year>2010</year><volume>12</volume><fpage>4458</fpage><lpage>4461</lpage><pub-id pub-id-type="doi">10.1021/ol101396n</pub-id><pub-id pub-id-type="pmid">20866076</pub-id></element-citation></ref><ref id="B166-marinedrugs-17-00282"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>She</surname><given-names>Z.</given-names></name></person-group><article-title>Dichloroisocoumarins with potential anti-Inflammatory activity from the mangrove endophytic fungus Ascomycota sp. CYSK-4</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>54</elocation-id><pub-id pub-id-type="doi">10.3390/md16020054</pub-id></element-citation></ref><ref id="B167-marinedrugs-17-00282"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Kang</surname><given-names>M.C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>E.A.</given-names></name><name><surname>Kang</surname><given-names>S.M.</given-names></name><name><surname>Jeon</surname><given-names>Y.J.</given-names></name></person-group><article-title>Anti-inflammatory activity of questinol isolated from marine-derived fungus Eurotium amstelodami in lipopolysaccharide-stimulated RAW 264.7 macrophages</article-title><source>J. Microbiol. Biotechnol.</source><year>2014</year><volume>24</volume><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.4014/jmb.1405.05035</pub-id><pub-id pub-id-type="pmid">24986678</pub-id></element-citation></ref><ref id="B168-marinedrugs-17-00282"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayeka</surname><given-names>P.A.</given-names></name></person-group><article-title>Potential of mushroom compounds as immunomodulators in cancer immunotherapy: A review</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2018</year><volume>2018</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1155/2018/7271509</pub-id></element-citation></ref><ref id="B169-marinedrugs-17-00282"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandaranayake</surname><given-names>W.M.</given-names></name></person-group><article-title>Traditional and medicinal uses of mangroves</article-title><source>Mangroves Salt Marshes</source><year>1998</year><volume>2</volume><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1023/A:1009988607044</pub-id></element-citation></ref><ref id="B170-marinedrugs-17-00282"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>K.</given-names></name></person-group><article-title>A review of studies on Pichavaram mangrove, southeast India</article-title><source>Hydrobiologia</source><year>2000</year><volume>430</volume><fpage>185</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1023/A:1004085417093</pub-id></element-citation></ref><ref id="B171-marinedrugs-17-00282"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahim</surname><given-names>A.A.</given-names></name><name><surname>Rocca</surname><given-names>E.</given-names></name><name><surname>Steinmetz</surname><given-names>J.</given-names></name><name><surname>Jain Kassim</surname><given-names>M.</given-names></name><name><surname>Sani Ibrahim</surname><given-names>M.</given-names></name><name><surname>Osman</surname><given-names>H.</given-names></name></person-group><article-title>Antioxidant activities of mangrove Rhizophora apiculata bark extracts</article-title><source>Food Chem.</source><year>2008</year><volume>107</volume><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2007.08.005</pub-id></element-citation></ref><ref id="B172-marinedrugs-17-00282"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahim</surname><given-names>A.A.</given-names></name><name><surname>Rocca</surname><given-names>E.</given-names></name><name><surname>Steinmetz</surname><given-names>J.</given-names></name><name><surname>Kassim</surname><given-names>M.J.</given-names></name><name><surname>Adnan</surname><given-names>R.</given-names></name><name><surname>Sani Ibrahim</surname><given-names>M.</given-names></name></person-group><article-title>Mangrove tannins and their flavanoid monomers as alternative steel corrosion inhibitors in acidic medium</article-title><source>Corros. Sci.</source><year>2007</year><volume>49</volume><fpage>402</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.corsci.2006.04.013</pub-id></element-citation></ref><ref id="B173-marinedrugs-17-00282"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agoramoorthy</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>F.-A.</given-names></name><name><surname>Venkatesalu</surname><given-names>V.</given-names></name><name><surname>Kuo</surname><given-names>D.-H.</given-names></name><name><surname>Shea</surname><given-names>P.-C.</given-names></name></person-group><article-title>Evaluation of antioxidant Polyphenols from selected mangrove plants of India</article-title><source>Asian J. Chem.</source><year>2008</year><volume>20</volume><fpage>1311</fpage></element-citation></ref><ref id="B174-marinedrugs-17-00282"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Premanathan</surname><given-names>M.</given-names></name><name><surname>Arakaki</surname><given-names>R.</given-names></name><name><surname>Izumi</surname><given-names>H.</given-names></name><name><surname>Kathiresan</surname><given-names>K.</given-names></name><name><surname>Nakano</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Nakashima</surname><given-names>H.</given-names></name></person-group><article-title>Antiviral properties of a mangrove plant, Rhizophora apiculata Blume, against human immunodeficiency virus</article-title><source>Antiviral Res.</source><year>1999</year><volume>44</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(99)00058-3</pub-id><pub-id pub-id-type="pmid">10669261</pub-id></element-citation></ref><ref id="B175-marinedrugs-17-00282"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhu</surname><given-names>V.V.</given-names></name><name><surname>Guruvayoorappan</surname><given-names>C.</given-names></name></person-group><article-title>Anti-inflammatory and anti-tumor activity of the marine mangrove Rhizophora apiculata</article-title><source>J. Immunotoxicol.</source><year>2012</year><volume>9</volume><fpage>341</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.3109/1547691X.2012.660997</pub-id><pub-id pub-id-type="pmid">22800297</pub-id></element-citation></ref><ref id="B176-marinedrugs-17-00282"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehrotra</surname><given-names>S.</given-names></name><name><surname>Mishra</surname><given-names>K.P.</given-names></name><name><surname>Maurya</surname><given-names>R.</given-names></name><name><surname>Srimal</surname><given-names>R.C.</given-names></name><name><surname>Yadav</surname><given-names>V.S.</given-names></name><name><surname>Pandey</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>V.K.</given-names></name></person-group><article-title>Anticellular and immunosuppressive properties of ethanolic extract of Acorus calamus rhizome</article-title><source>Int. Immunopharmacol.</source><year>2003</year><volume>3</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(02)00212-6</pub-id><pub-id pub-id-type="pmid">12538034</pub-id></element-citation></ref><ref id="B177-marinedrugs-17-00282"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>R.R.</given-names></name><name><surname>Leo Neto</surname><given-names>N.A.</given-names></name><name><surname>Brooks</surname><given-names>S.E.</given-names></name><name><surname>Albuquerque</surname><given-names>U.P.</given-names></name></person-group><article-title>Commercialization of animal-derived remedies as complementary medicine in the semi-arid region of Northeastern Brazil</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>124</volume><fpage>600</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.04.049</pub-id><pub-id pub-id-type="pmid">19422902</pub-id></element-citation></ref><ref id="B178-marinedrugs-17-00282"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A.M.</given-names></name><name><surname>Jacobson</surname><given-names>P.B.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name><name><surname>Jacobs</surname><given-names>R.S.</given-names></name><name><surname>Glaser</surname><given-names>K.B.</given-names></name></person-group><article-title>Pharmacological characterization of the pseudopterosins: Novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae</article-title><source>Life Sci.</source><year>1998</year><volume>62</volume><fpage>PL401-7</fpage><pub-id pub-id-type="doi">10.1016/S0024-3205(98)00229-X</pub-id><pub-id pub-id-type="pmid">9651113</pub-id></element-citation></ref><ref id="B179-marinedrugs-17-00282"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>V.</given-names></name><name><surname>Pennington</surname><given-names>M.W.</given-names></name><name><surname>Norton</surname><given-names>R.S.</given-names></name><name><surname>Tarcha</surname><given-names>E.J.</given-names></name><name><surname>Londono</surname><given-names>L.M.</given-names></name><name><surname>Sims-Fahey</surname><given-names>B.</given-names></name><name><surname>Upadhyay</surname><given-names>S.K.</given-names></name><name><surname>Lakey</surname><given-names>J.T.</given-names></name><name><surname>Iadonato</surname><given-names>S.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases</article-title><source>Toxicon</source><year>2012</year><volume>59</volume><fpage>529</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2011.07.016</pub-id><pub-id pub-id-type="pmid">21867724</pub-id></element-citation></ref><ref id="B180-marinedrugs-17-00282"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponkshe</surname><given-names>C.A.</given-names></name><name><surname>Indap</surname><given-names>M.M.</given-names></name></person-group><article-title>In vivo and in vitro evaluation for immunomodulatory activity of three marine animal extracts with reference to phagocytosis</article-title><source>Indian J. Exp. Biol.</source><year>2002</year><volume>40</volume><fpage>1399</fpage><lpage>1402</lpage><pub-id pub-id-type="pmid">12974404</pub-id></element-citation></ref><ref id="B181-marinedrugs-17-00282"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Mei</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Anti-Inflammatory effects of a Mytilus coruscus alpha-d-glucan (MP-A) in activated macrophage cells via TLR4/NF-kappaB/MAPK pathway Inhibition</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.3390/md15090294</pub-id></element-citation></ref><ref id="B182-marinedrugs-17-00282"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monmai</surname><given-names>C.</given-names></name><name><surname>Go</surname><given-names>S.H.</given-names></name><name><surname>Shin</surname><given-names>I.S.</given-names></name><name><surname>You</surname><given-names>S.G.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>S.B.</given-names></name><name><surname>Park</surname><given-names>W.J.</given-names></name></person-group><article-title>Immune-enhancement and anti-Inflammatory activities of fatty acids extracted from Halocynthia aurantium tunic in RAW264.7 cells</article-title><source>Mar. Drugs</source><year>2018</year><volume>16</volume><elocation-id>309</elocation-id><pub-id pub-id-type="doi">10.3390/md16090309</pub-id></element-citation></ref><ref id="B183-marinedrugs-17-00282"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>H.</given-names></name><name><surname>Hamasaki</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>K.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>Y.</given-names></name><name><surname>Udagawa</surname><given-names>S.-I.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name></person-group><article-title>Isolation of 2-acetylamino-3-hydroxy-4-methyloct-6-enoic acid, a derivative of the &#x0201c;C9-amino acid&#x0201d; residue of cyclosporins, produced by the fungus Neocosmospora vasinfecta E. F. Smith</article-title><source>Agric. Biol. Chem.</source><year>1988</year><volume>52</volume><fpage>1621</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.1080/00021369.1988.10868854</pub-id></element-citation></ref><ref id="B184-marinedrugs-17-00282"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>D.C.</given-names></name><name><surname>Yoon</surname><given-names>C.S.</given-names></name><name><surname>Ko</surname><given-names>W.M.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name><name><surname>Sohn</surname><given-names>J.H.</given-names></name><name><surname>Jang</surname><given-names>J.H.</given-names></name><name><surname>Ahn</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name></person-group><article-title>Anti-neuroinflammatory effects of citreohybridonol involving TLR4-MyD88-mediated inhibition of NF-small ka, CyrillicB and MAPK signaling pathways in lipopolysaccharide-stimulated BV2 cells</article-title><source>Neurochem. Int.</source><year>2016</year><volume>95</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2015.12.010</pub-id><pub-id pub-id-type="pmid">26724567</pub-id></element-citation></ref><ref id="B185-marinedrugs-17-00282"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>C.S.</given-names></name><name><surname>Kim</surname><given-names>D.C.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Ko</surname><given-names>W.</given-names></name><name><surname>Sohn</surname><given-names>J.H.</given-names></name><name><surname>Yim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name></person-group><article-title>Anti-neuroinflammatory effect of aurantiamide acetate from the marine fungus Aspergillus sp. SF-5921: Inhibition of NF-kappaB and MAPK pathways in lipopolysaccharide-induced mouse BV2 microglial cells</article-title><source>Int. Immunopharmacol.</source><year>2014</year><volume>23</volume><fpage>568</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.10.006</pub-id><pub-id pub-id-type="pmid">25448500</pub-id></element-citation></ref><ref id="B186-marinedrugs-17-00282"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>A.J.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Turlova</surname><given-names>E.</given-names></name><name><surname>Barszczyk</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>C.L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Deurloo</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>G.L.</given-names></name><etal/></person-group><article-title>Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury</article-title><source>Mar. Drugs</source><year>2014</year><volume>13</volume><fpage>29</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.3390/md13010029</pub-id><pub-id pub-id-type="pmid">25546517</pub-id></element-citation></ref><ref id="B187-marinedrugs-17-00282"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Sohn</surname><given-names>J.H.</given-names></name><name><surname>Yim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name></person-group><article-title>Anti-inflammatory effect of neoechinulin a from the marine fungus Eurotium sp. SF-5989 through the suppression of NF-small ka, CyrillicB and p38 MAPK Pathways in lipopolysaccharide-stimulated RAW264.7 macrophages</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>13245</fpage><lpage>13259</lpage><pub-id pub-id-type="doi">10.3390/molecules181113245</pub-id><pub-id pub-id-type="pmid">24165583</pub-id></element-citation></ref><ref id="B188-marinedrugs-17-00282"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Gong</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name></person-group><article-title>Chaetoglobosin Fex from the marine-derived endophytic fungus inhibits induction of inflammatory mediators via Toll-like receptor 4 signaling in macrophages</article-title><source>Biol. Pharm. Bull.</source><year>2011</year><volume>34</volume><fpage>1864</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1248/bpb.34.1864</pub-id><pub-id pub-id-type="pmid">22130243</pub-id></element-citation></ref><ref id="B189-marinedrugs-17-00282"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo</surname><given-names>T.R.</given-names></name><name><surname>Dejani</surname><given-names>N.N.</given-names></name><name><surname>Monnazzi</surname><given-names>L.G.</given-names></name><name><surname>Kossuga</surname><given-names>M.H.</given-names></name><name><surname>Berlinck</surname><given-names>R.G.</given-names></name><name><surname>Sette</surname><given-names>L.D.</given-names></name><name><surname>Medeiros</surname><given-names>A.I.</given-names></name></person-group><article-title>Potent anti-inflammatory activity of pyrenocine A isolated from the marine-derived fungus Penicillium paxilli Ma(G)K</article-title><source>Mediators Inflamm.</source><year>2014</year><volume>2014</volume><fpage>767061</fpage><pub-id pub-id-type="doi">10.1155/2014/767061</pub-id><pub-id pub-id-type="pmid">24574582</pub-id></element-citation></ref><ref id="B190-marinedrugs-17-00282"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A.R.</given-names></name><name><surname>Shin</surname><given-names>T.S.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name><name><surname>Park</surname><given-names>J.Y.</given-names></name><name><surname>Park</surname><given-names>K.E.</given-names></name><name><surname>Yoon</surname><given-names>N.Y.</given-names></name><name><surname>Kim</surname><given-names>J.S.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Jang</surname><given-names>B.C.</given-names></name><name><surname>Byun</surname><given-names>D.S.</given-names></name><etal/></person-group><article-title>Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and anti-inflammatory properties</article-title><source>J. Agric. Food Chem.</source><year>2009</year><volume>57</volume><fpage>3483</fpage><lpage>3489</lpage><pub-id pub-id-type="doi">10.1021/jf900820x</pub-id><pub-id pub-id-type="pmid">19338274</pub-id></element-citation></ref><ref id="B191-marinedrugs-17-00282"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allavena</surname><given-names>P.</given-names></name><name><surname>Signorelli</surname><given-names>M.</given-names></name><name><surname>Chieppa</surname><given-names>M.</given-names></name><name><surname>Erba</surname><given-names>E.</given-names></name><name><surname>Bianchi</surname><given-names>G.</given-names></name><name><surname>Marchesi</surname><given-names>F.</given-names></name><name><surname>Olimpio</surname><given-names>C.O.</given-names></name><name><surname>Bonardi</surname><given-names>C.</given-names></name><name><surname>Garbi</surname><given-names>A.</given-names></name><name><surname>Lissoni</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): Inhibition of macrophage differentiation and cytokine production</article-title><source>Cancer Res.</source><year>2005</year><volume>65</volume><fpage>2964</fpage><lpage>2971</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-4037</pub-id><pub-id pub-id-type="pmid">15805300</pub-id></element-citation></ref><ref id="B192-marinedrugs-17-00282"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fast</surname><given-names>M.D.</given-names></name><name><surname>Johnson</surname><given-names>S.C.</given-names></name><name><surname>Eddy</surname><given-names>T.D.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Ross</surname><given-names>N.W.</given-names></name></person-group><article-title>Lepeophtheirus salmonis secretory/excretory products and their effects on Atlantic salmon immune gene regulation</article-title><source>Parasite Immunol.</source><year>2007</year><volume>29</volume><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3024.2007.00932.x</pub-id><pub-id pub-id-type="pmid">17371455</pub-id></element-citation></ref><ref id="B193-marinedrugs-17-00282"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campa-Cordova</surname><given-names>A.I.</given-names></name><name><surname>Hernandez-Saavedra</surname><given-names>N.Y.</given-names></name><name><surname>Ascencio</surname><given-names>F.</given-names></name></person-group><article-title>Superoxide dismutase as modulator of immune function in American white shrimp (Litopenaeus vannamei)</article-title><source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source><year>2002</year><volume>133</volume><fpage>557</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/S1532-0456(02)00125-4</pub-id><pub-id pub-id-type="pmid">12458183</pub-id></element-citation></ref><ref id="B194-marinedrugs-17-00282"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerkar</surname><given-names>A.</given-names></name><name><surname>Ponkshe</surname><given-names>C.</given-names></name><name><surname>Indap</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of immunomodulatory activity of extracts from marine animals</article-title><source>Indian J. Geo-Mar. Sci.</source><year>2009</year><volume>38</volume><fpage>22</fpage><lpage>27</lpage></element-citation></ref><ref id="B195-marinedrugs-17-00282"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovodova</surname><given-names>R.G.</given-names></name><name><surname>Glazkova</surname><given-names>V.E.</given-names></name><name><surname>Mikheyskaya</surname><given-names>L.V.</given-names></name><name><surname>Molchanova</surname><given-names>V.I.</given-names></name><name><surname>Isakov</surname><given-names>V.V.</given-names></name><name><surname>Ovodov</surname><given-names>Y.S.</given-names></name><name><surname>Fernandez Molina</surname><given-names>L.E.</given-names></name></person-group><article-title>The structure of mytilan, a bioglycan-immunomodulator isolated from the mussel Crenomytilus grayanus</article-title><source>Carbohydr. Res.</source><year>1992</year><volume>223</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/0008-6215(92)80018-V</pub-id><pub-id pub-id-type="pmid">1596920</pub-id></element-citation></ref><ref id="B196-marinedrugs-17-00282"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>P.D.</given-names></name><name><surname>Zardo</surname><given-names>R.S.</given-names></name><name><surname>Figueiredo</surname><given-names>G.S.</given-names></name><name><surname>Silva</surname><given-names>B.V.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name></person-group><article-title>Anti-inflammatory properties of convolutamydine A and two structural analogues</article-title><source>Life Sci.</source><year>2014</year><volume>116</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2014.08.019</pub-id><?supplied-pmid 25200874?><pub-id pub-id-type="pmid">25200874</pub-id></element-citation></ref><ref id="B197-marinedrugs-17-00282"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>H.Y.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Chao</surname><given-names>C.H.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Wu</surname><given-names>Y.C.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Sheu</surname><given-names>J.H.</given-names></name></person-group><article-title>Cytotoxic and anti-inflammatory metabolites from the soft coral Scleronephthya gracillimum</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>1853</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.3390/md11061853</pub-id><?supplied-pmid 23760015?><pub-id pub-id-type="pmid">23760015</pub-id></element-citation></ref><ref id="B198-marinedrugs-17-00282"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>D.M.</given-names></name><name><surname>Correia-da-Silva</surname><given-names>G.</given-names></name><name><surname>Valentao</surname><given-names>P.</given-names></name><name><surname>Teixeira</surname><given-names>N.</given-names></name><name><surname>Andrade</surname><given-names>P.B.</given-names></name></person-group><article-title>Anti-inflammatory effect of unsaturated fatty acids and Ergosta-7,22-dien-3-ol from Marthasterias glacialis: Prevention of CHOP-mediated ER-stress and NF-kappaB activation</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e88341</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088341</pub-id><?supplied-pmid 24551093?><pub-id pub-id-type="pmid">24551093</pub-id></element-citation></ref><ref id="B199-marinedrugs-17-00282"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thao</surname><given-names>N.P.</given-names></name><name><surname>Cuong</surname><given-names>N.X.</given-names></name><name><surname>Luyen</surname><given-names>B.T.</given-names></name><name><surname>Quang</surname><given-names>T.H.</given-names></name><name><surname>Hanh</surname><given-names>T.T.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Koh</surname><given-names>Y.S.</given-names></name><name><surname>Nam</surname><given-names>N.H.</given-names></name><name><surname>Van Kiem</surname><given-names>P.</given-names></name><name><surname>Van Minh</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Anti-inflammatory components of the starfish Astropecten polyacanthus</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>2917</fpage><lpage>2926</lpage><pub-id pub-id-type="doi">10.3390/md11082917</pub-id><?supplied-pmid 23945602?><pub-id pub-id-type="pmid">23945602</pub-id></element-citation></ref><ref id="B200-marinedrugs-17-00282"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.K.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name></person-group><article-title>New cytotoxic cembranolides from the soft coral Lobophytum michaelae</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>306</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.3390/md10020306</pub-id><?supplied-pmid 22412802?><pub-id pub-id-type="pmid">22412802</pub-id></element-citation></ref><ref id="B201-marinedrugs-17-00282"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.C.</given-names></name><name><surname>Wen</surname><given-names>Z.-H.</given-names></name><name><surname>Chao</surname><given-names>C.H.</given-names></name><name><surname>Ahmed</surname><given-names>A.</given-names></name><name><surname>Su</surname><given-names>J.H.</given-names></name><name><surname>Chiang</surname><given-names>M.</given-names></name><name><surname>Kuo</surname><given-names>Y.-H.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Sheu</surname><given-names>J.-H.</given-names></name></person-group><article-title>Novel sesquiterenoids from the Formosan soft coral Paralemnalia thyrsoides</article-title><source>Tetrahedron Lett.</source><year>2006</year><volume>47</volume><fpage>8751</fpage><lpage>8755</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2006.10.002</pub-id></element-citation></ref><ref id="B202-marinedrugs-17-00282"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.W.</given-names></name><name><surname>Chang</surname><given-names>S.M.</given-names></name><name><surname>Huang</surname><given-names>C.Y.</given-names></name><name><surname>Chao</surname><given-names>C.H.</given-names></name><name><surname>Su</surname><given-names>J.H.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Wu</surname><given-names>Y.C.</given-names></name><name><surname>Sheu</surname><given-names>J.H.</given-names></name></person-group><article-title>Hirsutalins A-H, eunicellin-based diterpenoids from the soft coral Cladiella hirsuta</article-title><source>J. Nat. Prod.</source><year>2010</year><volume>73</volume><fpage>1785</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.1021/np100401f</pub-id><pub-id pub-id-type="pmid">20979397</pub-id></element-citation></ref><ref id="B203-marinedrugs-17-00282"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quang</surname><given-names>T.H.</given-names></name><name><surname>Ha</surname><given-names>T.T.</given-names></name><name><surname>Minh</surname><given-names>C.V.</given-names></name><name><surname>Kiem</surname><given-names>P.V.</given-names></name><name><surname>Huong</surname><given-names>H.T.</given-names></name><name><surname>Ngan</surname><given-names>N.T.T.</given-names></name><name><surname>Nhiem</surname><given-names>N.X.</given-names></name><name><surname>Tung</surname><given-names>N.H.</given-names></name><name><surname>Tai</surname><given-names>B.H.</given-names></name><name><surname>Thuy</surname><given-names>D.T.T.</given-names></name><etal/></person-group><article-title>Cytotoxic and anti-inflammatory cembranoids from the Vietnamese soft coral Lobophytum laevigatum</article-title><source>Biorg. Med. Chem.</source><year>2011</year><volume>19</volume><fpage>2625</fpage><lpage>2632</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.03.009</pub-id></element-citation></ref><ref id="B204-marinedrugs-17-00282"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>A.</given-names></name><name><surname>Hsieh</surname><given-names>Y.-T.</given-names></name><name><surname>Wen</surname><given-names>Z.-H.</given-names></name><name><surname>Wu</surname><given-names>Y.-C.</given-names></name><name><surname>Sheu</surname><given-names>J.-H.</given-names></name></person-group><article-title>Polyoxygenated Sterols from the Formosan Soft Coral Sinularia gibberosa</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>1275</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1021/np0601509</pub-id><pub-id pub-id-type="pmid">16989519</pub-id></element-citation></ref><ref id="B205-marinedrugs-17-00282"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reina</surname><given-names>E.</given-names></name><name><surname>Puentes</surname><given-names>C.</given-names></name><name><surname>Rojas</surname><given-names>J.</given-names></name><name><surname>Garcia</surname><given-names>J.</given-names></name><name><surname>Ramos</surname><given-names>F.A.</given-names></name><name><surname>Castellanos</surname><given-names>L.</given-names></name><name><surname>Aragon</surname><given-names>M.</given-names></name><name><surname>Ospina</surname><given-names>L.F.</given-names></name></person-group><article-title>Fuscoside E: A strong anti-inflammatory diterpene from Caribbean octocoral Eunicea fusca</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2011</year><volume>21</volume><fpage>5888</fpage><lpage>5891</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2011.07.092</pub-id><pub-id pub-id-type="pmid">21865038</pub-id></element-citation></ref><ref id="B206-marinedrugs-17-00282"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchbank</surname><given-names>D.H.</given-names></name><name><surname>Kerr</surname><given-names>R.G.</given-names></name></person-group><article-title>Semisynthesis of fuscoside B analogues and eunicosides, and analysis of anti-inflammatory activity</article-title><source>Tetrahedron</source><year>2011</year><volume>67</volume><fpage>3053</fpage><lpage>3061</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2011.03.006</pub-id></element-citation></ref><ref id="B207-marinedrugs-17-00282"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voultsiadou</surname><given-names>E.</given-names></name></person-group><article-title>Therapeutic properties and uses of marine invertebrates in the ancient Greek world and early Byzantium</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>130</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.04.041</pub-id><pub-id pub-id-type="pmid">20435126</pub-id></element-citation></ref><ref id="B208-marinedrugs-17-00282"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Chinese Marine Materia Medica. By Huashi Guan and Shuguang Wang. Shanghai Scientific and Technical Publishers, China Ocean Press, and Chemical Industry Press: Shanghai, Beijing, China, 2009; Hardback, 7064 pp; &#x000a5; 2920; ISBN 978-7-5323-9958-1/R&#x02022;2707; ISBN 978-7-5323-9973-4/R&#x02022;2708; ISBN 978-7-1220-6012-9</article-title><source>Mar. Drugs</source><year>2014</year><volume>3</volume><fpage>193</fpage><lpage>195</lpage></element-citation></ref><ref id="B209-marinedrugs-17-00282"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joung</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>Y.-S.</given-names></name><name><surname>Hwang</surname><given-names>J.-W.</given-names></name><name><surname>Han</surname><given-names>Y.-K.</given-names></name><name><surname>Jeong</surname><given-names>J.-H.</given-names></name><name><surname>Lee</surname><given-names>J.-S.</given-names></name><name><surname>Moon</surname><given-names>S.-H.</given-names></name><name><surname>Jeon</surname><given-names>B.-T.</given-names></name><name><surname>Park</surname><given-names>P.-J.</given-names></name></person-group><article-title>Anti-inflammatory effects of extract from Haliotis discus hannai fermented with Cordyceps militaris mycelia in RAW264.7 macrophages through TRIF-dependent signaling pathway</article-title><source>Fish Shellfish Immunol.</source><year>2014</year><volume>38</volume><fpage>184</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2014.03.018</pub-id><pub-id pub-id-type="pmid">24657261</pub-id></element-citation></ref><ref id="B210-marinedrugs-17-00282"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>Y.H.</given-names></name><name><surname>Chen</surname><given-names>W.F.</given-names></name><name><surname>Sung</surname><given-names>C.S.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name><name><surname>Huang</surname><given-names>S.Y.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Tai</surname><given-names>M.H.</given-names></name><name><surname>Tzeng</surname><given-names>S.F.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name></person-group><article-title>Capnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in rats</article-title><source>Br. J. Pharmacol.</source><year>2009</year><volume>158</volume><fpage>713</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00323.x</pub-id><pub-id pub-id-type="pmid">19663884</pub-id></element-citation></ref><ref id="B211-marinedrugs-17-00282"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.C.</given-names></name><name><surname>Wu</surname><given-names>S.S.</given-names></name><name><surname>Su</surname><given-names>W.Y.</given-names></name><name><surname>Lin</surname><given-names>Y.C.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Wu</surname><given-names>W.H.</given-names></name><name><surname>Chen</surname><given-names>C.H.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name></person-group><article-title>Anti-inflammatory and burn injury wound healing properties of the shell of Haliotis diversicolor</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><elocation-id>487</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-016-1473-6</pub-id><pub-id pub-id-type="pmid">27894302</pub-id></element-citation></ref><ref id="B212-marinedrugs-17-00282"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Chakraborty</surname><given-names>M.</given-names></name><name><surname>Bose</surname><given-names>M.</given-names></name><name><surname>Mukherjee</surname><given-names>D.</given-names></name><name><surname>Roychoudhury</surname><given-names>A.</given-names></name><name><surname>Dhar</surname><given-names>P.</given-names></name><name><surname>Mishra</surname><given-names>R.</given-names></name></person-group><article-title>Indian freshwater edible snail Bellamya bengalensis lipid extract prevents T cell mediated hypersensitivity and inhibits LPS induced macrophage activation</article-title><source>J. Ethnopharmacol.</source><year>2014</year><volume>157</volume><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.09.009</pub-id><pub-id pub-id-type="pmid">25291010</pub-id></element-citation></ref><ref id="B213-marinedrugs-17-00282"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>T.B.</given-names></name><name><surname>Rudd</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name><name><surname>Kotiw</surname><given-names>M.</given-names></name><name><surname>Mouatt</surname><given-names>P.</given-names></name><name><surname>Seymour</surname><given-names>L.M.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Benkendorff</surname><given-names>K.</given-names></name></person-group><article-title>Anti-Inflammatory Activity and Structure-Activity Relationships of Brominated Indoles from a Marine Mollusc</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>133</elocation-id><pub-id pub-id-type="doi">10.3390/md15050133</pub-id></element-citation></ref><ref id="B214-marinedrugs-17-00282"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>B.R.</given-names></name><name><surname>Belkowski</surname><given-names>S.M.</given-names></name><name><surname>Whitesides</surname><given-names>J.F.</given-names></name><name><surname>Davis</surname><given-names>P.</given-names></name><name><surname>Lawson</surname><given-names>J.W.</given-names></name></person-group><article-title>Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus</article-title><source>BMC Complement. Altern. Med.</source><year>2007</year><volume>7</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-7-20</pub-id><pub-id pub-id-type="pmid">17562016</pub-id></element-citation></ref><ref id="B215-marinedrugs-17-00282"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>R.</given-names></name></person-group><article-title>The inhibitory effect of a novel polypeptide fraction from Arca subcrenata on cancer-related inflammation in human cervical cancer HeLa cells</article-title><source>ScientificWorldJournal</source><year>2014</year><volume>2014</volume><fpage>768938</fpage><pub-id pub-id-type="pmid">24683359</pub-id></element-citation></ref><ref id="B216-marinedrugs-17-00282"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arancibia</surname><given-names>S.</given-names></name><name><surname>Espinoza</surname><given-names>C.</given-names></name><name><surname>Salazar</surname><given-names>F.</given-names></name><name><surname>Del Campo</surname><given-names>M.</given-names></name><name><surname>Tampe</surname><given-names>R.</given-names></name><name><surname>Zhong</surname><given-names>T.Y.</given-names></name><name><surname>De Ioannes</surname><given-names>P.</given-names></name><name><surname>Moltedo</surname><given-names>B.</given-names></name><name><surname>Ferreira</surname><given-names>J.</given-names></name><name><surname>Lavelle</surname><given-names>E.C.</given-names></name><etal/></person-group><article-title>A novel immunomodulatory hemocyanin from the limpet Fissurella latimarginata promotes potent anti-tumor activity in melanoma</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e87240</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087240</pub-id><?supplied-pmid 24466345?><pub-id pub-id-type="pmid">24466345</pub-id></element-citation></ref><ref id="B217-marinedrugs-17-00282"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Anti-inflammatory activity and mechanism of a lipid extract from hard-shelled mussel (Mytilus coruscus) on chronic arthritis in rats</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>568</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.3390/md12020568</pub-id><?supplied-pmid 24473164?><pub-id pub-id-type="pmid">24473164</pub-id></element-citation></ref><ref id="B218-marinedrugs-17-00282"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name></person-group><article-title>Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>192</volume><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.07.055</pub-id><?supplied-pmid 27452656?><pub-id pub-id-type="pmid">27452656</pub-id></element-citation></ref><ref id="B219-marinedrugs-17-00282"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>E.A.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis</article-title><source>Br. J. Nutr.</source><year>2012</year><volume>107</volume><fpage>S171</fpage><lpage>S184</lpage><pub-id pub-id-type="doi">10.1017/S0007114512001560</pub-id><pub-id pub-id-type="pmid">22591891</pub-id></element-citation></ref><ref id="B220-marinedrugs-17-00282"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lillsunde</surname><given-names>K.E.</given-names></name><name><surname>Festa</surname><given-names>C.</given-names></name><name><surname>Adel</surname><given-names>H.</given-names></name><name><surname>De Marino</surname><given-names>S.</given-names></name><name><surname>Lombardi</surname><given-names>V.</given-names></name><name><surname>Tilvi</surname><given-names>S.</given-names></name><name><surname>Nawrot</surname><given-names>D.A.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>L.</given-names></name><name><surname>DAuria</surname><given-names>M.V.</given-names></name><etal/></person-group><article-title>Bioactive cembrane derivatives from the Indian Ocean soft coral, Sinularia kavarattiensis</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>4045</fpage><lpage>4068</lpage><pub-id pub-id-type="doi">10.3390/md12074045</pub-id><pub-id pub-id-type="pmid">25056629</pub-id></element-citation></ref><ref id="B221-marinedrugs-17-00282"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.Y.</given-names></name><name><surname>Hwang</surname><given-names>T.L.</given-names></name><name><surname>Lin</surname><given-names>M.R.</given-names></name><name><surname>Chen</surname><given-names>Y.H.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name><name><surname>Fang</surname><given-names>L.S.</given-names></name><name><surname>Wang</surname><given-names>W.H.</given-names></name><name><surname>Wu</surname><given-names>Y.C.</given-names></name><name><surname>Sung</surname><given-names>P.J.</given-names></name></person-group><article-title>Carijoside A, a bioactive sterol glycoside from an octocoral Carijoa sp. (Clavulariidae)</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>2014</fpage><lpage>2020</lpage><pub-id pub-id-type="doi">10.3390/md8072014</pub-id><pub-id pub-id-type="pmid">20714421</pub-id></element-citation></ref><ref id="B222-marinedrugs-17-00282"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S.Y.</given-names></name><name><surname>Chuang</surname><given-names>C.T.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Wang</surname><given-names>S.K.</given-names></name><name><surname>Chiou</surname><given-names>S.F.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name></person-group><article-title>Bioactive norditerpenoids from the soft coral Sinularia gyrosa</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>3379</fpage><lpage>3386</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2010.04.012</pub-id><pub-id pub-id-type="pmid">20430633</pub-id></element-citation></ref><ref id="B223-marinedrugs-17-00282"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.-F.</given-names></name><name><surname>Chakraborty</surname><given-names>C.</given-names></name><name><surname>Sung</surname><given-names>C.-S.</given-names></name><name><surname>Feng</surname><given-names>C.-W.</given-names></name><name><surname>Jean</surname><given-names>Y.-H.</given-names></name><name><surname>Lin</surname><given-names>Y.-Y.</given-names></name><name><surname>Hung</surname><given-names>H.-C.</given-names></name><name><surname>Huang</surname><given-names>T.-Y.</given-names></name><name><surname>Huang</surname><given-names>S.-Y.</given-names></name><name><surname>Su</surname><given-names>T.-M.</given-names></name><etal/></person-group><article-title>Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson&#x02019;s model: A promising candidate for the treatment of Parkinson&#x02019;s disease</article-title><source>Naunyn-Schmiedeberg&#x02019;s Arch. Pharmacol.</source><year>2012</year><volume>385</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1007/s00210-011-0710-2</pub-id><pub-id pub-id-type="pmid">22119889</pub-id></element-citation></ref><ref id="B224-marinedrugs-17-00282"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.W.</given-names></name><name><surname>Chao</surname><given-names>C.H.</given-names></name><name><surname>Su</surname><given-names>J.H.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Sung</surname><given-names>P.J.</given-names></name><name><surname>Sheu</surname><given-names>J.H.</given-names></name></person-group><article-title>Anti-inflammatory eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex</article-title><source>Org. Biomol. Chem.</source><year>2010</year><volume>8</volume><fpage>2363</fpage><lpage>2366</lpage><pub-id pub-id-type="doi">10.1039/b926353e</pub-id><?supplied-pmid 20448893?><pub-id pub-id-type="pmid">20448893</pub-id></element-citation></ref><ref id="B225-marinedrugs-17-00282"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.-L.</given-names></name><name><surname>Su</surname><given-names>J.-H.</given-names></name><name><surname>Wen</surname><given-names>Z.-H.</given-names></name><name><surname>Hsu</surname><given-names>C.-H.</given-names></name><name><surname>Chen</surname><given-names>B.-W.</given-names></name><name><surname>Dai</surname><given-names>C.-F.</given-names></name><name><surname>Kuo</surname><given-names>Y.-H.</given-names></name><name><surname>Sheu</surname><given-names>J.-H.</given-names></name></person-group><article-title>Simplexins A-I, Eunicellin-based Diterpenoids from the soft coral klyxum simplex</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>994</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1021/np900064a</pub-id><?supplied-pmid 19391605?><pub-id pub-id-type="pmid">19391605</pub-id></element-citation></ref><ref id="B226-marinedrugs-17-00282"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanzola</surname><given-names>M.</given-names></name><name><surname>Furuta</surname><given-names>T.</given-names></name><name><surname>Kohno</surname><given-names>Y.</given-names></name><name><surname>Fukumitsu</surname><given-names>S.</given-names></name><name><surname>Yasukochi</surname><given-names>S.</given-names></name><name><surname>Watari</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>C.</given-names></name><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Miyamoto</surname><given-names>T.</given-names></name></person-group><article-title>Four new cembrane diterpenes isolated from an Okinawan soft coral Lobophytum crassum with inhibitory effects on nitric oxide production</article-title><source>Chem. Pharm. Bull. (Tokyo)</source><year>2010</year><volume>58</volume><fpage>1203</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1248/cpb.58.1203</pub-id><?supplied-pmid 20823600?><pub-id pub-id-type="pmid">20823600</pub-id></element-citation></ref><ref id="B227-marinedrugs-17-00282"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S.Y.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Wang</surname><given-names>S.K.</given-names></name><name><surname>Chiou</surname><given-names>S.F.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Chiang</surname><given-names>M.Y.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name></person-group><article-title>Unprecedented hemiketal cembranolides with anti-inflammatory activity from the soft coral Lobophytum durum</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1021/np800686k</pub-id><?supplied-pmid 19177635?><pub-id pub-id-type="pmid">19177635</pub-id></element-citation></ref><ref id="B228-marinedrugs-17-00282"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmiro</surname><given-names>C.L.</given-names></name><name><surname>Castelo-Branco</surname><given-names>M.T.</given-names></name><name><surname>Melim</surname><given-names>L.M.</given-names></name><name><surname>Schanaider</surname><given-names>A.</given-names></name><name><surname>Elia</surname><given-names>C.</given-names></name><name><surname>Madi</surname><given-names>K.</given-names></name><name><surname>Pavao</surname><given-names>M.S.</given-names></name><name><surname>de Souza</surname><given-names>H.S.</given-names></name></person-group><article-title>Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>11267</fpage><lpage>11278</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807211200</pub-id><?supplied-pmid 19258310?><pub-id pub-id-type="pmid">19258310</pub-id></element-citation></ref><ref id="B229-marinedrugs-17-00282"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S.Y.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Chiou</surname><given-names>S.F.</given-names></name><name><surname>Tsai</surname><given-names>C.W.</given-names></name><name><surname>Wang</surname><given-names>S.K.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Chiang</surname><given-names>M.Y.</given-names></name><name><surname>Wang</surname><given-names>W.H.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name></person-group><article-title>Ceramide and cerebrosides from the octocoral Sarcophyton ehrenbergi</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>465</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1021/np800362g</pub-id><?supplied-pmid 19006372?><pub-id pub-id-type="pmid">19006372</pub-id></element-citation></ref><ref id="B230-marinedrugs-17-00282"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.C.</given-names></name><name><surname>Huang</surname><given-names>S.Y.</given-names></name><name><surname>Jean</surname><given-names>Y.H.</given-names></name><name><surname>Chen</surname><given-names>W.F.</given-names></name><name><surname>Sung</surname><given-names>C.S.</given-names></name><name><surname>Kao</surname><given-names>E.S.</given-names></name><name><surname>Wang</surname><given-names>H.M.</given-names></name><name><surname>Chakraborty</surname><given-names>C.</given-names></name><name><surname>Duh</surname><given-names>C.Y.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name></person-group><article-title>Intrathecal lemnalol, a natural marine compound obtained from Formosan soft coral, attenuates nociceptive responses and the activity of spinal glial cells in neuropathic rats</article-title><source>Behav. Pharmacol.</source><year>2011</year><volume>22</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1097/FBP.0b013e32834d0ecb</pub-id><pub-id pub-id-type="pmid">22067479</pub-id></element-citation></ref><ref id="B231-marinedrugs-17-00282"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W.Y.</given-names></name><name><surname>Su</surname><given-names>J.H.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>Z.H.</given-names></name><name><surname>Dai</surname><given-names>C.F.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Sheu</surname><given-names>J.H.</given-names></name></person-group><article-title>Cytotoxic and anti-inflammatory cembranoids from the Dongsha Atoll soft coral Sarcophyton crassocaule</article-title><source>Bioorg. Med. Chem.</source><year>2010</year><volume>18</volume><fpage>1936</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2010.01.036</pub-id><pub-id pub-id-type="pmid">20144547</pub-id></element-citation></ref><ref id="B232-marinedrugs-17-00282"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleton</surname><given-names>D.R.</given-names></name><name><surname>Chuen</surname><given-names>C.S.</given-names></name><name><surname>Berridge</surname><given-names>M.V.</given-names></name><name><surname>Webb</surname><given-names>V.L.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name></person-group><article-title>Rossinones A and B, biologically active meroterpenoids from the Antarctic ascidian, Aplidium species</article-title><source>J. Org. Chem.</source><year>2009</year><volume>74</volume><fpage>9195</fpage><lpage>9198</lpage><pub-id pub-id-type="doi">10.1021/jo901846j</pub-id><pub-id pub-id-type="pmid">19863121</pub-id></element-citation></ref><ref id="B233-marinedrugs-17-00282"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S.-Y.</given-names></name><name><surname>Huang</surname><given-names>Y.-C.</given-names></name><name><surname>Wen</surname><given-names>Z.-H.</given-names></name><name><surname>Chiou</surname><given-names>S.-F.</given-names></name><name><surname>Wang</surname><given-names>S.-K.</given-names></name><name><surname>Hsu</surname><given-names>C.-H.</given-names></name><name><surname>Dai</surname><given-names>C.-F.</given-names></name><name><surname>Duh</surname><given-names>C.-Y.</given-names></name></person-group><article-title>Novel sesquiterpenes and norergosterol from the soft corals Nephthea erecta and Nephtheachabroli</article-title><source>Tetrahedron Lett.</source><year>2009</year><volume>50</volume><fpage>802</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2008.12.002</pub-id></element-citation></ref><ref id="B234-marinedrugs-17-00282"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanif</surname><given-names>N.</given-names></name><name><surname>Ohno</surname><given-names>O.</given-names></name><name><surname>Kitamura</surname><given-names>M.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Symbiopolyol, a VCAM-1 inhibitor from a symbiotic dinoflagellate of the jellyfish Mastigias papua</article-title><source>J. Nat. Prod.</source><year>2010</year><volume>73</volume><fpage>1318</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1021/np100221k</pub-id><pub-id pub-id-type="pmid">20557071</pub-id></element-citation></ref><ref id="B235-marinedrugs-17-00282"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>L.X.</given-names></name><name><surname>Cao</surname><given-names>D.L.</given-names></name><name><surname>Gao</surname><given-names>Y.J.</given-names></name></person-group><article-title>Spinal injection of docosahexaenoic acid attenuates carrageenan-induced inflammatory pain through inhibition of microglia-mediated neuroinflammation in the spinal cord</article-title><source>Neuroscience</source><year>2013</year><volume>241</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.03.003</pub-id><pub-id pub-id-type="pmid">23500096</pub-id></element-citation></ref><ref id="B236-marinedrugs-17-00282"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abad</surname><given-names>M.J.</given-names></name><name><surname>Bermejo</surname><given-names>P.</given-names></name></person-group><article-title>Bioactive natural products from marine sources</article-title><source>Stud. Nat. Prod. Chem.</source><year>2001</year><volume>25</volume><fpage>683</fpage><lpage>755</lpage></element-citation></ref><ref id="B237-marinedrugs-17-00282"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurienzo</surname><given-names>P.</given-names></name></person-group><article-title>Marine polysaccharides in pharmaceutical applications: An overview</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>2435</fpage><lpage>2465</lpage><pub-id pub-id-type="doi">10.3390/md8092435</pub-id><pub-id pub-id-type="pmid">20948899</pub-id></element-citation></ref><ref id="B238-marinedrugs-17-00282"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelik</surname><given-names>E.</given-names></name><name><surname>Bere</surname><given-names>W.W.</given-names></name><name><surname>Herberman</surname><given-names>R.B.</given-names></name></person-group><article-title>Role of NK cells in the antimetastatic effect of anticoagulant drugs</article-title><source>Int. J. Cancer</source><year>1984</year><volume>33</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910330115</pub-id><pub-id pub-id-type="pmid">6363308</pub-id></element-citation></ref><ref id="B239-marinedrugs-17-00282"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelik</surname><given-names>E.</given-names></name></person-group><article-title>Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice</article-title><source>Cancer Res.</source><year>1987</year><volume>47</volume><fpage>809</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">3802083</pub-id></element-citation></ref><ref id="B240-marinedrugs-17-00282"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Xin</surname><given-names>H.</given-names></name><name><surname>Sheng</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name></person-group><article-title>In vivo growth-inhibition of S180 tumor by mixture of 5-Fu and low molecular lambda-carrageenan from Chondrus ocellatus</article-title><source>Pharmacol. Res.</source><year>2005</year><volume>51</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2004.07.003</pub-id><pub-id pub-id-type="pmid">15629261</pub-id></element-citation></ref><ref id="B241-marinedrugs-17-00282"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumashi</surname><given-names>A.</given-names></name><name><surname>Ushakova</surname><given-names>N.A.</given-names></name><name><surname>Preobrazhenskaya</surname><given-names>M.E.</given-names></name><name><surname>D&#x02019;Incecco</surname><given-names>A.</given-names></name><name><surname>Piccoli</surname><given-names>A.</given-names></name><name><surname>Totani</surname><given-names>L.</given-names></name><name><surname>Tinari</surname><given-names>N.</given-names></name><name><surname>Morozevich</surname><given-names>G.E.</given-names></name><name><surname>Berman</surname><given-names>A.E.</given-names></name><name><surname>Bilan</surname><given-names>M.I.</given-names></name><etal/></person-group><article-title>Consorzio Interuniversitario Nazionale per la Bio-Oncologia, I. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds</article-title><source>Glycobiology</source><year>2007</year><volume>17</volume><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwm014</pub-id><?supplied-pmid 17296677?><pub-id pub-id-type="pmid">17296677</pub-id></element-citation></ref><ref id="B242-marinedrugs-17-00282"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luscher-Mattli</surname><given-names>M.</given-names></name></person-group><article-title>Polyanions&#x02014;A lost chance in the fight against HIV and other virus diseases?</article-title><source>Antivir. Chem. Chemother.</source><year>2000</year><volume>11</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1177/095632020001100401</pub-id><pub-id pub-id-type="pmid">10950387</pub-id></element-citation></ref><ref id="B243-marinedrugs-17-00282"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>R.</given-names></name></person-group><article-title>Fucoidan: Structure and bioactivity</article-title><source>Molecules</source><year>2008</year><volume>13</volume><fpage>1671</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.3390/molecules13081671</pub-id><pub-id pub-id-type="pmid">18794778</pub-id></element-citation></ref><ref id="B244-marinedrugs-17-00282"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>G.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Ewart</surname><given-names>H.S.</given-names></name></person-group><article-title>Chemical structures and bioactivities of sulfated polysaccharides from marine algae</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>196</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.3390/md9020196</pub-id><pub-id pub-id-type="pmid">21566795</pub-id></element-citation></ref><ref id="B245-marinedrugs-17-00282"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnel</surname><given-names>R.B.</given-names></name><name><surname>Esquenazi</surname><given-names>E.</given-names></name><name><surname>Leao</surname><given-names>T.</given-names></name><name><surname>Moss</surname><given-names>N.</given-names></name><name><surname>Mevers</surname><given-names>E.</given-names></name><name><surname>Pereira</surname><given-names>A.R.</given-names></name><name><surname>Monroe</surname><given-names>E.A.</given-names></name><name><surname>Korobeynikov</surname><given-names>A.</given-names></name><name><surname>Murray</surname><given-names>T.F.</given-names></name><name><surname>Sherman</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A Maldiisotopic approach to discover natural products: Cryptomaldamide, a hybrid tripeptide from the marine cyanobacterium Moorea producens</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1514</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00019</pub-id><?supplied-pmid 28448144?><pub-id pub-id-type="pmid">28448144</pub-id></element-citation></ref><ref id="B246-marinedrugs-17-00282"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>S.A.</given-names></name><name><surname>Moon</surname><given-names>P.D.</given-names></name><name><surname>Na</surname><given-names>H.J.</given-names></name><name><surname>Park</surname><given-names>R.K.</given-names></name><name><surname>Um</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>H.M.</given-names></name><name><surname>Hong</surname><given-names>S.H.</given-names></name></person-group><article-title>Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-&#x003ba;B activation</article-title><source>Clin. Exp. Allergy</source><year>2006</year><volume>36</volume><fpage>785</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2006.02508.x</pub-id><?supplied-pmid 16776680?><pub-id pub-id-type="pmid">16776680</pub-id></element-citation></ref><ref id="B247-marinedrugs-17-00282"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolaus</surname><given-names>B.</given-names></name><name><surname>Kambourova</surname><given-names>M.</given-names></name><name><surname>Oner</surname><given-names>E.T.</given-names></name></person-group><article-title>Exopolysaccharides from extremophiles: From fundamentals to biotechnology</article-title><source>Environ. Technol.</source><year>2010</year><volume>31</volume><fpage>1145</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1080/09593330903552094</pub-id><?supplied-pmid 20718297?><pub-id pub-id-type="pmid">20718297</pub-id></element-citation></ref><ref id="B248-marinedrugs-17-00282"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guezennec</surname><given-names>J.</given-names></name></person-group><article-title>From extreme environments to biologically active exopolysaccharides</article-title><source>Commun. Agric. Appl. Biol. Sci.</source><year>2003</year><volume>68</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">15296169</pub-id></element-citation></ref><ref id="B249-marinedrugs-17-00282"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maugeri</surname><given-names>T.L.</given-names></name><name><surname>Gugliandolo</surname><given-names>C.</given-names></name><name><surname>Caccamo</surname><given-names>D.</given-names></name><name><surname>Stackebrandt</surname><given-names>E.</given-names></name></person-group><article-title>Three novel halotolerant and thermophilic Geobacillus strains from shallow marine vents</article-title><source>Syst. Appl. Microbiol.</source><year>2002</year><volume>25</volume><fpage>450</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1078/0723-2020-00119</pub-id><pub-id pub-id-type="pmid">12421083</pub-id></element-citation></ref><ref id="B250-marinedrugs-17-00282"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poli</surname><given-names>A.</given-names></name><name><surname>Anzelmo</surname><given-names>G.</given-names></name><name><surname>Nicolaus</surname><given-names>B.</given-names></name></person-group><article-title>Bacterial exopolysaccharides from extreme marine habitats: Production, characterization and biological activities</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>1779</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.3390/md8061779</pub-id><pub-id pub-id-type="pmid">20631870</pub-id></element-citation></ref><ref id="B251-marinedrugs-17-00282"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gugliandolo</surname><given-names>C.</given-names></name><name><surname>Lentini</surname><given-names>V.</given-names></name><name><surname>Span&#x000f2;</surname><given-names>A.</given-names></name><name><surname>Maugeri</surname><given-names>T.L.</given-names></name></person-group><article-title>New bacilli from shallow hydrothermal vents of Panarea Island (Italy) and their biotechnological potential</article-title><source>J. Appl. Microbiol.</source><year>2012</year><volume>112</volume><fpage>1102</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05272.x</pub-id><pub-id pub-id-type="pmid">22372433</pub-id></element-citation></ref><ref id="B252-marinedrugs-17-00282"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dembitsky</surname><given-names>V.M.</given-names></name></person-group><article-title>Bromo- and iodo-containing alkaloids from marine microorganisms and sponges</article-title><source>Bioorg. Khim</source><year>2002</year><volume>28</volume><fpage>196</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">12077845</pub-id></element-citation></ref><ref id="B253-marinedrugs-17-00282"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guven</surname><given-names>K.C.</given-names></name><name><surname>Percot</surname><given-names>A.</given-names></name><name><surname>Sezik</surname><given-names>E.</given-names></name></person-group><article-title>Alkaloids in marine algae</article-title><source>Mar. Drugs</source><year>2010</year><volume>8</volume><fpage>269</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.3390/md8020269</pub-id><?supplied-pmid 20390105?><pub-id pub-id-type="pmid">20390105</pub-id></element-citation></ref><ref id="B254-marinedrugs-17-00282"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewapriya</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.X.</given-names></name><name><surname>Himaya</surname><given-names>S.W.</given-names></name><name><surname>Pangestuti</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>S.K.</given-names></name></person-group><article-title>Neoechinulin A suppresses amyloid-beta oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity</article-title><source>Neurotoxicology</source><year>2013</year><volume>35</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2012.12.004</pub-id><?supplied-pmid 23261590?><pub-id pub-id-type="pmid">23261590</pub-id></element-citation></ref><ref id="B255-marinedrugs-17-00282"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruhn</surname><given-names>J.G.</given-names></name><name><surname>Bruhn</surname><given-names>C.</given-names></name></person-group><article-title>Alkaloids and ethnobotany of Mexican peyote cacti and related species</article-title><source>Econ. Bot.</source><year>1973</year><volume>27</volume><fpage>241</fpage><pub-id pub-id-type="doi">10.1007/BF02872994</pub-id></element-citation></ref><ref id="B256-marinedrugs-17-00282"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harborne</surname><given-names>J.B.</given-names></name><name><surname>Williams</surname><given-names>C.A.</given-names></name></person-group><article-title>Advances in flavonoid research since 1992</article-title><source>Phytochemistry</source><year>2000</year><volume>55</volume><fpage>481</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)00235-1</pub-id><pub-id pub-id-type="pmid">11130659</pub-id></element-citation></ref><ref id="B257-marinedrugs-17-00282"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>L.</given-names></name></person-group><article-title>Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance</article-title><source>Nutr. Rev.</source><year>1998</year><volume>56</volume><fpage>317</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.1998.tb01670.x</pub-id><pub-id pub-id-type="pmid">9838798</pub-id></element-citation></ref><ref id="B258-marinedrugs-17-00282"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheynier</surname><given-names>V.</given-names></name></person-group><article-title>Polyphenols in food are more complex than often thought</article-title><source>Am. J. Clin. Nutr.</source><year>2005</year><volume>81</volume><fpage>223S</fpage><lpage>229S</lpage><pub-id pub-id-type="doi">10.1093/ajcn/81.1.223S</pub-id><pub-id pub-id-type="pmid">15640485</pub-id></element-citation></ref><ref id="B259-marinedrugs-17-00282"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>K.E.</given-names></name><name><surname>Tagliaferro</surname><given-names>A.R.</given-names></name><name><surname>Bobilya</surname><given-names>D.J.</given-names></name></person-group><article-title>Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships</article-title><source>J. Nutr. Biochem.</source><year>2002</year><volume>13</volume><fpage>572</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/S0955-2863(02)00208-5</pub-id><pub-id pub-id-type="pmid">12550068</pub-id></element-citation></ref><ref id="B260-marinedrugs-17-00282"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andriantsitohaina</surname><given-names>R.</given-names></name><name><surname>Auger</surname><given-names>C.</given-names></name><name><surname>Chataigneau</surname><given-names>T.</given-names></name><name><surname>Etienne-Selloum</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Martinez</surname><given-names>M.C.</given-names></name><name><surname>Schini-Kerth</surname><given-names>V.B.</given-names></name><name><surname>Laher</surname><given-names>I.</given-names></name></person-group><article-title>Molecular mechanisms of the cardiovascular protective effects of polyphenols</article-title><source>Br. J. Nutr.</source><year>2012</year><volume>108</volume><fpage>1532</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1017/S0007114512003406</pub-id><pub-id pub-id-type="pmid">22935143</pub-id></element-citation></ref><ref id="B261-marinedrugs-17-00282"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middleton</surname><given-names>E.</given-names><suffix>Jr.</suffix></name><name><surname>Kandaswami</surname><given-names>C.</given-names></name><name><surname>Theoharides</surname><given-names>T.C.</given-names></name></person-group><article-title>The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer</article-title><source>Pharmacol. Rev.</source><year>2000</year><volume>52</volume><fpage>673</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">11121513</pub-id></element-citation></ref><ref id="B262-marinedrugs-17-00282"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recio</surname><given-names>M.C.</given-names></name><name><surname>Andujar</surname><given-names>I.</given-names></name><name><surname>Rios</surname><given-names>J.L.</given-names></name></person-group><article-title>Anti-inflammatory agents from plants: Progress and potential</article-title><source>Curr. Med. Chem.</source><year>2012</year><volume>19</volume><fpage>2088</fpage><lpage>2103</lpage><pub-id pub-id-type="doi">10.2174/092986712800229069</pub-id><pub-id pub-id-type="pmid">22414101</pub-id></element-citation></ref><ref id="B263-marinedrugs-17-00282"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puupponen-Pimia</surname><given-names>R.</given-names></name><name><surname>Nohynek</surname><given-names>L.</given-names></name><name><surname>Meier</surname><given-names>C.</given-names></name><name><surname>Kahkonen</surname><given-names>M.</given-names></name><name><surname>Heinonen</surname><given-names>M.</given-names></name><name><surname>Hopia</surname><given-names>A.</given-names></name><name><surname>Oksman-Caldentey</surname><given-names>K.M.</given-names></name></person-group><article-title>Antimicrobial properties of phenolic compounds from berries</article-title><source>J. Appl. Microbiol.</source><year>2001</year><volume>90</volume><fpage>494</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2001.01271.x</pub-id><pub-id pub-id-type="pmid">11309059</pub-id></element-citation></ref><ref id="B264-marinedrugs-17-00282"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovannini</surname><given-names>C.</given-names></name><name><surname>Scazzocchio</surname><given-names>B.</given-names></name><name><surname>Vari</surname><given-names>R.</given-names></name><name><surname>Santangelo</surname><given-names>C.</given-names></name><name><surname>D&#x02019;Archivio</surname><given-names>M.</given-names></name><name><surname>Masella</surname><given-names>R.</given-names></name></person-group><article-title>Apoptosis in cancer and atherosclerosis: Polyphenol activities</article-title><source>Ann. Ist. Super. Sanita</source><year>2007</year><volume>43</volume><fpage>406</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">18209274</pub-id></element-citation></ref><ref id="B265-marinedrugs-17-00282"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquilano</surname><given-names>K.</given-names></name><name><surname>Baldelli</surname><given-names>S.</given-names></name><name><surname>Rotilio</surname><given-names>G.</given-names></name><name><surname>Ciriolo</surname><given-names>M.R.</given-names></name></person-group><article-title>Role of nitric oxide synthases in Parkinson&#x02019;s disease: A review on the antioxidant and anti-inflammatory activity of polyphenols</article-title><source>Neurochem. Res.</source><year>2008</year><volume>33</volume><fpage>2416</fpage><lpage>2426</lpage><pub-id pub-id-type="doi">10.1007/s11064-008-9697-6</pub-id><pub-id pub-id-type="pmid">18415676</pub-id></element-citation></ref><ref id="B266-marinedrugs-17-00282"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villegas</surname><given-names>I.</given-names></name><name><surname>Sanchez-Fidalgo</surname><given-names>S.</given-names></name><name><surname>Alarcon de la Lastra</surname><given-names>C.</given-names></name></person-group><article-title>New mechanisms and therapeutic potential of curcumin for colorectal cancer</article-title><source>Mol. Nutr. Food Res.</source><year>2008</year><volume>52</volume><fpage>1040</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200700280</pub-id><pub-id pub-id-type="pmid">18655004</pub-id></element-citation></ref><ref id="B267-marinedrugs-17-00282"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakibaei</surname><given-names>M.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Resveratrol addiction: To die or not to die</article-title><source>Mol. Nutr. Food Res.</source><year>2009</year><volume>53</volume><fpage>115</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200800148</pub-id><pub-id pub-id-type="pmid">19072742</pub-id></element-citation></ref><ref id="B268-marinedrugs-17-00282"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name></person-group><article-title>Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis</article-title><source>Cancer Genet. Cytogenet.</source><year>2006</year><volume>165</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.cancergencyto.2005.06.016</pub-id><pub-id pub-id-type="pmid">16490592</pub-id></element-citation></ref><ref id="B269-marinedrugs-17-00282"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes-McNary</surname><given-names>M.</given-names></name><name><surname>Baldwin</surname><given-names>A.S.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase</article-title><source>Cancer Res.</source><year>2000</year><volume>60</volume><fpage>3477</fpage><lpage>3483</lpage><pub-id pub-id-type="pmid">10910059</pub-id></element-citation></ref><ref id="B270-marinedrugs-17-00282"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhami</surname><given-names>V.M.</given-names></name><name><surname>Afaq</surname><given-names>F.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group><article-title>Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol</article-title><source>Neoplasia</source><year>2003</year><volume>5</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/S1476-5586(03)80019-2</pub-id><pub-id pub-id-type="pmid">12659672</pub-id></element-citation></ref><ref id="B271-marinedrugs-17-00282"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manna</surname><given-names>S.K.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation</article-title><source>J. Immunol.</source><year>2000</year><volume>164</volume><fpage>6509</fpage><lpage>6519</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.12.6509</pub-id><pub-id pub-id-type="pmid">10843709</pub-id></element-citation></ref><ref id="B272-marinedrugs-17-00282"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovanovi&#x00107;-&#x00160;anta</surname><given-names>S.S.</given-names></name><name><surname>Petri</surname><given-names>E.T.</given-names></name><name><surname>Klisuri&#x00107;</surname><given-names>O.R.</given-names></name><name><surname>Sz&#x000e9;csi</surname><given-names>M.</given-names></name><name><surname>Kova&#x0010d;evi&#x00107;</surname><given-names>R.</given-names></name><name><surname>Petrovi&#x00107;</surname><given-names>J.A.</given-names></name></person-group><article-title>Antihormonal potential of selected D-homo and D-seco estratriene derivatives</article-title><source>Steroids</source><year>2015</year><volume>97</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.steroids.2014.08.026</pub-id><pub-id pub-id-type="pmid">25204595</pub-id></element-citation></ref><ref id="B273-marinedrugs-17-00282"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>L.M.</given-names></name><name><surname>Grimes</surname><given-names>D.A.</given-names></name><name><surname>Schulz</surname><given-names>K.F.</given-names></name><name><surname>Curtis</surname><given-names>K.M.</given-names></name></person-group><article-title>Steroidal contraceptives: Effect on bone fractures in women</article-title><source>Cochrane Database Syst. Rev.</source><year>2011</year><volume>6</volume><fpage>CD006033</fpage></element-citation></ref><ref id="B274-marinedrugs-17-00282"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattanasopa</surname><given-names>C.</given-names></name><name><surname>Phungphong</surname><given-names>S.</given-names></name><name><surname>Wattanapermpool</surname><given-names>J.</given-names></name><name><surname>Bupha-Intr</surname><given-names>T.</given-names></name></person-group><article-title>Significant role of estrogen in maintaining cardiac mitochondrial functions</article-title><source>J. Steroid Biochem. Mol. Biol.</source><year>2015</year><volume>147</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.11.009</pub-id><pub-id pub-id-type="pmid">25448746</pub-id></element-citation></ref><ref id="B275-marinedrugs-17-00282"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thao</surname><given-names>N.P.</given-names></name><name><surname>Luyen</surname><given-names>B.T.T.</given-names></name><name><surname>Kim</surname><given-names>E.J.</given-names></name><name><surname>Kang</surname><given-names>J.I.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Cuong</surname><given-names>N.X.</given-names></name><name><surname>Nam</surname><given-names>N.H.</given-names></name><name><surname>Kiem</surname><given-names>P.V.</given-names></name><name><surname>Minh</surname><given-names>C.V.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name></person-group><article-title>Steroidal Constituents from the Edible Sea Urchin Diadema savignyi Michelin Induce Apoptosis in Human Cancer Cells</article-title><source>J. Med. Food</source><year>2014</year><volume>18</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1089/jmf.2013.3105</pub-id><?supplied-pmid 25211186?><pub-id pub-id-type="pmid">25211186</pub-id></element-citation></ref><ref id="B276-marinedrugs-17-00282"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortet</surname><given-names>B.</given-names></name><name><surname>Biver</surname><given-names>E.</given-names></name><name><surname>Borg</surname><given-names>S.</given-names></name><name><surname>Chopin</surname><given-names>F.</given-names></name><name><surname>Hopp&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Laroche</surname><given-names>M.</given-names></name><name><surname>Morel</surname><given-names>G.</given-names></name><name><surname>Razjbaum</surname><given-names>G.</given-names></name><name><surname>Roux</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Management of male osteoporosis: Lessons for clinical practice</article-title><source>Joint Bone Spine</source><year>2011</year><volume>78</volume><fpage>S208</fpage><lpage>S210</lpage><pub-id pub-id-type="doi">10.1016/S1297-319X(11)70006-9</pub-id><pub-id pub-id-type="pmid">22153672</pub-id></element-citation></ref><ref id="B277-marinedrugs-17-00282"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aav</surname><given-names>R.</given-names></name><name><surname>Kanger</surname><given-names>T.</given-names></name><name><surname>Pehk</surname><given-names>T.</given-names></name><name><surname>Lopp</surname><given-names>M.</given-names></name></person-group><article-title>Unexpected reactivity of ethyl 2-(Diethylphosphono)propionate toward 2,2-disubstituted-1,3-cyclopentanediones</article-title><source>Phosphorus Sulfur Silicon Related Elem.</source><year>2005</year><volume>180</volume><fpage>1739</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1080/10426500590885309</pub-id></element-citation></ref><ref id="B278-marinedrugs-17-00282"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorucci</surname><given-names>S.</given-names></name><name><surname>Distrutti</surname><given-names>E.</given-names></name><name><surname>Bifulco</surname><given-names>G.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name></person-group><article-title>Marine sponge steroids as nuclear receptor ligands</article-title><source>Trends Pharmacol. Sci.</source><year>2012</year><volume>33</volume><fpage>591</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2012.08.004</pub-id><?supplied-pmid 23000093?><pub-id pub-id-type="pmid">23000093</pub-id></element-citation></ref><ref id="B279-marinedrugs-17-00282"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sepe</surname><given-names>V.</given-names></name><name><surname>Ummarino</surname><given-names>R.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>Mencarelli</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Amore</surname><given-names>C.</given-names></name><name><surname>Renga</surname><given-names>B.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name><name><surname>Fiorucci</surname><given-names>S.</given-names></name></person-group><article-title>Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity</article-title><source>J. Med. Chem.</source><year>2011</year><volume>54</volume><fpage>4590</fpage><lpage>4599</lpage><pub-id pub-id-type="doi">10.1021/jm200241s</pub-id><?supplied-pmid 21599020?><pub-id pub-id-type="pmid">21599020</pub-id></element-citation></ref><ref id="B280-marinedrugs-17-00282"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mencarelli</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Amore</surname><given-names>C.</given-names></name><name><surname>Renga</surname><given-names>B.</given-names></name><name><surname>Cipriani</surname><given-names>S.</given-names></name><name><surname>Carino</surname><given-names>A.</given-names></name><name><surname>Sepe</surname><given-names>V.</given-names></name><name><surname>Perissutti</surname><given-names>E.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>M.V.</given-names></name><name><surname>Zampella</surname><given-names>A.</given-names></name><name><surname>Distrutti</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis</article-title><source>Mar. Drugs</source><year>2013</year><volume>12</volume><fpage>36</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.3390/md12010036</pub-id><pub-id pub-id-type="pmid">24368568</pub-id></element-citation></ref><ref id="B281-marinedrugs-17-00282"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behl</surname><given-names>C.</given-names></name><name><surname>Moosmann</surname><given-names>B.</given-names></name></person-group><article-title>Antioxidant neuroprotection in Alzheimer&#x02019;s disease as preventive and therapeutic approach22This article is part of a series of reviews on &#x0201c;Causes and Consequences of Oxidative Stress in Alzheimer&#x02019;s Disease.&#x0201d; The full list of papers may be found on the homepage of the journal</article-title><source>Free Radical Biol. Med.</source><year>2002</year><volume>33</volume><fpage>182</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">12106814</pub-id></element-citation></ref><ref id="B282-marinedrugs-17-00282"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snow</surname><given-names>B.J.</given-names></name><name><surname>Rolfe</surname><given-names>F.L.</given-names></name><name><surname>Lockhart</surname><given-names>M.M.</given-names></name><name><surname>Frampton</surname><given-names>C.M.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>J.D.</given-names></name><name><surname>Fung</surname><given-names>V.</given-names></name><name><surname>Smith</surname><given-names>R.A.</given-names></name><name><surname>Murphy</surname><given-names>M.P.</given-names></name><name><surname>Taylor</surname><given-names>K.M.</given-names></name><name><surname>Protect Study</surname><given-names>G.</given-names></name></person-group><article-title>A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson&#x02019;s disease</article-title><source>Mov. Disord.</source><year>2010</year><volume>25</volume><fpage>1670</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1002/mds.23148</pub-id><pub-id pub-id-type="pmid">20568096</pub-id></element-citation></ref><ref id="B283-marinedrugs-17-00282"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaro</surname><given-names>S.</given-names></name><name><surname>Chamorro</surname><given-names>A.</given-names></name></person-group><article-title>Translational stroke research of the combination of thrombolysis and antioxidant therapy</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>1495</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.615039</pub-id><pub-id pub-id-type="pmid">21474803</pub-id></element-citation></ref><ref id="B284-marinedrugs-17-00282"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs-Tarlovsky</surname><given-names>V.</given-names></name></person-group><article-title>Role of antioxidants in cancer therapy</article-title><source>Nutrition</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2012.02.014</pub-id><pub-id pub-id-type="pmid">22784609</pub-id></element-citation></ref><ref id="B285-marinedrugs-17-00282"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>T.</given-names></name></person-group><article-title>Molecular hydrogen: New antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases</article-title><source>Curr. Pharm. Des.</source><year>2013</year><volume>19</volume><fpage>6375</fpage><lpage>6381</lpage><pub-id pub-id-type="doi">10.2174/13816128113199990507</pub-id><?supplied-pmid 23859555?><pub-id pub-id-type="pmid">23859555</pub-id></element-citation></ref><ref id="B286-marinedrugs-17-00282"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Davidson</surname><given-names>B.P.</given-names></name><name><surname>Yue</surname><given-names>Q.</given-names></name><name><surname>Belcik</surname><given-names>T.</given-names></name><name><surname>Xie</surname><given-names>A.</given-names></name><name><surname>Inaba</surname><given-names>Y.</given-names></name><name><surname>McCarty</surname><given-names>O.J.</given-names></name><name><surname>Tormoen</surname><given-names>G.W.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Ruggeri</surname><given-names>Z.M.</given-names></name><etal/></person-group><article-title>Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition</article-title><source>Circ. Cardiovasc. Imaging</source><year>2013</year><volume>6</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.112.975193</pub-id><?supplied-pmid 23239832?><pub-id pub-id-type="pmid">23239832</pub-id></element-citation></ref><ref id="B287-marinedrugs-17-00282"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meydani</surname><given-names>S.N.</given-names></name><name><surname>Meydani</surname><given-names>M.</given-names></name><name><surname>Verdon</surname><given-names>C.P.</given-names></name><name><surname>Shapiro</surname><given-names>A.A.</given-names></name><name><surname>Blumberg</surname><given-names>J.B.</given-names></name><name><surname>Hayes</surname><given-names>K.C.</given-names></name></person-group><article-title>Vitamin E supplementation suppresses prostaglandin E1(2) synthesis and enhances the immune response of aged mice</article-title><source>Mech. Ageing Dev.</source><year>1986</year><volume>34</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/0047-6374(86)90034-5</pub-id><pub-id pub-id-type="pmid">3487685</pub-id></element-citation></ref><ref id="B288-marinedrugs-17-00282"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meydani</surname><given-names>S.N.</given-names></name><name><surname>Barklund</surname><given-names>M.P.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Meydani</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>R.A.</given-names></name><name><surname>Cannon</surname><given-names>J.G.</given-names></name><name><surname>Morrow</surname><given-names>F.D.</given-names></name><name><surname>Rocklin</surname><given-names>R.</given-names></name><name><surname>Blumberg</surname><given-names>J.B.</given-names></name></person-group><article-title>Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects</article-title><source>Am. J. Clin. Nutr.</source><year>1990</year><volume>52</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1093/ajcn/52.3.557</pub-id><?supplied-pmid 2203257?><pub-id pub-id-type="pmid">2203257</pub-id></element-citation></ref><ref id="B289-marinedrugs-17-00282"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekmezci</surname><given-names>D.</given-names></name></person-group><article-title>Vitamin E and immunity</article-title><source>Vitam. Horm.</source><year>2011</year><volume>86</volume><fpage>179</fpage><lpage>215</lpage><?supplied-pmid 21419272?><pub-id pub-id-type="pmid">21419272</pub-id></element-citation></ref><ref id="B290-marinedrugs-17-00282"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salimian</surname><given-names>J.</given-names></name><name><surname>Arefpour</surname><given-names>M.A.</given-names></name><name><surname>Riazipour</surname><given-names>M.</given-names></name><name><surname>Poursasan</surname><given-names>N.</given-names></name></person-group><article-title>Immunomodulatory effects of selenium and vitamin E on alterations in T lymphocyte subsets induced by T-2 toxin</article-title><source>Immunopharmacol. Immunotoxicol.</source><year>2014</year><volume>36</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.3109/08923973.2014.931420</pub-id><?supplied-pmid 24953123?><pub-id pub-id-type="pmid">24953123</pub-id></element-citation></ref><ref id="B291-marinedrugs-17-00282"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>M.</given-names></name><name><surname>Huntley</surname><given-names>M.E.</given-names></name><name><surname>Olaizola</surname><given-names>M.</given-names></name></person-group><article-title>Haematococcus astaxanthin: Applications for human health and nutrition</article-title><source>Trends Biotechnol.</source><year>2003</year><volume>21</volume><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0167-7799(03)00078-7</pub-id><pub-id pub-id-type="pmid">12727382</pub-id></element-citation></ref><ref id="B292-marinedrugs-17-00282"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>G.</given-names></name><name><surname>Sankawa</surname><given-names>U.</given-names></name><name><surname>Goto</surname><given-names>H.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name></person-group><article-title>Astaxanthin, a carotenoid with potential in human health and nutrition</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>443</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1021/np050354+</pub-id><pub-id pub-id-type="pmid">16562856</pub-id></element-citation></ref><ref id="B293-marinedrugs-17-00282"><label>293.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miyashita</surname><given-names>K.A.H.M.</given-names></name></person-group><source>Antiobesity Effect of Allenic Carotenoid, Fucoxanthin</source><publisher-name>Wiley-Blackwell</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2009</year><fpage>145</fpage><lpage>160</lpage></element-citation></ref><ref id="B294-marinedrugs-17-00282"><label>294.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Olaizola</surname><given-names>M.</given-names></name></person-group><article-title>The Production and Health Benefits of Astaxanthin</article-title><source>Marine Nutraceuticals and Functional Foods</source><person-group person-group-type="editor"><name><surname>Barrow</surname><given-names>C.</given-names></name><name><surname>Shahidi</surname><given-names>F.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2007</year><fpage>321</fpage></element-citation></ref><ref id="B295-marinedrugs-17-00282"><label>295.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miyashita</surname><given-names>K.</given-names></name><name><surname>Hosokawa</surname><given-names>M.</given-names></name></person-group><article-title>Beneficial Health Effects of Seaweed Carotenoid, Fucoxanthin</article-title><source>Marine Nutraceuticals and Functional Foods</source><person-group person-group-type="editor"><name><surname>Barrow</surname><given-names>C.</given-names></name><name><surname>Shahidi</surname><given-names>F.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2008</year></element-citation></ref><ref id="B296-marinedrugs-17-00282"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohgami</surname><given-names>K.</given-names></name><name><surname>Shiratori</surname><given-names>K.</given-names></name><name><surname>Kotake</surname><given-names>S.</given-names></name><name><surname>Nishida</surname><given-names>T.</given-names></name><name><surname>Mizuki</surname><given-names>N.</given-names></name><name><surname>Yazawa</surname><given-names>K.</given-names></name><name><surname>Ohno</surname><given-names>S.</given-names></name></person-group><article-title>Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo</article-title><source>Invest. Ophthalmol. Vis. Sci.</source><year>2003</year><volume>44</volume><fpage>2694</fpage><lpage>2701</lpage><pub-id pub-id-type="doi">10.1167/iovs.02-0822</pub-id><pub-id pub-id-type="pmid">12766075</pub-id></element-citation></ref><ref id="B297-marinedrugs-17-00282"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>C.-P.</given-names></name><name><surname>Hou</surname><given-names>Y.-H.</given-names></name></person-group><article-title>First Evidence for the Anti-inflammatory Activity of Fucoxanthin in High-Fat-Diet-Induced Obesity in Mice and the Antioxidant Functions in PC12 Cells</article-title><source>Inflammation</source><year>2014</year><volume>37</volume><fpage>443</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1007/s10753-013-9757-1</pub-id><pub-id pub-id-type="pmid">24146106</pub-id></element-citation></ref><ref id="B298-marinedrugs-17-00282"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>B.</given-names></name><name><surname>Qiao</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Vitamin C: An immunomodulator that attenuates anaphylactic reactions to soybean glycinin hypersensitivity in a swine model</article-title><source>Food Chem.</source><year>2009</year><volume>113</volume><fpage>914</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2008.08.018</pub-id></element-citation></ref><ref id="B299-marinedrugs-17-00282"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenorio-Rodr&#x000ed;guez</surname><given-names>P.</given-names></name><name><surname>M&#x000e9;ndez-Rodr&#x000ec;guez</surname><given-names>L.</given-names></name><name><surname>Serviere-Zaragoza</surname><given-names>E.</given-names></name><name><surname>OHara</surname><given-names>T.</given-names></name><name><surname>Zenteno-Sav&#x000ed;n</surname><given-names>T.</given-names></name></person-group><article-title>Antioxidant substances and trace element content in macroalgae from a subtropical lagoon in the West Coast of the Baja California Peninsula</article-title><source>Vitam Trace Elem</source><year>2013</year><volume>2</volume><fpage>2167-0390</fpage></element-citation></ref><ref id="B300-marinedrugs-17-00282"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornish</surname><given-names>M.</given-names></name><name><surname>Garbary</surname><given-names>D.</given-names></name></person-group><article-title>Antioxidants from macroalgae: Potential applications in human health and nutrition</article-title><source>Algae</source><year>2010</year><volume>25</volume><fpage>155</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.4490/algae.2010.25.4.155</pub-id></element-citation></ref><ref id="B301-marinedrugs-17-00282"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohite</surname><given-names>O.S.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>H.U.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name></person-group><article-title>Genome-Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production</article-title><source>Biotechnol. J.</source><year>2019</year><volume>14</volume><fpage>1800377</fpage><pub-id pub-id-type="doi">10.1002/biot.201800377</pub-id></element-citation></ref><ref id="B302-marinedrugs-17-00282"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>R.G.</given-names></name><name><surname>Olano</surname><given-names>C.</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>C.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Bra&#x000f1;a</surname><given-names>A.F.</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name><name><surname>de la Calle</surname><given-names>F.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>Characterization and engineering of the biosynthesis gene cluster for antitumor macrolides PM100117 and PM100118 from a marine actinobacteria: Generation of a novel improved derivative</article-title><source>Microb. Cell Factories</source><year>2016</year><volume>15</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0443-5</pub-id></element-citation></ref><ref id="B303-marinedrugs-17-00282"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassel</surname><given-names>S.</given-names></name><name><surname>Schewe</surname><given-names>H.</given-names></name><name><surname>Schmidt</surname><given-names>I.</given-names></name><name><surname>Schrader</surname><given-names>J.</given-names></name><name><surname>Sandmann</surname><given-names>G.</given-names></name></person-group><article-title>Multiple improvement of astaxanthin biosynthesis in Xanthophyllomyces dendrorhous by a combination of conventional mutagenesis and metabolic pathway engineering</article-title><source>Biotechnol. Lett.</source><year>2013</year><volume>35</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1007/s10529-012-1103-4</pub-id><pub-id pub-id-type="pmid">23187756</pub-id></element-citation></ref><ref id="B304-marinedrugs-17-00282"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blazeck</surname><given-names>J.</given-names></name><name><surname>Alper</surname><given-names>H.</given-names></name></person-group><article-title>Systems metabolic engineering: Genome-scale models and beyond</article-title><source>Biotechnol. J.</source><year>2010</year><volume>5</volume><fpage>647</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1002/biot.200900247</pub-id><pub-id pub-id-type="pmid">20151446</pub-id></element-citation></ref><ref id="B305-marinedrugs-17-00282"><label>305.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>S.</given-names></name><name><surname>Conway</surname><given-names>M.</given-names></name><name><surname>Li&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Angione</surname><given-names>C.</given-names></name></person-group><article-title>Optimization of Multi-Omic Genome-Scale Models: Methodologies, Hands-on Tutorial, and Perspectives</article-title><source>Metabolic Network Reconstruction and Modeling: Methods and Protocols</source><person-group person-group-type="editor"><name><surname>Fondi</surname><given-names>M.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2018</year><fpage>389</fpage><lpage>408</lpage></element-citation></ref><ref id="B306-marinedrugs-17-00282"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Fischbach</surname><given-names>M.A.</given-names></name></person-group><article-title>Computational approaches to natural product discovery</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>639</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1884</pub-id><pub-id pub-id-type="pmid">26284671</pub-id></element-citation></ref><ref id="B307-marinedrugs-17-00282"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.Q.</given-names></name></person-group><article-title>Genome-based studies of marine microorganisms to maximize the diversity of natural products discovery for medical treatments</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2011</year><volume>2011</volume><fpage>384572</fpage><pub-id pub-id-type="doi">10.1155/2011/384572</pub-id><pub-id pub-id-type="pmid">21826184</pub-id></element-citation></ref><ref id="B308-marinedrugs-17-00282"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>Y.-J.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name></person-group><article-title>Metabolic engineering of Escherichia coli using CRISPR&#x02013;Cas9 meditated genome editing</article-title><source>Metab. Eng.</source><year>2015</year><volume>31</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2015.06.006</pub-id><pub-id pub-id-type="pmid">26141150</pub-id></element-citation></ref><ref id="B309-marinedrugs-17-00282"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>L.</given-names></name><name><surname>Ran</surname><given-names>F.A.</given-names></name><name><surname>Cox</surname><given-names>D.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Barretto</surname><given-names>R.</given-names></name><name><surname>Habib</surname><given-names>N.</given-names></name><name><surname>Hsu</surname><given-names>P.D.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Marraffini</surname><given-names>L.A.</given-names></name><etal/></person-group><article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1126/science.1231143</pub-id><?supplied-pmid 23287718?><pub-id pub-id-type="pmid">23287718</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="marinedrugs-17-00282-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structure of anti-inflammatory and immunomodulatory marine-derived compounds.</p></caption><graphic xlink:href="marinedrugs-17-00282-g001"/></fig><fig id="marinedrugs-17-00282-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic diagram showing omics data analysis and genome-scale metabolic modelling for improvement of production.</p></caption><graphic xlink:href="marinedrugs-17-00282-g002"/></fig><table-wrap id="marinedrugs-17-00282-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00282-t001_Table 1</object-id><label>Table 1</label><caption><p>Marine bacteria and their therapeutic chemical constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immunomodulatory Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref(s)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aplidium albicus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclic depsipeptide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo activity in the plasmocytoma murine model of xenograft. Applidine exhibits antimyeloma activity in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-marinedrugs-17-00282" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nocardiopsis</italic> sp. K-252, <italic>Nonomuraea longicatena</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lestaurtinib (Alkaloid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent PKC and calmodulin inhibitor. Prevents myelin oligoglycoprotein induced encephalomyelitis in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-marinedrugs-17-00282" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bryozoa neritina</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bryostatin polyketide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits antitumor activity against malignant melanoma. IL-6 and TNF-<italic>&#x003b1;</italic> levels rise in patients within 24 hours of the treatment.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-marinedrugs-17-00282" ref-type="bibr">32</xref>,<xref rid="B33-marinedrugs-17-00282" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Micrococcus luteus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-Micrococcus luteus antibodies</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunosuppressive potential through the expansion of immunoregulatory T cell subsets.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-marinedrugs-17-00282" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Trididemnum solidum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Didemnin B (Depsipeptides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits strong anti-inflammatory and immunosuppressive activity. The expression of iNOS and NF-<italic>&#x003ba;</italic>B was inhibited in vitro.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-marinedrugs-17-00282" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-17-00282" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bacillus licheniformis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPS 1-T14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulates Th1 cell-mediated immunity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-marinedrugs-17-00282" ref-type="bibr">23</xref>,<xref rid="B24-marinedrugs-17-00282" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Thermus aquaticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPS TA-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encourages the TLR2-dependent release of TNF-<italic>&#x003b1;</italic> and IL-6 in murine macrophages.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-marinedrugs-17-00282" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Serratia marcescens, Vibrio psychroerythrus, Pseudoalteromonas denitrificans &#x00026; Zooshikella rubidus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prodigiosin &#x00026;<break/>Cycloprodigisin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory. Inhibits the activation of TNF-<italic>&#x003b1;</italic> induced NF-<italic>&#x003ba;</italic>B.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-17-00282" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-17-00282" ref-type="bibr">28</xref>,<xref rid="B37-marinedrugs-17-00282" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Bacillus</italic> sp. HC001, <italic>Piscicoccus</italic> sp. 12L081</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diketopiperazines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory. Downregulates the release of TNF-<italic>&#x003b1;</italic> and IL-6 and suppress NF-<italic>&#x003ba;</italic>B expression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-marinedrugs-17-00282" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Salinispora arenicola</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arenamides<break/>(Cyclic depsipeptide)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocks TNF-<italic>&#x003b1;</italic> in RAW 264.7 and human embryonic kidney cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-marinedrugs-17-00282" ref-type="bibr">38</xref>,<xref rid="B39-marinedrugs-17-00282" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces</italic> sp. SCRC-A20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aburatubolactams</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant. Inhibits TPA-induced superoxide anion generation in human neutrophils.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-marinedrugs-17-00282" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces</italic> sp. CNB-982</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyclomarins (Heptapeptides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory. Inhibits oedema and pain in vivo.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-marinedrugs-17-00282" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salinamides (Peptides)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory on phorbol ester-induced oedema mouse.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B42-marinedrugs-17-00282" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces strain</italic> CNQ43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Splenocin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory. Potent inhibitors of pro-inflammatory cytokine IL-5, IL-13 and TNF-<italic>&#x003b1;</italic>.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-marinedrugs-17-00282" ref-type="bibr">43</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>EPS, exopolysaccharide; iNOS, inducible nitric oxide synthase; IL, interleukin; NF-<italic>&#x003ba;</italic>B nuclear factor-<italic>&#x003ba;</italic>B; PKC, protein kinase C; TPA, 12-O-tetradecanoylphorbol-13-acetate; TLR, toll-like receptor; TNF, tumor necrosis factor.</p></fn></table-wrap-foot></table-wrap></floats-group></article>